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“The man who believes that the secrets of the world are forever hidden lives in mystery and fear. 
Superstition will drag him down. The rain will erode the deeds of his life. But that man who sets 
himself the task of singling out the thread of order from the tapestry will by the decision alone 
have taken charge of the world and it is only by such taking charge that he will effect a way to 
dictate the terms of his own fate.” 
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 Precisely tuned regulation of pre and post-synaptic communication depends on the 
coordinated action of protein synthesis and degradation mechanisms to shape the synaptic 
landscape.  The mechanistic target of rapamycin complex 1 (mTORC1), a kinase involved in 
regulating translation initiation, has recently emerged as a critical player responsible for 
orchestrating dynamic changes in local protein synthesis in response to altered synaptic activity. 
Here we identify a novel mode of synaptic regulation conferred by local mTORC1-dependent 
signaling in dendrites, wherein mTORC1 activation gates a local retrograde signaling mechanism 
that drives changes in presynaptic function from apposed postsynaptic terminals. This unique 
trans-synaptic role for dendritic mTORC1 signaling is critically dependent on BDNF release, 
which serves to couple loss of excitatory synaptic drive with retrograde compensation of 
presynaptic function. Acute activation of mTORC1 signaling using the lipid second messenger 
phosphatidic acid (PA) or overexpression of the endogenous mTOR activation RhebGTPase is 
sufficient to exert a powerful influence on network function, which is also critically dependent 
on dendritic synthesis of BDNF as a retrograde signal. We identify an additional feature of the 
putative postsynaptic homeostatic sensor mechanism, showing that phospholipase D (PLD)-
mediated hydrolysis of the lipid second messenger phosphatidic acid (PA) is a crucial component 
of the signaling pathway which relays homeostatic signals to postsynaptic mTORC1 after loss of 
excitatory input. Lastly, we find that mTORC1-dependent retrograde signaling acts in 
coordination with dynamic relocalization of the ubiquitin proteasome system to and from axonal 




We show that increasing neuronal firing rates enriches proteasome accumulation at synaptic 
terminals, whereas inhibiting neuronal firing results in a dramatic redistribution away from 
synaptic terminals to non-synaptic areas. This altered localization is due, at least in part, to an 
activity-dependent active sequestration mechanism at presynaptic terminals. Moreover, activity-
dependent phosphorylation of the Rpt6 subunit of the 19S proteasome is necessary and sufficient 
for axonal proteasome redistribution, and this altered localization plays a critical role in 
establishing mTORC1-dependent retrograde homeostatic changes in presynaptic function after 
loss of postsynaptic drive. Several monogenic neurodevelopmental conditions related to Autism 
Spectrum Disorder and Intellectual Disability share the common molecular phenotype of 
increased mTORC1 signaling. As such, a more thorough understanding of how mTORC1 
regulates synaptic function may provide insights for targeting this signaling pathway as a 














         In even the simplest of organisms, the cells of the nervous system are embedded in a 
complex array of individual units whose connections are subject to dynamic regulation. 
According to our current understanding, information is thought to be represented, processed or 
stored in this cellular lattice via a process that either depends on or itself elicits changes in the 
efficiency of signal transfer between individual synaptic contacts. We now have a detailed, if far 
from complete, biochemical account of various forms of synaptic plasticity that follow a positive 
feedback system: so-called Hebbian forms of plasticity such as long term potentiation (LTP) and 
long term depression (LTD) would fall into this category. Far less understood are types of 
plasticity involving synaptic adaptations to disruptive perturbations in baseline function, 
commonly described as “homeostatic”. This form of plasticity has been a topic of intensive study 
in recent years, and much effort has been spent in defining the phenomenon in functional terms 




(Poza and Goda, 2010), and advancing new conceptual approaches borrowed from control theory 
which may aid in our understanding of its proper physiological role (O‟Leary and Wyllie, 2011). 
One defining feature of many forms of neuronal plasticity is a requirement for new protein 
synthesis in the implementation of persistent changes in synapse function (Kelleher et al., 2004). 
While altered gene expression is a critical for many aspects of long-lasting plasticity (Redondo 
and Morris, 2011), we now have a growing appreciation for the important role played by 
localized protein synthesis in dendrites (Sutton and Schuman, 2006). However, our 
understanding of how localized changes in protein translation may contribute to homeostatic 
forms of synaptic plasticity remains limited. The work presented here reflects an attempt to 
address a potential role for dendritic protein synthesis during the induction or maintenance of 
homeostatic changes in synaptic strength. Specifically, we have elucidated a novel function of 
the mechanistic target of rapamycin complex 1 (mTORC1) in a form of homeostatic plasticity 
involving fast acting, postsynaptic modulation of presynaptic function via a dendritically 
synthesized retrograde signal.  We find that postsynaptic mTORC1 signaling regulates local 
translation of BDNF in dendrites, which functions to modulate neurotransmitter release from 
apposed presynaptic terminals. We then establish in greater mechanistic detail, the manner in 
which this form of synaptic homeostasis is implemented, revealing a role for postsynaptic 
phospholipase-D signaling in its induction, and activity dependent redistribution of the ubiquitin 
proteasome system in its expression. As a means of providing proper context and background for 
the work presented in subsequent chapters, what follows is a focused review of the cellular and 
molecular mechanisms involved in localized translation regulation in dendrites, an introduction 




a summary of what is currently known about how local regulation of dendritic protein synthesis 
specifically mediates homeostatic forms of synaptic plasticity. 
 
1.2 Localized translational control in dendrites: Mechanistic overview and cellular 
phenomenology 
 
1.2.1 Translation initiation as a critical point of regulation 
 Protein translation occurs in three discrete stages, progressing through phases of 
initiation, elongation, and termination. Though there is evidence for each of these processes 
being highly regulated, it is generally believed that the signaling pathways which regulate 
translational control act on the initiation phase, which is the rate limiting step during which the 
ribosome is recruited to the mRNA (Roux and Topisirovic, 2012). At any given point in the life 
of a cell, the global population of mRNAs undergoing active translation is influenced by a wide 
range of intracellular and extracellular signaling cues, including nutrient availability, energy 
status, stress-related factors, or hormone and growth factor-induced signals (Sonenberg and 
Hinnebusch, 2009). Ultimately, this multitude of intra- and extracellular signals converge on a 
limited number of core pathways devoted to controlling translation initiation, largely via 
phosphorylation of numerous eukaryotic initiation factors (eIFs), of which at least 12 have been 
identified (Aitken and Lorch, 2012). These critical signaling pathways involve the activity of 
multiple interacting components, including PAK2, Cdk11, GSk3 and CK2 (Roux and 
Topisirovic, 2012). Among these, two pathways in particular are widely regarded as central to 
the dynamic control of translation initiation: the mechanistic target of rapamycin complex 1 




 The mechanistic target of rapamycin (mTOR) is a serine/threonine kinase which has a 
vital, evolutionarily conserved role in mediating cellular responses to stress and nutrient levels, 
and orchestrates cell growth and proliferation (Ma and Blenis, 2009). When associated with its 
binding partner raptor, mTOR operates in a collection of proteins known as mTOR complex 1 
(mTORC1), other components of which include mLST8, PRAS40, and Deptor (Laplante and 
Sabatini, 2012). mTORC1 signaling can be influenced by a number of upstream signals 
emanating from phosphpoinositde 3-kinase (PI3K), AMPK, Ras/MAPK, or the RagGTPses (Hay 
and Sonenberg, 2004). Among the stimuli which impinge on these pathways and thus alter 
mTORC1-dependent control of protein translation, include growth factors, hormones, signals of 
energy status, and the availability of essential factors such as oxygen and amino acids (Laplante 
and Sabatini, 2012). Whether unique sets of stimuli recruit mTORC1 signaling in neurons is 
currently an open question, though one of central importance to the work presented in later 
chapters. mTORC1 has a number of well characterized downstream targets, including  the 
p70S6Ks, eIF4E-binding proteins (4E-BPs), growth factor receptor-bound protein 10 (Grb10) 
and hATG1. Among these substrates, the effects of S6K and 4E-BP phosphorylation are the most 
thoroughly understood with respect to mTORC1-dependent regulation of translation initiation. 
When not phosphorylated, 4E-BP acts as a translational repressor, out-competing eIF4G for 
association with eIF4E, thus impairing formation of the eIF4F initiation complex (Pause et al., 
1994). mTORC1 phosphorylates 4E-BP in a two-step process beginning at Thr37/Thr46, which 
biases subsequent phosphorylation at Ser65 and Thr70 (Gingras et al., 2001), resulting in the 
dissociation of 4E-BP from eIF4E and disinhibition of eIF4F complex formation. p70S6Ks, the 
other major players in mTORC1-mediated translational control, are members of the AGC kinase 




2011). S6Ks do not impinge on the translational machinery directly but instead influence the 
translation initiation process via phosphorylation of several downstream targets including eIF4B, 
programmed cell death 4 protein (PDCD4), and ribosomal protein S6. Phosphorylation of eIF4B 
promotes eIF4A-mediated helicase activity at secondary structures in the mRNA 5‟UTR, thereby 
facilitating the scanning process by which 40S ribosomal subunits encounter initiation codons 
(Parsyan et al., 2011). PDCD4 normally serves to inhibit translation by binding to eIF4A and 
limiting assembly of the eIF4F preinitiation complex (Yang et al., 2003). Upon phosphorylation 
by p70S6K, PDCD4 is rapidly degraded by the ubiquitin proteasome system, thus releasing its 
inhibitory brake on translation (Dorello et al., 2006). Through phosphorylation of ribosomal 
protein S6 at 235/236 is a commonly used readout of mTORC1 kinase activity, the mechanism 
by which rpS6 influences translation initiation is not well understood. Indeed, MEFs harvested 
from knock-in mice containing alanine substitutions at all five phosphorylatable serine residues 
in rpS6 actually exhibit enhanced rates of protein synthesis (Ruvinsky et al., 2005), highlighting 
a complex role for rpS6 in translation initiation that require further characterization. Though 
mTORC1-mediated phosphorylation of p70S6K and 4E-BP are both vital for regulation of 
translation initiation, there is evidence to suggest divergent functional roles attributed to each, 
with the 4E-BPS largely playing a role in cell proliferation (Dowling et al., 2010), while 
activation of S6K mediates cell growth (Ohanna et al., 2005).  Interestingly, while 4E-BP2 
knockout mice display enhanced L-LTP resulting from disinhibited translation (Banko et al., 
2005), neither S6K1 nor S6K2 knockout mice exhibit any functional alterations in protein-
synthesis-dependent LTP (Antion et al., 2008), suggesting that a similar type of functional 
divergence in 4E-BP and S6K-mediated translational control might also be present in post-




 MAPKs are ubiquitously expressed in eukaryotic cells and are involved in a variety of 
fundamental processes, including cell division, differentiation, motility, growth, and apoptosis 
(Pearson et al., 2001). The most commonly studied MAPKs, including ERK1/2, JNKs, and p38, 
exert their influence largely via phosphorylation of other kinases termed MAPK-activated 
protein kinases (MAPKAPKs). Of the multiple MAPKAPKs which have been identified, two 
have been directly linked to the regulation of translation initiation: MNK and RSK. MNK is 
believed to regulate formation of the preinitiation complex via phosphorylation of eIF4E at 
Ser209 (Waskiewicz et al., 1997). Though we do not have a complete understanding of how 
MNK‟s activity at eIF4E influences translation initiation, it has been suggested that 
phosphorylation of eIF4E changes its ability to bind the 5‟-mRNA cap, given the relative 
location of the critical S209 residue to eIF4E‟s cap-binding region (Topisirovic et al., 2011). The 
RSK family, which is preferentially activated via ERK1/2 signaling (Carriere et al., 2008), 
regulates translation initiation through phosphorylation eIF4B, which enhances its affinity for the 
eIF3 complex (Shahbazian et al., 2006), and catalyzes eIF4A helicase activity (Rozen et al., 
1990).  Interestingly, RSK has also been shown to phosphorylate several core components of the 
mTOR signaling pathway including TSC2, Raptor, and Deptor (Mendoza et al., 2011), 
highlighting a potential role for shared feedback between the two major signaling arms involved 
in the regulation of translation initiation.  
  
1.2.2 Local translation in dendrites: mRNA targets 
         Though many forms of synaptic plasticity and learning models are known to depend 
crucially on new protein synthesis (Huang et al., 1996), for many years research in this area 




response to plasticity-inducing stimuli. Interest in a potential role for localized control of protein 
synthesis at the level of translation in dendrites did not arrive until many years later with the 
discovery of polysomes in distal regions of dentate granule cells (Steward and Levy, 1982). This 
finding extended the initial discovery of ribosomes localized out in the proximal dendrites of 
primate spinal neurons (Bodian, 1965), and catalyzed the field to reassess the potential for local 
regulation of translation in the context of synaptic plasticity. Work from Schuman and colleagues 
provided the first functional demonstration of a requirement for local protein synthesis in 
dendrites in a form of synaptic plasticity in the mammalian brain (Kang and Schuman 1996). 
Findings from multiple labs have since verified a role for dendritic translation in various forms 
of synaptic plasticity, with multiple studies having provided functional evidence for the local 
synthesis of CamKIIa (Ouyang et al., 1999; Miller et al., 2002), AMPA receptor subunits 
(Grooms et al., 2006), NMDA receptor subunits (Benson, 1997), brain-derived neurotrophic 
factor (BDNF; Liao et al., 2012), Arc (Steward and Worley, 2001), and components of the 
translational machinery itself (Tsokas, et al., 2005). A comprehensive identification of the pool 
of dendritically localized mRNA transcripts subject to local translation regulation has been 
heavily sought after (Poon et al., 2006; Zhong et al., 2006), yet a comparison of recent attempts 
to characterize this group reveals a disconcertingly small degree of overlap among the multiple 
lists of putative dendritic transcripts generated by multiple labs. Recently, Schuman and 
colleagues (Cajigas et al., 2011) utilized an approach involving deep sequencing of extracted 
RNA from micro-dissected synaptic neuropil to generate what they consider to be a 
comprehensive list of the dendritic transcriptome in area CA1 of the rat hippocampus. In an 
effort to avoid spurious inclusion of any putative mRNA on the master list, the authors 




mRNA visualization strategy. After subtracting transcripts that were experimentally determined 
to be enriched in glial or somatic preparations and controlling for contamination from 
mitochondrial or blood vessel derived genes, Schuman and colleagues were left with a group of 
2550 transcripts believed to be uniquely localized to neuronal dendrites.  This deep sequencing 
approach, which has extraordinary utility in detecting transcripts of low abundance, revealed that 
levels of dendritically localized transcripts differed by as much as three orders of magnitude.  
These results have important implications for future efforts to understand how dendrites may 
utilize localized translation regulation to homeostatically regulate synaptic strength.  
 
1.3 Homeostatic plasticity: Global and local adaptive changes in synapse function 
1.3.1 Achieving homeostasis: set points, sensors and feedback control 
 Forms of neuronal plasticity that have been deemed „homeostatic‟ encompass a wide 
range of functional changes (Davis and Bezprozvanny, 2001; Marder and Goaillard, 2006; Lee et 
al., 2013). It will useful at the outset to define certain core features of homeostatic processes that 
are common to both biological and engineered systems, and to orient these features with respect 
to maintenance of synaptic function. As a foundational principle, homeostatic systems are those 
which display a constant output (Davis 2006). This output level is defined by a set point, which 
is either explicitly established or arises as an emergent property of many interacting forces. 
Taking neuronal firing properties as an example, it has been suggested that a set point for 
neuronal activity might be genetically defined via terminal selector transcription factors, akin to 
the process of cell fate specification (Davis, 2013, Hobert, 2011). However, as revealed by the 
pioneering work of Eve Marder‟s group and others, nearly indistinguishable firing properties can 




to argue for an emergent, rather than precisely defined set point (Marder, 2011). Regardless of 
how it is defined, all homeostatic systems are equipped with sensors to detect deviations out of 
the appropriate output range established by the set point. Several putative homeostatic sensors 
have been identified in neurons, though accumulating evidence suggests that multiple sensors 
likely act simultaneously throughout the cell to regulate several homeostatically constrained 
aspects of neuronal function, as discussed below. Lastly, once outside the critical output range 
defined by the setpoint, homeostatic systems enact feedback control, mediated by „effector‟ 
mechanisms, to return output levels to an acceptable range. Undoubtedly, neurons are endowed 
with a multitude of such effector mechanisms, the molecular identity of which corresponds to the 
particular feature of neural activity being regulated. Indeed, homeostatic forms of plasticity in 
neurons are believed to operate via three well-characterized types of changes, and as such, 
effector mechanisms at work in a given form of synaptic homeostasis are those that typically 
regulate shifts in intrinsic excitability, postsynaptic receptor content, or presynaptic release 
characteristics.  
 
1.3.2 Possibility of multiple homeostatic sensors 
 The original characterization of the phenomenon now referred to as homeostatic 
plasticity were conducted by Turrigano and colleagues, who used dissociated cortical neurons to 
examine the impact of chronic changes in neuronal activity on synapse function driven by 
prolonged exposure to the voltage-gated Na-channel blocker TTX, or the ionotrpic GABA-A 
receptor blocker Bicuculine (Turrigiano et al., 1998). Prolonged periods of increased or 
decreased neuronal activity, after Bicuculine or TTX treatment, respectively, elicited a response 




miniature excitatory postsynaptic current (mEPSC) amplitude. These initial observations implied 
a “global” shift in postsynaptic strength at every synapse across the cell. Conceptually, this has 
proven to be a logically appealing explanation for how neurons achieve the task of implementing 
changes in overall excitability while preserving relative synaptic weights of potentiated and 
depressed synapses distributed across the dendritic arbor (Turrigiano et al., 2011). Similar types 
of experiments utilizing pharmacological manipulation of synaptic responsiveness or spike rates 
have driven the field of homeostatic plasticity through much of its development.  Though these 
types of approaches have the advantage of ease of use, they are coarse manipulations and may 
obscure the nature of the neuronal homeostat and the types of stimuli to which it may be 
sensitive. This problem is particularly relevant in experiments in dissociated cells where 
manipulations primarily designed to perturb spike rates (TTX, Bicuculine) also exert effects on 
levels of synaptic input. It has long been an assumption that homeostatic mechanisms operate in 
neurons in order to maintain firing rates within some defined range (Turrigiano and Nelson, 
2004; Turrigiano 2008). This assumption is not without reason, as cells are clearly sensitive to 
prolonged changes in spike output.  For example, cell-autonomous silencing of action potential 
firing via somatic-localized perfusion of TTX triggers compensatory increases in AMPAR 
content (Ibata et al., 2008). Additionally, diminished spike rate via overexpression of the 
inwardly rectifying K+ channel Kir2.1 results in an increase in both synapse number and 
function, depending on developmental time period at which experimental manipulations are 
performed (Burrone et al., 2002). This sensitivity to firing rate is bidirectional, as prolonged 
elevation of spike output via intermittent optical stimulation in ChR2 expressing cells leads to 
adaptive decrements in both AMPAR and NMDAR currents (Goold and Nicoll, 2010). These 




rates, and utilizes changes in transcriptional output to exert cell wide changes in synapse number 
or function. Such a mechanism would correspond well with proposed utility of global forms of 
“synaptic scaling” (Turrigiano, 2008). 
         Likely operating in concert with homeostatic sensors of cell firing rate, powerful 
evidence from recent studies suggests that an additional homeostatic mechanism may be at work 
inside neurons; one sensitive to changes in and designed to regulate ongoing levels of synaptic 
input. A putative synaptic homeostat operating in neuronal dendrites would be well positioned to 
influence both pre and post synaptic function in an effort to align the rate and intensity of 
information transfer across the synaptic cleft. Indeed, it has been know for several years that the 
functional properties of presynaptic inputs are exquisitely sensitive to the identity and activity 
levels of their postsynaptic partners. For example, Ca2
+
 influx and vesicle release properties at 
individual boutons from a single pyramidal cell show different characteristics depending on 
whether they form synapses onto bitufted or multipolar interneurons (Koester and Johnston, 
2005). More recently, the release probability of axon terminals emanating from a single cell were 
shown to differ markedly when forming synapses on different branches of the same target cell, 
with synapses impinging on the same branch displaying similar rates of vesicle release (Branco 
et al., 2008). Remarkably, presynaptic release properties were demonstrated to adaptively 
compensate for branch-specific changes in depolarization, implying the existence of a locally 
implemented homeostatic mechanism that regulates steady-state levels of synaptic 
communication (Branco et al., 2008). A complementary set of experiments making use of novel 
genetic approaches to manipulate activity levels at individual synaptic inputs have demonstrated 
that single synapses can actually exhibit robust homeostatic responses. For instance, excitatory 




via overexpression of Kir2.1, display increases in immunoreactivity against AMPAR subunits 
(Hou et al., 2008) and enhanced AMPAR current evoked by focal uncaging of glutamate (Beique 
et al., 2011). This effect is bidirectional, as repeated activation of individual excitatory synapses 
via light-activated glutamate receptors (LiGluR) results in NMDAR-dependent endocytosis of 
AMPARs and a weakening of synaptic strength (Hou et al., 2011). These experiments suggest 
that at least one set of mechanisms involved in responding to deviations from a putative set point 
are sensitive to small changes in synaptic input, perhaps via “sensors” at individual synapses or 
dendritic branches.  
         These data highlight a growing recognition of the important differences between globally 
and locally manifested forms of synaptic homeostasis, but it is possible to distinguish unique 
signaling pathways or induction paradigms that would indicate mechanistically unique sensors 
for synaptic input and spike rate?  Work from the Chen lab suggests that Retinoic Acid (RA) 
synthesis might function in a pathway sensitive to synaptic blockade but not action potential 
(AP) inhibition. Postsynaptic adaptation produced by prolonged AP blockade (TTX, 48Hr) is 
blocked by transcription inhibitors such as actinomysin-D, is not sensitive to blockers of RA 
synthesis such as DEAB (Soden and Chen, 2010), and does not promote internal RA-synthesis 
(Wang et al., 2011A). In contrast, postsynaptic compensation induced via concurrent AP + 
excitatory synapse blockade (TTX+APV) is not sensitive to transcription inhibition, and reliably 
results in internal RA synthesis.  Another clear indication that AP blockade alone exerts effects 
on synaptic strength that are mediated by a separate pathway than that utilized in response to 
blockade of synaptic receptors comes from the work of Hall and colleagues (Wang et al., 
2011B). Neurons from transgenic mice in which the GluN2B subunit of the NMDAR is replaced 




impairment in excitatory neurotransmission, yet are completely deficient in synaptic 
compensation under conditions of TTX+APV treatment. After prolonged periods of pike 
blockade with TTX, however, these cells exhibit homeostatic increases in mEPSC amplitude that 
are identical to responses seen in neurons from WT mice (Wang et al., 2011B).  Collectively, 
these data point to the existence multiple components acting as part of a locally implemented 
homeostatic response system operating in dendrites, the molecular identities of which are just 
beginning to be reveled.  
 
1.3.3 Trans-synaptic signaling by retrograde signals during HSP 
 The type of locally implemented, dynamic coupling between pre and postsynaptic 
function described by Branco et al. (2008) implies the existence of a retrograde signaling 
mechanism that could signal changes in postsynaptic responsiveness to the presynaptic neuron. 
This type of retrograde homeostatic signal has been extensively characterized at the drosophila 
neuromuscular junction (NMJ). For example, knockdown of GluAII subunits (DiAntonio et al., 
1999; Petersen et al., 1997) or postsynaptic overexpression of a constitutively active variant of 
PKA (Davis et al., 1998), results in dramatically reduced responsiveness of the muscle cell to 
presynaptically released glutamate vesicles. After this reduction in postsynaptic responsiveness, 
the synapse compensates by increasing presynaptic release probability, thus restoring the total 
charge transfer measured in response to evoked stimulation back to control levels. Mutations in 
genes which regulate glutamate receptor clustering in the muscle, including the Rho-type 
GTPase effector gene Pak (Albin and Davis, 2004), NFKB and IKB (Heckscher et al., 2007), 
and nanos (Menon et al., 2009) also result in similar types of compensatory changes in 




protocol for inducing a similar type of homeostatic response by using the GluA1 subtype-
selective AMPA receptor antagonist Philanthotoxin-433 (PhTx) to attenuate postsynaptic 
responsiveness at the fly NMJ (Frank et al., 2006). This form of synaptic homeostasis is notable 
for the speed in which it emerges, operating on the time scale of minutes rather than hours or 
days. Having a pharmacological means of inducing synaptic homeostasis at this synapse has 
proven extremely useful in that it made feasible forward genetic screens to search for mutants 
with deficits in specific aspects of the homeostatic response. A number of molecules that control 
specific features of synaptic homeostasis have been identified using this approach in recent 
years, many of which serve the role of presynaptic effectors. These include, but are not limited 
to, Cacaphony (Frank et al, 2006), Eph (Frank et al., 2009), Ephexin (Frank et al., 2009), Cdc42 
(Frank et al., 2009), Dysbindin (Dickman and Davis, 2009), Rab3-GAP (Muller et al., 2011), 
SNAP25 (Dickman et al., 2012), RIM (Muller et al., 2012), and Snapin (Dickman et al., 2012). 
However, despite its utility as an experimental model, there appear to be crucial differences in 
how this fast form of homeostasis is implemented compared with more chronic manipulations. 
Crucially, PhTx-induced homeostasis is not protein synthesis dependent and does not require 
presynaptic spiking for its expression (Frank et al., 2006), two factors which, as we will see, are 
absolutely vital for the types of similar homeostatic responses observed at mammalian central 
synapses. 
 Muscle cells are not only sensitive to changes in glutamate receptor function, however. It 
seems any number of manipulations that serve to reduce steady-state levels of postsynaptic 
depolarization will also recruit trans-synaptic homeostatic signals to increase presynaptic release 
and restore signal transfer across the synapse. For example, muscle-specific expression of the 




resting membrane potential compared to control cells. Similar to the result seen in GluAII 
mutants, Kir2.1 expressing synapses exhibit a compensatory increase in presynaptic release 
probability (Paradis et al., 2004). When mutations in the cell adhesion molecule Fasciclin II were 
used to misdirect synapse formation at individual muscles, the question of whether postsynaptic 
cells are sensitive to relative amounts of presynaptic innervation could be addressed directly. 
Recording from neighboring muscle cells in the same animal, Davis and colleagues were able to 
show that postsynaptic cells which receive fewer synaptic connections have increased quantal 
content, while those with abnormally high levels of innervation exhibit a reduction in presynaptic 
release (Davis and Goodman, 1998). These later findings are very much in line with the 
previously detailed characterization of functional compensation across individual boutons along 
an axon in response to dendrite branch-specific changes in levels of depolarization (Branco et al., 
2008). To reiterate a point introduced at the start of this section, this form of constitutive 
feedback between pre- and postsynaptic compartments would be ideally implemented by release 
of retrograde signal whose synthesis is under some degree of homeostatic control.  
 Accumulating evidence clearly demonstrates the general utility retrograde signaling as 
means of matching pre and post-synaptic efficacy (Regehr et al., 2009). Though the preceding 
studies were conducted at the fly NMJ, there is accumulating evidence that a similar type of 
homeostatic mechanism in which postsynaptic deprivation results in presynaptic augmentation 
also operates at mammalian central synapses.  Using a combination of ultrastructural analysis 
and FM1-43 based assessment of presynaptic release, Murthy and colleagues provided an initial 
characterization of this form of plasticity, revealing increases in the number of docked vesicles 
and size of the readily releasable pool (RRP) after 48 Hr of AMPAR blockade with NBQX 




the frequency of spontaneous miniature excitatory postsynaptic currents (mEPSCs) in dissociated 
hippocampal neurons (Thiagarajan et al., 2002).  Though this is contrary to the originally 
reported observation of no change in mEPSC frequency after chronic CNQX-treatment in 
cortical neurons (Turrigiano et al., 1998), similar homeostatic changes in presynaptic function 
have been observed after loss of AMPAR input across multiple labs and cell types (Thiagarajan 
et al., 2005; Gong et al., 2007; Wang et al., 2011).  
 Further solidifying the mechanistic link to the homeostatic phenomenon characterized at 
the drosophila NMJ, work from our lab and others have identified a critical role for retrograde 
signaling in the expression of presynaptic augmentation after AMPAR blockade (Jakawich et al., 
2010; Lindskog et al., 2010; Groth et al., 2010). The specific molecular players involved in this 
retrograde signaling may be a point of evolutionary divergence between mammals and 
invertebrates, however. While BDNF has been identified as the retrograde signal at work in 
hippocampal neurons (Jakawch et al., 2010), orthologs of BDNF do not exist in the fly. Instead, 
several studies have shown that the muscle-derived BMP ligand Glass Bottom Boat (Gbb) may 
act as a retrograde signal via the presynaptic receptor Wishful Thinking (Wit) during forms of 
synaptic homeostasis induced by either PhTx or GluRIIA knockout at the fly NMJ (Haghighi et 
al., 2003; Goold and Davis, 2007).  
 
1.4 Local protein synthesis during HSP: Initial findings 
         The first demonstration of a role for dendritic translation in homeostatic plasticity came 
from experiments involving simultaneous blockade of NMDA-type glutamate receptors 
(NMDARs) with APV and action potentials (AP) with TTX (Sutton et al., 2006). Similar to the 




simultaneous inhibition of spike activity and NMDAR function (TTX+APV) resulted in a 
protein synthesis-dependent increase in the amplitude of spontaneous mEPSCs in cultured 
hippocampal neurons as well as in acute hippocampal slices (Sutton et al, 2006).  At the time, the 
speed at which this effect emerged was much faster than had been observed in the context of 
spike blockade alone (1-3 Hrs vs 24 Hrs or more; though see Ibata et al., 2008), highlighting a 
potential unique contribution of translation rather than transcription. Experiments utilizing local 
microperfusion across spatially restricted regions of the dendrite provided clear evidence for the 
importance of dendritc protein synthesis in this phenomenon: local perfusion of APV induced an 
anisomycin-sensitive increase in GluA1 subunits in the perfused region, while local perfusion of 
ansiomysin under conditions of bath NMDAR blockade resulted in a relative decrement in 
GluA1 subunit immunoreactivity in the perfused region (Sutton et al., 2006). This was the first 
indication that spatially restricted alterations in activity could induce homeostatic changes in 
synaptic protein content, and provided further support for the important role of ongoing 
spontaneous neurotransmission in stabilizing levels of protein synthesis at the synapse (Sutton et 
al., 2004). 
         Local synaptic homeostasis need not involve concurrent AP and synaptic blockade, 
however, as recent studies have demonstrated that simply removing the primary facet of 
excitatory input is sufficient to induce a compensatory response at mammalian central synapses. 
Interestingly, this manipulation has been observed to induce adaptations at both sides of the 
synapse: treatment of cultured hippocampal neurons with CNQX or NBQX for 3-24 hrs 
produces an adaptive enhancement in both pre and postsynaptic function (Jakawich et al., 2010; 
Groth et al., 2010; Lindskog et al., 2011). Signaling through βCaMKII plays an integral role in 




mEPSC amplitude and AMPAR subunit expression after AMPAR blockade, and overexpression 
of βCaMKII alone is sufficient to enhance expression of GluA1 homomeric AMPARs (Groth et 
al. 2010). Interestingly, removal of synaptic blockade after a period of deprivation causes Ca2
+ 
influx through these uniquely Ca2
+
 permeable AMPARs, triggering the release of a retrograde 
signal to enhance presynaptic function (Groth et al., 2010; Lindskog et al., 2011). Though 
evidence suggests potential roles for both Nitric Oxide (NO) (Lindskog et al, 2011) and BDNF 
(Jakawich et al,, 2010) in retrograde signaling during this form of synaptic homeostasis, 
eliminating postsynaptic BDNF synthesis using RNAi completely blocked CNQX-induced 
increases in presynaptic function, suggesting that BDNF‟s action as a retrograde signal may be 
necessary in this context, while NO may provide a supporting role. In addition, BDNF was 
shown to be locally synthesized in dendrites in response to AMPAR blockade (Jakawhich et al., 
2010), highlighting the importance of local translational regulation in this form of compensation. 
Some insight into the potential mechanism behind the augmenting effects of BDNF release on 
presynaptic function may be gleaned from data indicating that elimination of presynaptic spiking 
during AMPAR blockade-induced homeostasis or after acute BDNF application on its own is 
effective in completely blocking the increase in presynaptic release observed after either of these 
treatments (Jakawich et al, 2010). Additional data supports a role for presynaptic Ca2
+
 influx 
through P/Q and N-type Ca2
+
 channels operating in tandem with BDNF-triggered TrkB 
signaling to mediate changes in presynaptic function. Further characterization of the nature of 







1.5 Local protein synthesis during HSP: Molecular Players 
 Recent efforts from multiple labs have provided an emerging view of the molecular 
mechanisms responsible for controlling local protein synthesis during homeostatic forms of 
synaptic plasticity. The majority of this work has focused on translational control of proteins 
responsible for modulating postsynaptic function, though additional insights into the mechanism 
responsible for presynaptically expressed homeostasis will be presented in subsequent chapters 
 
eEF2K 
         Additional work has highlighted a role for the eukaryotic elongation factor-2 kinase 
(eEF2K) in mediating homeostatic responses to synaptic blockade. Phosphorylation of eEF2K, 
inhibits eEF2 mediated catalysis of ribosomal translocation during polypeptide elongation, 
thereby inhibiting translation. Initial experiments from Sutton et al., 2007 demonstrated that 
eEF2 phosophrylation levels significantly decrease in response to simultaneous blockade of APs 
and AMPA or NMDA-type glutamate receptors, concurrent with an increase in dendritic protein 
synthesis observed under these conditions (Sutton et al., 2004). Importantly, eEF2 
phosphorylation was shown to be differentially regulated by specific forms of neurotransmission, 
with blockade of AP-induced vesicle release (via TTX application) leading to increased eEF2 
phosphorylation and diminished translation elongation, and concurrent AP and excitatory 
receptor blockade having an opposite effect. Interesting research has emerged recently to suggest 
that Neuronatin mRNA is potential target of eEF2-mediated translational control under 
conditions of TTX/APV blockade (Oyang et al., 2011). One intriguing implication from these 
results is that spontaneous and evoked neurotransmission activate specific sets of postsynaptic 




dendritic translation during synaptic homeostasis.  In line with this, experiments from a number 
of labs have provided experimental support for the functional segregation of postsynaptic 
receptors that are positioned to receive input from spontaneous over evoked neurotransmission 
(Sara et al., 2011; Melon et al., 2013). Coupled with the growing support for the notion of 
separate vesicle pools used for spontaneous or evoked neurotransmission (Chung et al., 2010; 
Ramirez and Kavalali, 2011; Rameriz et al. 2012), an argument may be made for unique 
signaling via spontaneous neurotransmission in the adaptive regulation of protein translation 
during in synaptic homeostasis. 
         Less clear, however, is the specific role (if any) played by particular families of 
excitatory neurotransmitter receptors in the context of synaptic blockade. While initial 
experiments did not show differential effects of blocking NMDA vs. NMDA+AMPAR type 
glutamate receptors (Sutton et al., 2004, Sutton et al., 2007), recent work has highlighted a 
unique facet of synaptic homeostasis that appears to involve changes in translation in response to 
transient NMDAR blockade. In one instance, Monteggia and colleagues demonstrated that acute 
blockade of NMDARs with systemically administered NMDAR antagonists, including ketamine, 
MK-801 and APV, drives protein synthesis through dephosphorylation of eEF2, an effect which 
is particularly strong in hippocampal dendrites (Autry et al., 2011). Interestingly, low doses of 
ketamine or other NMDAR antagonists also act as particularly strong antidepressants, with 
significant reductions in immobility on a forced swim test observed up to a week after initial 
injection (Autry et al., 2011). The authors identify BDNF as one of potentially many targets of 
altered translational regulation in response to low dose NMDAR-antagonists, and provide 
evidence suggesting that de novo BDNF synthesis enhances AMPAR currents. The finding that 




the forced swim test supports the author‟s assertion that an important role is played by enhanced 
AMPAR currents as an effector of ketamine- induced plasticity. 
 
mTORC1 
         The effects of transient NMDAR blockade may not be mediated solely via eEF2 
signaling, however. Work from the Duman lab has shown that acute NMDAR blockade via 
ketamine activates an alternative mediator of translation regulation, namely that of the 
mechanistic target of rapamycin (mTOR) pathway. mTOR, when assembled with its binding 
partner raptor, forms a complex (mTORC1) which has a well-characterized role in regulating 
translation initiation (Ma and Blenis, 2009). Systemic injection of low dose ketamine resulted in 
an increase in mTORC1 signaling in synaptoneurosomes prepared from rat prefrontal cortex (Li 
et al., 2010).  The effect of ketamine on mTORC1 activation was shorter lived than the 
ketamine-induced enhancement in eEF2 signaling reported by Autry et al (2011), returning back 
down to baseline levels within 2 Hr post-injection. Concurrent with the change in mTORC1 
signaling, ketamine produced a rapamycin-sensitive increase in levels of synaptic proteins, 
including PSD-95, synapsin and GluA1 AMPAR subunits, as well as an increase in spine density 
and frequency of spontaneous EPSCs (Li et al., 2010).  Regarding specificity of the postsynaptic 
receptor as a relevant signaling factor in this phenomenon, it is interesting to note that ketamine-
induced increases in mTORC1 singling were completely blocked by co-administration of the 
AMPAR blocker NBQX (Li et al., 2010), which mirrors the reduced efficacy of ketamine in the 
forced swim task when co-administered with NBQX (Autry et al., 2011). This suggests that it is 
not mere blockade of excitatory minis that elicits the antidepressant response, but potentially 




NR2B-specific inhibitor replicated the effects of ketamine in terms of enhanced expression of 
synaptic proteins and antidepressant like effects on behavioral assays (Li et al., 2010). This is 
complimented by recent work using a genetic mouse model in which the GluN2B subunit of the 
NMDAR is replaced with GluN2A throughout development (Wang et al., 2011A).  In cortical 
cultures prepared from these animals, lack of signaling through GluN2B containing receptors 
resulted in heightened mTORC1 signaling in dendrites, as well as a deficit in synaptic adaptation 
induced by concurrent AP and NMDAR blockade (TTX+APV), compared to WT cultures. These 
findings, combined with those from Li et al., suggest that spontaneous mEPSC signaling through 
NR2B containing NMDARs may tonically suppress mTORC1 signaling at these synapses, 
cessation of which may engage a form of synaptic homeostasis that depends on dendritic protein 
synthesis. 
 At the drosophila neuromuscular junction (NMJ), a well-characterized form of synaptic 
homeostasis elicited by deprivation of excitatory synaptic input has recently also been linked to 
the mechanistic target of rapamycin (mTOR) signaling pathway (Penney et al., 2012). Genetic 
deletion of the GluAII AMPAR subunit reduces the amplitude of spontaneous mEJCs.  However, 
the size of evoked current remains comparable to WT levels due to a compensatory increase in 
quantal content, as described earlier (Petersen et al., 1997). Interestingly, double mutants for 
GluAII and mTOR show a 50% reduction in evoked current compared to WT levels, indicating a 
role for mTOR-dependent translation in the adaptive shift in quantal content (Penney et al., 
2012). Restoration of mTOR function in the muscle, but not in the presynaptic motor neuron, 
rescues the homeostatic adaptation in quantal content, suggesting that postsynaptic mTOR 
mediates translation of a retrograde signal in response to loss of excitatory input. This novel role 




presented here (Chapter 2), and thus establishes a remarkable evolutionary conservation for 
postsynaptic mTORC1 in the homeostatic regulation of presynaptic function. 
 
Retinoic acid 
 Recently, work from Lu Chen‟s lab established a non-canonical role for all-trans-retinoic 
acid signaling, wherein application of RA to dissociated cultures or hippocampal slices produced 
a multiplicative scaling of mEPSC amplitude similar to that observed in homeostatic forms of 
plasticity (Aoto et al., 2008). Curiously, given the known function of RA in acting as a 
transcription factor, this effect was blocked by inhibitors of translation, but not by blockers of 
transcription.  In support of RA signaling mediating a direct effect on local translation occurring 
in dendrites, additional experiments also revealed that RA stimulates synthesis of GulA1 
subunits in synaptoneurosome preparations (Poon and Chen, 2008). Pharmacological blockade of 
RA synthesis or shRNA knockdown of the endogenous RA receptor RARa completely 
eliminated synaptic scaling induced by TTX and APV, indicating that RA-mediated stimulation 
of local protein synthesis in dendrites is an essential component of postsynaptic adaptation 
(Aoto, 2008). Critically, while RA is necessary for forms of synaptic homeostasis that emerge 
after synaptic blockade, via TTX+APV, TTX+CNQX or CNQX alone (Wang et al., 2008), it is 
completely unnecessary for the adaptive functional response observed after prolonged period of 
spike blockade via TTX. This finding provides further support to the earlier-stated idea that 
multiple homeostatic sensors operate in neurons, and that those operating at the level of 
individual synapses or dendritic branches use distinct methods to exert functional changes 
compared to those that sense changes in individual spike output. Critically, Chen and colleagues 
demonstrated that diminished Ca2
+




intracellular RA synthesis (Wang et al, 2008), thereby positioning RA as a particularly attractive 
candidate to act as a homeostatic sensor mediating postsynaptic responsiveness in dendrites. 
Because RA-induced increases in postsynaptic function are mediated by de novo translation of 
uniquely Ca2
+
 permeable GluA2-lacking AMPARs (Aoto et al 2008), this proposed homeostatic 
circuit comes equipped with a built-in feedback mechanism to dampen RA synthesis after an 
initial phase of postsynaptic strengthening.  
 
FMRP  
         The RNA-binding protein FMRP is an additional modulator of translation regulation that 
has recently been determined to be involved in local homeostatic synaptic adaptations. Soden 
and Chen (2010) have identified FMRP as integral to a previously characterized form of 
homeostatic plasticity that depends on retinoic-acid (RA) mediated local protein synthesis (Aoto 
et al., 2008). FMRP mice show no compensation in mEPSC amplitude or synaptic GluA1 levels 
after 36 Hrs of treatment with TTX and APV (Soden and Chen 2010). FMRP is not necessary for 
RA-synthesis after TTX+APV treatment, but is necessary for RA-induced local translation of 
synaptic proteins (Soden and Chen, 2010). The fact that FMRP and the RA receptor RAR 
appear to not interact directly suggests a combinatorial action of multiple signaling pathways 
operating in parallel but converging at the level of specific transcript targets, thereby allowing 
for more finely-tuned translational regulation. 
         FMRP may also play a role in an alternative form of homeostasis, namely that of synaptic 
downregulation during sleep. Work from the labs of Cirelli and Tononi have advanced the 
intriguing hypothesis that a major function of slow-wave sleep is the homeostatic weakening of 




2003). In both mammals (Vyazovskiy et al., 2008) and in drosophila (Gilestro et al, 2009), 
periods of wakefulness are associated with synaptic alterations reflecting potentiated excitatory 
responses, including enhanced GluA1 expression, elevated AMPAR and CaMKII 
phosphorylation levels, and increased amplitude of evoked responses. In contrast, slow wave 
sleep is associated with diminished evoked currents, and a general decrease in expression levels 
of synaptic proteins. Intensity of slow-wave delta band activity is tied to overall synaptic weight, 
and thus displays decreased amplitude over time during sleep as synapses are homeostatically 
weakened (Tononi and Cirelli, 2003).  In drosophila, dFMR1 levels have been shown to increase 
markedly as a consequence of sleep deprivation, and genetic manipulation of dFMR1 exerts 
profound bidirectional changes in the duration of sleep bouts (Bushey et al., 2009). These effects 
on sleep duration in dFMR1 mutant flies were later shown to be synaptically mediated.  While 
sleep deprivation typically results in enhanced morphological complexity of dendrites in 
mushroom body neurons, overexpression of dFMR1 eliminates these adaptations, effectively 
rendering sleep deprived flies identical to those with normal sleep patterns (Bushey et al., 2011). 
More work is needed to tie translation regulation by FMRP to the particular form of synaptic 
homeostasis observed during sleep, but these data raise the interesting possibility that translation 
regulation may have a pivotal role to play in a form of synaptic homeostasis observed in a 
ubiquitously observed behavioral phenomenon such as sleep. 
 
1.6 Translational control by dendritic mTORC1 during state-dependent synaptic 
homeostasis 
 Here we present our efforts to characterize a novel role for dendritic mTORC1 in the 




that blockade of AMPA-type glutamate receptors with CNQX increases mTORC1 kinase 
activity in the postsynaptic domain, leading to the synthesis of BDNF as a retrograde signal 
(Chapter 2). Retrograde signaling through BDNF appears to emerge as an immediate 
consequence of mTORC1 activation, as genetic upregulation via postsynaptic Rheb GTPase 
overexpression or acute activation of mTORC1 with the lipid second messenger phosphatidic 
acid (PA) is sufficient to stimulate BDNF-dependent increases in presynaptic efficacy (Chapter 
3). We further demonstrate that a pathway involving the intracellular synthesis of PA by 
phospholipase-D appears to serve as a homeostatic sensor mechanism, translating shifts in 
postsynaptic excitation to increased mTORC1 signaling and altered BDNF synthesis. 
Interestingly, this PLD/PA signaling mechanism is not a feature of mTORC1 activation shared 
with the phenomenon of chemically induced LTP (Chapter 4). Finally, we show that activity 
dependent relocalization of the ubiquitin proteasome system (UPS) acts as an important gate on 
this form of state-dependent homeostasis, wherein mTOR-dependent retrograde BDNF signaling 
drives changes in presynaptic function via the UPS-mediated disinhibition of vesicle release 
probability (Chapter 5). Understanding the molecular mechanisms involved in this evolutionarily 
conserved form of synaptic homeostasis contributes to our growing understanding of basic 
synapse function, and potentially yields insights into the contribution of dysregulated mTORC1 
signaling to commonly observed circuit abnormalities in mTOR-related neurodevelopmental 
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 Mutations that alter signaling through the mammalian target of rapamycin complex 1 
(mTORC1), a well-established regulator of neuronal protein synthesis, have been linked to 
autism and cognitive dysfunction. Although previous studies have established a role for 
mTORC1 as necessary for enduring changes in postsynaptic function, here we demonstrate that 
dendritic mTORC1 activation in rat hippocampal neurons also drives a retrograde signaling 
mechanism promoting enhanced neurotransmitter release from apposed presynaptic terminals. 
This novel mode of synaptic regulation conferred by dendritic mTORC1 is locally implemented, 
requires downstream synthesis of brain-derived neurotrophic factor as a retrograde messenger, 
and is engaged in an activity-dependent fashion to support homeostatic trans-synaptic control of 
presynaptic function. Our findings thus reveal that mTORC1-dependent translation in dendrites 
subserves a unique mode of synaptic regulation, highlighting an alternative regulatory pathway 
that could contribute to the social and cognitive dysfunction that accompanies dysregulated 






 Although principal neurons receive many thousands of synapses, the ability to tune 
synaptic strength independently along specific regions of the dendritic arbor is thought to confer 
the increased computational capacity necessary for new learning and memory storage in neural 
circuits (Rabinowitch and Segev, 2008; Branco and Haüsser, 2010). The discovery of 
polyribosomes in the distal dendrites of dentate granule neurons (Steward and Levy, 1982) first 
suggested that dendritic translation might participate in controlling synaptic function on a local 
level, an idea that has been clearly substantiated by work in a wide range of model systems 
(Kang and Schuman, 1996; Martin et al., 1997; Huber et al., 2000; Sutton et al., 2006). In 
particular, the mammalian target of rapamycin (mTOR) is known to be an important control 
point for protein synthesis related to synaptic plasticity (Casadio et al., 1999; Tang et al., 2002; 
Cammalleri et al., 2003; Gong et al., 2006) and memory (Tischmeyer et al., 2003; Dash et al., 
2006; Blundell et al., 2008). 
 mTOR is a serine/threonine protein kinase that integrates into two distinct protein 
complexes, mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2) (Ma and Blenis, 
2009). Of these, mTORC1 promotes translation of specific classes of mRNAs via 
phosphorylation of downstream effectors, such as eIF4E binding protein (4EBP) and p70 S6 
kinase (S6K1) (Wang and Proud, 2006; Costa-Mattioli et al., 2009; Zoncu et al., 2011). A wide 
array of extracellular signals regulates mTORC1 signaling through the mTORC1 repressor 
tuberous sclerosis complex (TSC) or the small GTPase Rheb, which promotes mTORC1 
activation (Yang and Guan, 2007). 
 Animal studies have clearly implicated mTORC1 in hippocampal synaptic plasticity and 




et al., 2010; Hoeffer and Klann, 2010). Moreover, human mutations that result in dysregulation 
of mTORC1 signaling have been associated with vulnerability to autism, cognitive impairment, 
and epilepsy (Onda et al., 2002; Butler et al., 2005; Johannessen et al., 2005; Kelleher and Bear, 
2008), underscoring the importance of this signaling complex for proper neural circuit function 
in the human brain. At vertebrate synapses, dendritic mTORC1 has been most clearly implicated 
in enduring forms of long-term potentiation (LTP) and long-term depression (LTD) that are 
induced and expressed postsynaptically (Tang et al., 2002; Cammalleri et al., 2003, Sharma et 
al., 2010; Hoeffer et al., 2008), suggesting that mTORC1-dependent translational control may 
participate in maintaining altered AMPA receptor (AMPAR) expression at synapses, promoting 
structural synaptic changes, or both. 
 Here, we demonstrate that mTORC1-dependent translation in dendrites exerts a novel 
form of regulatory control over synapse function. Unlike enduring changes in postsynaptic 
function during LTP and LTD, we find that homeostatic enhancement of postsynaptic function 
induced by acute loss of excitatory synaptic drive occurs via mTORC1-independent protein 
synthesis. Instead, we find that dendritic mTORC1 activation is both necessary and sufficient for 
driving protein synthesis-dependent compensatory changes in neurotransmitter release from 
apposed presynaptic terminals, revealing that parallel translational control pathways operate 
locally in dendrites to mediate distinct homeostatic adaptations at synapses. 
 
2.3 Results 
Loss of excitatory synaptic input drives dendritic mTORC1 activation 
 Previous work has established that strong synaptic activation can drive mTORC1 




unclear how the activity-dependent regulation of mTORC1 signaling is sculpted by loss of 
synaptic drive. To explore this question, we examined the regulation of several downstream 
targets of mTORC1 signaling in active networks of cultured hippocampal neurons subject to 
acute blockade of excitatory transmission through either AMPARs or NMDARs. Treating 
cultured hippocampal neurons with the AMPAR antagonist CNQX (40 μM), but not the 
NMDAR antagonist APV (50 μM), induced a rapid time-dependent increase in phosphorylation 
of ribosomal protein S6 at S235/236 (Figure 2.1A–C), a downstream target of mTORC1 
activation. Likewise, CNQX treatment (40 μM, 30 min) induced phosphorylation of S6K1 at 
Thr389 and 4EBP at Thr37/46 (Figure 1D-E), both direct mTORC1 phosphorylation sites. The 
mTORC1 inhibitor rapamycin (100 nM) completely suppressed both basal and enhanced S6 and 
S6K1 phosphorylation (Figure. 2.1C-D), as well as enhanced phosphorylation of 4EBP1 (Figure 
2.1E), confirming a role for mTORC1 activation in these effects. Another AMPAR antagonist, 
NBQX (10 μM), produced similar rapamycin-sensitive effects on S6, S6K1, and 4EBP1 
phosphorylation (data not shown). Finally, immunocytochemistry revealed that AMPAR 
blockade induced significant S6 phosphorylation in both the cell bodies and dendrites of 
hippocampal neurons (Figure 1F-G), whereas MAP2 expression from these same neurons was 
unchanged. Under our staining conditions, virtually all PS6 immunofluorescence was abolished 
by pretreatment with 100 nM rapamycin (data not shown), verifying PS6 staining as a valid 
readout of mTORC1 activation. These results indicate that mTORC1 signaling is activated in 
response to acute loss of excitatory synaptic drive as well as in response to patterned synaptic 
activation. 
 A drop in excitatory synaptic input is also known to regulate translation through 




Nosyreva and Kavalali, 2010). eEF2 kinase can be regulated by mTORC1 activation (Wang and 
Proud, 2006), so we also examined eEF2 phosphorylation in response to AMPAR blockade and 
its reliance on intact mTORC1 signaling. While AMPAR blockade induced rapid eEF2 
dephosphorylation consistent with translational activation, this effect was insensitive to 
coincident mTORC1 inhibition with rapamycin (Figure 2.1H-I). These results suggest that 
AMPAR blockade engages multiple translational regulatory pathways in hippocampal neurons. 
 
Homeostatic enhancement of postsynaptic function is not dependent mTORC1 activation 
 We next examined whether activation of mTORC1 accompanying AMPAR blockade 
contributes to the homeostatic enhancement of postsynaptic function induced by such loss of 
synaptic activity, which is dependent on new protein synthesis (Sutton et al., 2006; Aoto et al., 
2008). Indeed, rapid postsynaptic compensation shares with translation-dependent late-phase 
LTP (L-LTP) in the hippocampus a recruitment of AMPARs to synapses (Makino and Malinow, 
2009), and mTORC1 signaling is known to be necessary for the enduring changes in 
postsynaptic function associated with L-LTP (Tang et al., 2002). Despite these similarities, we 
found that the increase in surface GluA1 expression at synapses following AMPAR blockade 
was not altered by the mTORC1 inhibitor rapamycin (100 nM; Figure 2.2A-B). Likewise, 
mTORC1 inhibition with either rapamycin or an mTOR active site inhibitor C-401 (10 μM; 
Ballou et al., 2007) did not affect the rapid compensatory increase in amplitude of mEPSCs 
accompanying AMPAR blockade (40 μM CNQX, 3 h), recorded immediately following CNQX 
washout (Figure 2.2C-D). Similar to previous reports (Thiagarajan et al., 2005; Sutton et al., 
2006; Aoto et al., 2008), we found that the homeostatic increase in mEPSC amplitude is 




containing AMPARs, are blocked by polyamine toxins, such as 1-napthylacetylspermine 
(NASPM). We found that mTORC1 inhibition coincident with AMPAR blockade also did not 
affect the NASPM sensitivity of scaled mEPSCs (Figure 2.2F-G), indicating that GluA1 
homomeric receptors are recruited to synapses in the absence of mTORC1 signaling. The effects 
of NASPM in these conditions are specific for mEPSC amplitude. While coincident rapamycin 
and C-401 treatment each block the increase in mEPSC frequency induced by AMPAR 
blockade, NASPM treatment after these treatments does not further reduce mEPSC frequency 
below control levels (data not shown). Together, these observations suggest that, while mTORC1 
activation during L-LTP and mGluR-LTD is necessary for enduring changes in postsynaptic 
function (Hou and Klann, 2004; Antion et al., 2008), the homeostatic enhancement of 
postsynaptic function driven by loss of synaptic activity does not require mTORC1 signaling. 
 
mTORC1 is necessary for retrograde enhancement of presynaptic function 
 In addition to triggering rapid postsynaptic compensation, AMPAR blockade also drives 
compensatory increases in presynaptic function (Murthy et al., 2001; Thiagarajan et al., 2005) 
that depend on retrograde signaling from the postsynaptic cell (Jakawich et al., 2010; Lindskog 
et al., 2010; Groth et al., 2011). Thus, AMPAR blockade drives not only an increase in mEPSC 
amplitude, but also an increase in mEPSC frequency in hippocampal neurons. This increase in 
frequency reflects enhanced release probability from existing presynaptic terminals (Jakawich et 
al., 2010). Likewise, at the Drosophila neuromuscular junction, acute blockade of postsynaptic 
AMPARs triggers rapid compensatory increases in quantal content (Frank et al., 2006), 
suggesting an evolutionarily conserved mode of regulation whereby postsynaptic glutamate 




activation is not necessary for compensatory enhancement of postsynaptic function following 
AMPAR blockade, we found that such activation was essential for the development of 
homeostatic changes in presynaptic function. Thus, both rapamycin and C-401 completely 
suppressed the increase in mEPSC frequency induced by AMPAR blockade (Figure 2.2C-E). 
Similar to AMPAR blockade, chronic (>24 h) treatment with L-type Ca2
+
 channel inhibitors 
induces compensatory enhancement of presynaptic and postsynaptic function (Thiagarajan et al., 
2005; Gong et al., 2007), raising the question of whether mTORC1 plays a similar role during 
homeostatic plasticity induced by loss of L-type channel function. Indeed, we found that 
blocking L-type channels with 10 μM nifedipine over a 3 h period induced a significant increase 
in both mEPSC amplitude (mean ± SEM mEPSC amplitude: controls, 13.15 ± 0.60 pA, n = 11 
cells; 3 h nifedipine, 15.38 ± 0.70 pA, n = 14 cells; p < 0.05; data not shown) and frequency 
(mean ± SEM mEPSC frequency: controls, 1.99 ± 0.33 Hz; 3 h nifedipine, 4.82 ± 0.75 Hz; p < 
0.05; data not shown). As we observed with AMPAR blockade, coincident inhibition of 
mTORC1 with 100 nM rapamycin did not affect the compensatory increase in mEPSC amplitude 
(3 h nifedipine plus rapamycin, 15.76 ± 0.94 pA, n = 10 cells; p < 0.05 vs control), but strongly 
suppressed the increase in mEPSC frequency (3 h nifedipine plus rapamycin, 2.35 ± 0.30 Hz; not 
significant vs control) induced by nifedipine treatment. Thus, during homeostatic changes driven 
by either AMPAR blockade or loss of L-type Ca2
+
 channel function, mTORC1 inhibition 
selectively suppresses compensatory enhancement of mEPSC frequency, but not mEPSC 
amplitude. 
 To ensure that these mTORC1-dependent changes in mEPSC frequency following 
AMPAR blockade reflect compensatory enhancement of presynaptic function, we visualized 




against the lumenal domain of synaptotagmin 1 (syt-lum) followed by fixation and labeling with 
an antibody against the vesicular glutamate transporter, vglut1, to mark excitatory terminals. To 
estimate relative presynaptic function under control conditions and following AMPAR blockade, 
we measured the proportion of vglut1-positive terminals with detectable syt-lum staining under 
conditions of spontaneous vesicle release (15 min pretreatment with 2 μM TTX before labeling). 
Using this unambiguous readout of presynaptic function, we found that neither rapamycin nor C-
401 altered basal syt-lum uptake, but each prevented the increase in syt-lum uptake induced by 
AMPAR blockade (Figure 2.3A-B). To confirm these observations and assess whether mTORC1 
is necessary for homeostatic changes in action potential-driven vesicle release, we directly 
visualized evoked glutamate release by imaging activity-dependent changes in vglut1-pHluorin 
fluorescence at presynaptic terminals identified by coexpression of mCherry-tagged 
synaptophysin (Figure 2.3C). As previously reported (Voglmaier et al., 2006), basal vglut1-
pHluorin fluorescence at presynaptic terminals was low due to effective quenching by the acidic 
environment of synaptic vesicles, allowing for optical detection of action potential-triggered 
synaptic vesicle fusion when the lumen of the vesicle is exposed to the neutral extracellular 
space. To induce action potentials across the network, we applied field stimulation via parallel 
platinum-iridium electrodes under conditions where individual pulses each faithfully produced 
an action potential, verified by the characteristic cell-wide Ca2
+
 transient accompanying each 
stimulus (data not shown). In control (vehicle-treated) neurons, a 10 s train of action potentials 
delivered at 10 Hz induced a clear increase in vglut1-pHluorin fluorescence at presynaptic 
terminals, but following AMPAR blockade (40 μM CNQX, 3 h), this evoked vesicle fusion was 
markedly enhanced (Figure 2.3C-D). Blocking mTORC1 activation during AMPAR blockade 




effects on spontaneous neurotransmitter release, mTORC1 activation is necessary for the 
enhancement of evoked release following AMPAR blockade. Together, these findings suggest 
that mTORC1 is specifically required for homeostatic changes in presynaptic function induced 
by loss of AMPAR-mediated synaptic activity. 
 
Homeostatic enhancement of presynaptic function is dependent on postsynaptic mTORC1 
activation 
 The fact that AMPAR blockade elicits mTORC1 activation in dendrites (Figure 2.1H-I) 
raises the possibility that postsynaptic mTORC1 activation is necessary to drive retrograde 
compensation in presynaptic terminals. To address this issue, we overexpressed the tuberous 
sclerosis complex proteins TSC1 and TSC2, which together act as endogenous suppressors of 
mTORC1 activation (Inoki et al., 2002, 2003). To examine the specific role of postsynaptic 
mTORC1 activation, we used a low-efficiency strategy where <1% of neurons are transfected. 
This enabled us to examine selective mTORC1 inhibition in single transfected neurons that 
receive synapses from untransfected cells with unperturbed mTORC1 signaling (Figure 2.4A). 
As expected, phosphorylation of S6, downstream of mTORC1 activity, was substantially reduced 
in neurons transfected with TSC1/2 relative to both untransfected neighboring neurons (Figure 
2.4B) and neurons transfected with EGFP alone (Figure 2.4C). Moreover, TSC1/2 expression 
also prevented mTORC1 activation induced by AMPAR blockade (Figure 2.4C). We next 
examined the effects of TSC1/2 expression on synaptic compensation. Consistent with our 
previous observations, postsynaptic knockdown of mTORC1 activation did not alter the ability 
of AMPAR blockade to drive postsynaptic compensation, as similar increases in mEPSC 




control neurons after treatment with 40 μM CNQX (3 h, added 21 h post-transfection; Figure 
2.4D-E). However, the enhancement of mEPSC frequency accompanying AMPAR blockade was 
strongly inhibited in TSC1/2-expressing neurons relative to both untransfected controls and 
neurons in sister cultures transfected with EGFP alone (Figure 4.4F). Importantly, TSC1/2 
overexpression for 24 h did not alter basal mEPSC frequency or amplitude in the absence of 
AMPAR blockade (Figure 2.4D–F). Because the increase in mEPSC frequency accompanying 
AMPAR blockade is known to reflect an enhancement in release probability in presynaptic 
terminals synapsing on the recorded neuron (Jakawich et al., 2010), these results suggest that 
postsynaptic mTORC1 activation is necessary for retrograde changes in presynaptic function 
driven by AMPAR blockade. 
 
Local mTORC1 activation in dendrites is necessary for retrograde changes in presynaptic 
function 
 We next examined whether local mTORC1 signaling in dendrites is necessary for 
retrograde changes in presynaptic function. To address this possibility, we used restricted 
microperfusion of rapamycin (200 nM) either alone or in conjunction with AMPAR blockade 
(bath 40 μM CNQX, 120 min; Figure 2.5A), and examined subsequent live syt-lum uptake as a 
readout of presynaptic changes. We found that spatially restricted inhibition of mTORC1 
signaling during AMPAR blockade induced a selective inhibition of syt-lum uptake at terminals 
apposed to the treated dendritic segment (Figure 2.5B-C), while vglut1 immunofluorescence in 
those same segments was not significantly altered. By contrast, local rapamycin treatment in the 
absence of AMPAR blockade (Figure 2.5D) did not alter syt-lum uptake, demonstrating a 




blockade. Importantly, the brief (5 min) syt-lum labeling period used in these microperfusion 
experiments argues against a major influence from the transit of synaptic vesicles between 
different presynaptic terminals. Indeed, we observed only minimal fluorescence recovery over a 
50 min period after locally photobleaching syt-lum signal (data not shown), indicating that the 
signal observed in treated dendritic segments under brief labeling conditions primarily reflects 
uptake at synapses apposed to those segments. These results thus suggest that mTORC1 
activation in dendrites plays a spatially restricted role in driving retrograde homeostatic changes 
in presynaptic function in response to AMPAR blockade. 
 
mTORC1 operates upstream of BDNF synthesis during homeostatic plasticity 
 Postsynaptic release of BDNF is necessary for retrograde changes in presynaptic function 
driven by AMPAR blockade (Jakawich et al., 2010; Lindskog et al., 2010), raising the question 
of whether mTORC1 operates upstream or downstream of BDNF action. Indeed, exogenous 
BDNF application is known to activate mTORC1 signaling (Schratt et al., 2004), raising the 
possibility that mTORC1 activation in the context of synaptic attenuation might be secondary to 
BDNF release. However, contrary to this notion, we found that mTORC1 activation induced by 
AMPAR blockade was BDNF-independent as scavenging extracellular BDNF with TrkB-Fc (1 
μg/ml) did not affect phosphorylation of mTORC1 effectors in response to CNQX treatment 
(Figure 2.6A-B). To explore this issue further, we examined whether presynaptic changes driven 
by direct BDNF application were sensitive to coincident mTORC1 inhibition with rapamycin. As 
shown in Figure 2.6C-D, application of BDNF (250 ng/ml) to cultured neurons for 60 min 
induced a sustained increase in mEPSC frequency that remained persistent following BDNF 




BDNF application induced a similar increase in mEPSC frequency in the presence or absence of 
rapamycin (Figure 2.6C-D), indicating that BDNF modulates presynaptic function in an 
mTORC1-independent fashion. Likewise, BDNF-induced enhancement of syt-lum uptake at 
vglut1-positive excitatory terminals was similarly unaffected by coincident rapamycin treatment 
(Figure 2.6E-F), indicating that BDNF acts downstream of mTORC1 activation to drive 
enhancement of presynaptic function. Given the role of mTORC1 in translational control, these 
findings suggest that mTORC1 activation might participate in the regulation of de novo BDNF 
synthesis, which is necessary for retrograde homeostatic changes in presynaptic function 
(Jakawich et al., 2010). Consistent with this possibility, Western blots of hippocampal neuron 
lysates revealed that the increase in BDNF expression in response to AMPAR blockade was 
prevented by rapamycin (Figure 2.7A-B). To assess the cellular compartments where this 
mTORC1-dependent regulation of BDNF occurs, we examined BDNF expression by 
immunocytochemistry. Consistent with earlier reports (Jakawich et al., 2010), AMPAR blockade 
induced a significant increase in BDNF expression in dendrites without altering somatic BDNF 
levels (Fig. 7C,D). This highly compartmentalized increase in dendritic BDNF expression 
induced by AMPAR blockade was prevented by mTORC1 inhibition with rapamycin. These 
findings suggest that mTORC1 is a critical regulator of new BDNF synthesis following AMPAR 
blockade. 
 
Cell-autonomous enhancement of synaptic activity accompanies postsynaptic mTORC1 
activation 
 We next asked whether postsynaptic mTORC1 activation in the absence of AMPAR 




question, we again used a sparse expression strategy while transfecting the mTORC1 activating 
GTPase Rheb (data not shown) or a hyperactive RhebQ64L mutant (Figure 2.8A) that is 
persistently in its GTP-bound state (Jiang and Vogt, 2008). In non-neuronal cells, expression of 
Rheb or RhebQ64L is sufficient to drive sustained cell-autonomous mTORC1 signaling (Tee et 
al., 2003; Long et al., 2005). Likewise, 24 h following transfection, immunocytochemistry 
against PS6 confirmed robust dendritic and somatic mTORC1 activation in RhebQ64L-
transfected neurons relative to either surrounding untransfected neurons (Figure 2.8B) or neurons 
from sister cultures transfected with EGFP alone (Figure 2.8C). To examine the impact of cell-
autonomous mTORC1 activation on overall excitatory synaptic drive in active networks, we 
compared spontaneous excitatory synaptic activity in RhebQ64L-expressing neurons with 
neighboring untransfected neurons in the same culture and EGFP-transfected neurons in sister 
cultures in the absence of TTX. Recording spontaneous EPSCs in the presence of bicuculine and 
APV, we found that overall excitatory network activity was significantly enhanced onto 
RhebQ64L-expressing neurons, reflected in >5-fold increase in charge transfer relative to 
untransfected neurons in the same culture (Figure 2.8D-E). To examine whether these changes in 
synaptic efficacy derive from growth of new synaptic connections, we examined the density of 
dendritic spines in response to either chronic suppression (with TSC1/2 overexpression) or 
hyperactivation (with RhebQ64L expression) of mTORC1. We found that alteration of mTORC1 
signaling for ∼24 h or 5 d failed to alter the density of dendritic spines (Figure 2.8F–H) relative 
to control neurons expressing GFP alone, despite clear mTORC-dependent regulation of cell 
soma size (5 d). While it is likely that more prolonged changes in mTORC1 signaling are 




synaptic efficacy observed here results largely from altered function of existing synaptic 
connections. 
 
Postsynaptic mTORC1 activation is sufficient to drive retrograde changes in presynaptic 
function 
 We next examined the mechanisms by which postsynaptic mTORC1 activation leads to 
enhanced synaptic efficacy. Given that the enhancement of dendritic BDNF expression following 
AMPAR blockade is dependent on mTORC1 (Figure 2.7C-D), we first assessed whether 
postsynaptic mTORC1 activation is sufficient to alter BDNF expression in the cell body or 
dendritic compartment of hippocampal neurons. Indeed, RhebQ64L-expressing neurons 
exhibited a striking increase in dendritic BDNF expression without altering MAP2 levels in the 
same neurons (Figure 2.9A-B). Moreover, the pattern of changes following mTORC1 activation 
was highly reminiscent of changes in BDNF expression that accompany AMPAR blockade 
(Figure 2.7C-D), as the change in BDNF expression was again highly compartmentalized, with 
no significant alteration in somatic BDNF levels (Figure 2.9A-B). A strikingly similar pattern 
was observed with overexpression of wild-type Rheb, where dendritic BDNF expression 
increased significantly (mean ± SEM percentage change in BDNF fluorescence relative to GFP 
expression alone, +145.7 ± 26.1; p < 0.05; data not shown) without concomitant changes in 
steady-state BDNF expression in the cell body (mean ± SEM percentage change in BDNF 
fluorescence relative to GFP expression alone, −13.4 ± 5.1, not significant; data not shown). 
These selective changes in dendritic BDNF expression are not due to compartment-selective 
mTORC1 activation, as expression of both Rheb (data not shown) and RhebQ64L (Figure 2.8B) 




dendritic and somatic expression of BDNF is subject to distinct compartment-specific regulatory 
control. 
 To determine how postsynaptic mTORC1 activation alters synaptic efficacy and to what 
extent the changes in BDNF expression contribute, we recorded mEPSCs from RhebQ64L-
transfected neurons or neighboring untransfected control neurons with unaltered mTORC1 
signaling. The sparse transfection conditions gave rise to isolated RhebQ64L-expressing neurons 
that receive nearly all their synaptic inputs from untransfected neurons with unaltered mTORC1 
signaling (Figure 2.8A), enabling us to evaluate the effects of postsynaptic mTORC1 activation 
on both presynaptic and postsynaptic function. Despite the strong increase in synaptic drive 
induced by postsynaptic RhebQ64L expression (24 h post-transfection), the amplitude of 
mEPSCs onto these neurons was not altered relative to neighboring untransfected neurons 
(Figure 2.9C-D) or neurons expressing GFP alone (Figure 2.4E). However, RhebQ64L-
expressing neurons exhibited a marked increase in mEPSC frequency (Figure 2.9C–E), 
suggesting enhanced spontaneous release from synaptic terminals that impinge on dendrites with 
activated mTORC1 signaling. Like the changes induced by AMPAR blockade, these retrograde 
changes in presynaptic function driven by postsynaptic mTORC1 activation required BDNF 
release, as they were completely prevented by the extracellular BDNF scavenger TrkB-Fc (1 
μg/ml; Figure 2.9C–E). A very similar pattern of results was observed with postsynaptic 
expression of wild-type Rheb in parallel experiments, where postsynaptic Rheb expression 
induced a significant increase in mEPSC frequency (mean ± SEM mEPSC frequency, 
nontransfected controls: 1.52 ± 0.17 Hz; Rheb transfected neurons: 2.35 ± 0.40 Hz, p < 0.05 one-
tailed; data not shown) without altering mEPSC amplitude (mean ± SEM mEPSC amplitude, 




significant; data not shown). As with RhebQ64L, the increase in mEPSC frequency with Rheb 
overexpression is similarly abolished by scavenging extracellular BDNF (mean ± SEM mEPSC 
frequency, nontransfected controls with TrkB-Fc: 1.51 ± 0.19 Hz; Rheb transfected neurons: 
1.29 ± 0.15 Hz; data not shown). 
 To examine whether a similar enhancement of evoked neurotransmission is also 
established by postsynaptic mTORC1, we examined a use-dependent block of evoked NMDAR-
mediated EPSCs onto RhebQ64L-expressing neurons and untransfected neurons from the same 
cultures with the open-channel blocker MK-801 to assess neurotransmitter release probability 
(Hessler et al., 1993; Rosenmund et al., 1993). Immediately before recording, evoked NMDAR 
EPSCs were pharmacologically isolated and elicited at a rate of 0.33 Hz with an extracellular 
stimulating electrode positioned near the recording neuron. Before MK-801 treatment, the 
kinetics of evoked NMDAR EPSCs in RhebQ64L-expressing neurons, untransfected neurons, 
and control GFP-expressing neurons were similar (mean ± SEM time to 50% decay, 
nontransfected controls: 75.40 ± 9.34 ms, n = 10 cells; GFP-expressing neurons: 81.72 ± 9.15 
ms, n = 11 cells; RhebQ64L-expressing neurons: 85.09 ± 7.75 ms, n = 9 cells; F(2,27) = 0.29, 
not significant), suggesting similar NMDAR subunit composition in the three conditions. As 
expected for an increase in release probability, we found that MK-801 blockade of NMDAR 
currents was significantly accelerated in RhebQ64L-expressing neurons relative to untransfected 
neurons from the same cultures, as well as from control neurons expressing GFP in sister 
cultures (Figure 2.9F-G). Again, the extracellular BDNF scavenger TrkB-Fc completely 
eliminated the enhanced release probability onto RhebQ64L-expressing neurons, suggesting that 
postsynaptic mTORC1 activation controls evoked neurotransmitter release through the release of 




activation is sufficient to drive retrograde enhancement of presynaptic function in a BDNF-
dependent fashion, a manner similar to homeostatic changes in presynaptic function induced by 
loss of excitatory synaptic input. 
 
2.4 Discussion 
 Our results identify a novel mode of synaptic regulation conferred by local mTORC1-
dependent signaling in dendrites. While the role of mTORC1 in contributing to alterations in 
postsynaptic function during protein synthesis-dependent forms of synaptic plasticity is well 
established (Tang et al., 2002; Cammalleri et al., 2003; Hou and Klann, 2004), here we have 
shown that dendritic mTORC1 activation also gates a local retrograde signaling mechanism that 
drives changes in presynaptic function from apposed postsynaptic terminals. This unique trans-
synaptic role for dendritic mTORC1 signaling is critically dependent on BDNF release, which 
serves to couple loss of excitatory synaptic drive with retrograde compensation of presynaptic 
function. Finally, we show that dendritic mTORC1 plays a spatially restricted role in retrograde 
modulation of presynaptic function induced by AMPAR blockade, revealing a unique role for 
mTORC1 as part of a homeostatic translational control pathway that operates locally in dendrites 
and underlies trans-synaptic control of presynaptic function. 
 
Parallel translational regulatory pathways in dendrites mediate distinct homeostatic 
adaptations at synapses 
 While alterations in postsynaptic firing have been shown to exert cell-wide homeostatic 
changes in synaptic strength (Ibata et al., 2008; Goold and Nicoll, 2010), several groups have 




dendrites (Sutton et al., 2006; Aoto et al., 2008; Jakawich et al., 2010), even at individual 
synapses (Lee et al., 2010; Béïque et al., 2011; Hou et al., 2011). Indeed, acute loss of excitatory 
synaptic input induces a rapid and local recruitment of GluA1 homomeric receptors to affected 
synapses. This recruitment is critically dependent on dendritic protein synthesis (Sutton et al., 
2006; Aoto et al., 2008; Maghsoodi et al., 2008). In hippocampal neurons, this rapid postsynaptic 
compensation can be induced by blockade of either AMPARs or NMDARs, whereas retrograde 
compensation of presynaptic terminals accompanies AMPAR blockade but not NMDAR 
blockade (Jakawich et al., 2010). We also find that AMPAR blockade rapidly activates mTORC1 
signaling in dendrites of hippocampal neurons, but NMDAR blockade over the same period does 
not. However, it is clear that patterned synaptic activity drives mTORC1 signaling in 
hippocampal neurons through an NMDAR-dependent mechanism (Tang et al., 2002; Cammalleri 
et al., 2003), and that loss of NMDAR activity in cortical neurons can also activate mTORC1 
signaling (Li et al., 2010; Wang et al., 2011). Whether these differences reflect unique coupling 
of AMPARs to inactivation-induced mTORC1 signaling in hippocampal neurons or differences 
in the timing or context of NMDAR blockade await future studies. On the other hand, the 
coupling between AMPARs and mTORC1 activation that we describe in hippocampal neurons 
has also been recently observed at the Drosophila neuromuscular junction (NMJ). Similar to our 
findings, Penney and colleagues (2012) document a requirement for postsynaptic TOR activation 
in vivo during retrograde homeostatic plasticity driven by AMPAR blockade at the NMJ, and 
also find that genetic upregulation of postsynaptic TOR activity is sufficient to drive retrograde 
enhancement of presynaptic function. Together with our results, these findings suggest that the 




 We find that postsynaptic compensation induced by AMPAR blockade, which, in 
hippocampal neurons, is highly similar to that following acute loss of NMDAR activity, is 
insensitive to mTORC1 inhibitors or postsynaptic knockdown of mTORC1 signaling (but see 
Wang et al., 2011). Consistent with our results, Maghsoodi et al. (2008) found that mTORC1 
inhibition with rapamycin did not disrupt postsynaptic compensation induced by retinoic acid, 
which is an essential intermediate in the recruitment of GluA1 homomeric receptors to synapses 
during NMDAR blockade (Aoto et al., 2008; Soden and Chen, 2010). These results illustrate that 
homeostatic plasticity of postsynaptic function differs from L-LTP and mGluR-LTD in 
hippocampal neurons in relying on a distinct mTORC1-independent translational control 
pathway in dendrites for its induction. We speculate that the dependence on unique translation 
regulatory events likely reflects a requirement for a distinct set of newly synthesized effector 
proteins in each case, despite the common regulation of synaptic AMPAR content as a mode of 
expression. Interestingly, we found that postsynaptic mTORC1 activation over a time-frame that 
encompasses L-LTP and mGluR-LTD induction was insufficient to drive changes in 
postsynaptic function directly. This suggests that the unique complement of postsynaptic proteins 
synthesized in an mTORC1-dependent fashion (Schratt et al., 2004; Slipczuk et al., 2009; Neasta 
et al., 2010) must interact with other activity-dependent signaling events to alter postsynaptic 
function in an enduring fashion. While relatively acute mTORC1 activation (<24 h) in our 
experiments did not alter postsynaptic function directly, there is evidence to suggest that longer, 
chronic hyperactivation of neuronal mTORC1, via knockdown of TSC1 or TSC2, is associated 
with morphological and functional changes in the postsynaptic compartment (Tavazoie et al., 
2005; Bateup et al., 2011). Our findings raise the intriguing possibility that the alterations in 




activation might be secondary to altered neurotransmitter release from apposed synaptic 
terminals, given that these functional changes in the presynaptic compartment are the first to 
emerge following mTORC1 activation. 
 While the functional role of dendritic protein synthesis on postsynaptic function has been 
heavily studied, it is now clear that alteration of presynaptic function by dendrite-derived factors 
can exert an important additional level of regulatory control at synapses (Regehr et al., 2009). 
Such retrograde signaling is also known to play a pivotal role in synaptic homeostasis (Frank et 
al., 2006; Branco et al., 2008; Jakawich et al., 2010; Lindskog et al., 2010). For example, local 
activity in a specific dendritic branch has been shown to homeostatically modulate release 
probability from apposed presynaptic terminals (Branco et al., 2008), and similar retrograde 
changes in presynaptic function are dependent on local dendritic protein synthesis (Jakawich et 
al., 2010). Our results demonstrate an essential role for mTORC1 activation in this local 
retrograde modulation of presynaptic function. Hence, parallel mTORC1-dependent and 
mTORC1-independent translational control pathways in dendrites subserve rapid homeostatic 
adjustment of presynaptic and postsynaptic function. 
 
mTORC1-dependent retrograde signaling requires BDNF as a downstream effector 
 We identified BDNF as a critical effector acting downstream of mTORC1 activation in 
driving enhancement of presynaptic function. mTORC1 signaling is necessary for enhanced 
BDNF expression accompanying AMPAR blockade, and postsynaptic mTORC1 activation in 
the absence of AMPAR blockade is sufficient to enhance dendritic BDNF expression. Given that 
mTORC1 is required locally in dendrites for presynaptic compensation and that AMPAR 




dendritic mTORC1 likely directly controls BDNF synthesis in dendrites. Consistent with this 
notion, we find that mTORC1 activation induces highly compartmentalized changes in BDNF 
expression, with significant elevation in dendrites despite no measurable changes in the cell body 
from the same neurons. Presently, it is unclear what mechanisms account for the compartment-
specific changes in BDNF expression accompanying mTORC1 activation, although it is known 
that the BDNF mRNA pool comprises up to 16–22 transcripts with unique 5′ and/or 3′ UTRs 
(Aid et al., 2007). Moreover, these distinct BDNF transcripts exhibit differences in activity-
dependent dendritic trafficking (Pattabiraman et al., 2005; Chiaruttini et al., 2008) as well as 
constitutive dendritic localization (An et al., 2008; Baj et al., 2011), raising the possibility that 
only a small subset of these, which may comprise a greater relative proportion of the dendritic 
BDNF mRNA pool (Baj et al., 2011), are responsive to mTORC1 activation (Liao et al., 2012). 
Future studies are needed to map the mTORC1-responsive sites (or lack thereof) in each BDNF 
transcript to test this idea. Another unresolved question relates to the relative influence of 
proBDNF and mature BDNF in driving the presynaptic changes induced by dendritic mTORC1 
activation. Whereas mature BDNF is clearly upregulated by AMPAR blockade in a rapamycin-
sensitive fashion (Figure 2.7A-B), further studies are needed to test whether the presynaptic 
changes induced by dendritic mTORC1 activation require the release of proBDNF, mature 
BDNF, or some combination of the two. 
 
A novel target for cognitive dysfunction caused by dysregulated mTORC1 signaling? 
 Several disorders resulting in cognitive impairment and mental retardation have been 
suggested to share dysregulation of local protein synthesis in dendrites as a common feature 




monogenic disorders resulting in overactive mTORC1 signaling, such as tuberous sclerosis 
complex, neurofibramatosis type 1, and PTEN (phosphatase and tensin homolog deleted on 
chromosome 10) harmatoma syndrome (Kwiatkowski, 2003; Butler et al., 2005; Johannessen et 
al., 2005; Ehninger et al., 2008) have high comorbidity rates with autism spectrum disorders 
(ASDs), leading to the idea that altered protein synthesis in neurons may be a common 
phenotype central to the emergence of aberrant cognitive and behavioral characteristics related to 
ASD (Kelleher and Bear, 2008). Indeed, the well-established role for mTORC1 in supporting 
protein synthesis-dependent changes in postsynaptic function suggests that the resulting defects 
in postsynaptic adaptability stemming from dysregulated mTORC1 signaling are likely to 
contribute to these syndromes. Our findings reveal an integral role for dendritic mTORC1 in 
supporting retrograde modulation of presynaptic function, illustrating an alternative mode of 
synaptic regulation that may also be relevant for ASD and other disorders caused by synaptic 
dysfunction. 
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Figure 2.1: Acute loss of excitatory synaptic drive activates dendritic mTORC1 signaling. 
(A) Representative Western blots depicting phosphorylated (S235/236) and total ribosomal 
protein S6 following AMPAR blockade with 40 μM CNQX (n = 8 experiments) or NMDAR 
blockade with 50 μM APV (n = 6 experiments) for the indicated times. (B) Mean (±SEM) 
expression of PS6 in neurons subject to AMPAR or NMDAR blockade; AMPAR blockade 
induced a significant (*p < 0.05 relative to 0 min control) increase in S6 phosphorylation, 
whereas NMDAR blockade did not. (C–E) Representative Western blots and summary data from 
experiments (n = 5) where neurons were treated with CNQX (40 μM, 30 min) plus rapamycin 
(100 nM, 30 min pretreatment) before harvesting; *p < 0.05 relative to controls. AMPAR 
blockade stimulates phosphorylation of downstream mTORC1 effectors ribosomal protein S6 
(C), p70S6K (D), and 4E-BP1 (E) (upper band) in a rapamycin-sensitive fashion. The increase in 
phosphorylation of S6, p70S6K, as well as 4E-BP1 accompanying AMPAR blockade is 
prevented by rapamycin (*p < 0.05 relative to untreated control). F, Representative examples of 
PS6 staining from cells treated with CNQX (40 μM, 60 min) or control; straightened dendrites 
are shown below each full-frame image. Scale bar, 10 μm. PS6 fluorescence intensity indicated 
by color look-up table. (G) Mean (+SEM) expression of MAP2 and PS6 in somatic and dendritic 
compartments, normalized to average control values, in neurons treated as indicated. PS6 
fluorescence was significantly (*p < 0.05, relative to control) enhanced by AMPAR blockade (n 
= 28 cells) relative to control neurons (n = 30 cells), in both the dendritic and somatic 
compartments. MAP2 expression did not differ between groups. (H-I) Representative Western 
blots and summary data from experiments (n = 8 and 5 experiments for H and I, respectively) 
assessing changes in eEF2 phosphorylation as a result of AMPAR blockade. Neurons were 
treated with CNQX plus rapamycin as above before harvesting; *p < 0.05 relative to controls. 
AMPAR blockade elicits dephosphorylation of eEF2 (favoring translation elongation) that is 


































Figure 2.2: mTORC1 is not involved in adaptive postsynaptic compensation induced by 
AMPAR blockade. (A-B) Representative examples (A) and mean (+SEM) normalized synaptic 
surface GluA1 (sGluA1) expression (B) in cultured neurons treated with 40 μM CNQX for 120 
min or control (n = 30 images), with or without pretreatment with rapamycin (100 nM, 30 min 
before CNQX) (n = 30 images/group). mTORC1 activity is not required for enhanced synaptic 
sGluA1 expression after AMPAR blockade. Scale bar: A, 10 μm. *p < 0.05 versus untreated 
control or rapamycin alone, respectively. (C–E) Representative mEPSC recordings (C) and mean 
(+SEM) mEPSC amplitude (D) and frequency (E) in neurons following washout of treatment 
with CNQX (40 μM, 3 h) with or without 30 min pretreatment with rapamycin (100 nM) or the 
mTOR active site inhibitor C-401 (10 μM). Cell numbers for the indicated groups: control, n = 
18; CNQX, n = 19; rapamycin alone, n = 7; CNQX plus rapamycin, n = 13; C401 alone, n = 11; 
CNQX plus C401, n = 10. A significant (*p < 0.05 vs control) increase in mEPSC amplitude and 
frequency follows AMPAR blockade; treatment with either mTORC1 inhibitor blocked the 
increase in mEPSC frequency but not the increase in mEPSC amplitude. (F) Representative 
recording from an example subjected to AMPAR blockade in the presence of C-401, both before 
and after acute treatment with the polyamine toxin NASPM. (G) Mean (+SEM) mEPSC 
amplitude in neurons pretreated with either rapamycin (100 nM) or C401 (10 μM) and then 
subject to brief AMPAR blockade (CNQX, 40 μm, 3 h), followed by recording in the presence or 
absence of 10 μM NASPM. Sample sizes (# cells) for the indicated groups: control, n = 18; 
CNQX, n = 19; rapamycin alone, n = 7; CNQX plus rapamycin, n = 13; CNQX plus rapamycin 
plus NASPM, n = 12; C401 alone, n = 11; CNQX plus C401, n = 10; CNQX plus C401 plus 
NASPM, n = 5. Coincident mTORC1 inhibition did not affect the sensitivity of scaled mEPSCs 
to NASPM, indicating that the protein synthesis-dependent recruitment of GluA1 homomeric 
















   




Figure 2.3: AMPAR blockade drives mTORC1-dependent enhancements in spontaneous 
and evoked vesicle release. (A-B) Representative examples (A) and mean (+SEM) syt-lum 
uptake (B) from experiments where the indicated groups were pretreated (30 min before CNQX) 
with either rapamycin (100 nM) or C401 (10 μM) and then subject to brief AMPAR blockade 
(CNQX, 40 μM, 3 h) before staining. Results for indicated groups: control, n = 30 images; 
CNQX alone, n = 30 images; rapamycin alone, n = 30 images; CNQX plus rapamycin, n = 30 
images; C401 alone, n = 30 images; CNQX plus C401, n = 30 images. AMPAR blockade 
induces a significant (*p < 0.05, relative to control) increase in syt-lum uptake prevented by 
coincident inhibition of mTORC1 activity. Scale bar: A, 10 μm. (C-D) Example images of axon 
terminals coexpressing mCherry-synaptophysin (mCh-Syn, top) as well as vglut-pHluorin (vglut-
pH, bottom). Bottom, Images of the same set of synapses after termination of a 10 Hz 10 s 
stimulus train. Treatment with the AMPAR blocker CNQX (40 μM, 3 h) enhances the changes in 
vglut-pHluorin fluorescence intensity, compared with cells treated with vehicle in response to an 
identical stimulus train. Scale bar: C, 10 μm. (D) Relative change in vglut-pHluorin fluorescence 
over time in response to a 10 Hz 10 s stimulus train, recorded from cells treated with vehicle, 
CNQX, CNQX plus rapamycin, or rapamycin alone. Black bar represents onset of 10 s stimulus 
train. Black, Vehicle control (n = 579 synapses). Red, CNQX (n = 287 synapses). Green, CNQX 
plus rapamycin (n = 746 synapses). Blue, Rapamycin alone (n = 566 synapses). Evoked changes 
in vglut-pHluorin fluorescence intensity were significantly (*p < 0.05, relative to vehicle controls 
at peak fluorescence levels at immediate termination of stimulus train) enhanced by treatment 
with CNQX, and this effect was blocked by concurrent treatment with the mTORC1 inhibitor 
rapamycin. 




















Figure 2.4: Postsynaptic mTORC1 activation is required for retrograde enhancement of 
presynaptic function. (A) Experimental rationale: low-efficiency transfection using calcium 
phosphate yields isolated transfected neurons surrounded by nontransfected cells. During 
recordings from TSC1/2(+) cells, mTORC1 signaling is impaired postsynaptically, while 
presynaptic mTORC1 activity is preserved (red insert). (B) Example of a TSC1/2-overexpressing 
neuron in a network of untransfected neurons depicting GFP (cotransfected with TSC1/2) and 
PS6 expression, as indicated; PS6 fluorescence intensity indicated by color look-up table. Scale 
bar, 40 μm. PS6 expression in the transfected neuron is substantially reduced relative to 
surrounding cells. (C) Mean (+SEM) normalized PS6 expression in transfected neurons. TSC1/2 
overexpression (n = 19 neurons) significantly (*p < 0.05, t test) reduced basal PS6 levels 
compared with transfection with EGFP alone (n = 11 cells), and also blocked increases in PS6 by 
CNQX (n = 16 cells); *p < 0.05 versus EGFP alone. D–F, Representative mEPSC recordings (D) 
and mean (+SEM) mEPSC amplitude (E) and frequency (F) in neurons cotransfected with 
TSC1/2 and EGFP (n = 11) with (n = 15) or without (n = 11) treatment with CNQX (40 μM, 3 
h); mEPSCs in these neurons were compared with those from untransfected neighboring cells as 
well as from neurons from sister cultures transfected with EGFP alone. Cells were transfected at 
DIV 21–25 and then used for recordings 24 h later. Postsynaptic inhibition of mTORC1 
signaling via overexpression of TSC1/2 blocked the increase in mEPSC frequency but not the 
increase in mEPSC amplitude induced by AMPAR blockade. For the groups listed left to right in 











Figure 2.5: mTOR acts locally in dendrites to modulate presynaptic function after AMPAR 
blockade. (A) Representative differential interference contrast image of a cultured hippocampal 
neuron exposed to AMPAR blockade (90 min bath application of 40 μM CNQX) with 
superimposed rapamycin (200 nM) perfusion spot (green) and the same neuron after staining 
with α-syt. (B) Linearized primary dendrite from the cell shown in A with corresponding α-syt 
and vglut1 staining registered to the perfusion area (green). Scale bars: 25 μm. A decrease in syt-
lum uptake is evident in the perfused area, whereas vglut1 expression remains stable. C, D, Mean 
(±SEM) normalized syt-lum/vglut1 staining in treated and untreated dendritic segments from 
cells subject to local microperfusion of rapamycin (200 nM) with or without concurrent AMPAR 
blockade; all data are expressed as a percentage change in fluorescence relative to the average 
value in untreated segments. Local rapamycin perfusion significantly (*p < 0.05) decreased syt-
lum uptake in the treated area relative to vglut1 expression in the same dendritic segment when 
CNQX was present (C) (n = 10 dendrites from 10 neurons), but not when vehicle was applied to 













Figure 2.6: BDNF enhances presynaptic function downstream of mTORC1. (A-B) 
Representative Western blots and summary data from experiments (n = 5) examining the 
phosphorylation of downstream mTORC1 effectors S6 (A) and p70S6K (B) during AMPAR 
blockade. Cultured neurons were treated with CNQX (40 μM) with or without TrkB-Fc (1 μg/ml, 
30 min pretreatment) before harvesting; *p < 0.05 relative to 0 min control. Phosphorylation of 
S6 at S235/236 and p70S6K at Thr389 during AMPAR blockade is not affected by scavenging 
extracellular BDNF. (C-D) Representative recordings (C) and mean (+SEM) mEPSC frequency 
(D) after BDNF application (250 ng/ml, 2 h) in the presence or absence of rapamycin (100 nM, 
30 min pretreatment). For the groups indicated left to right, n = 7, 6, and 7 cells. BDNF induces a 
significant (*p < 0.05) sustained increase in mEPSC frequency evident 30–50 min following 
BDNF washout. This increase is unaltered by concurrent treatment with the mTORC1 inhibitor 
rapamycin. (E-F) Representative examples (E) and mean (+SEM) syt-lum uptake (F) from 
experiments (n = 15/group) where neurons were treated with BDNF (250 ng, 60 min) with or 
without rapamycin (100 nM; 30 min before BDNF). Inhibiting mTORC1 signaling did not 
impact enhanced syt-lum uptake induced by BDNF treatment (*p < 0.05, relative to control). 
























Figure 2.7: Compartmentalized enhancement in BDNF expression by AMPAR blockade 
requires mTORC1. (A-B) Representative Western blots (A) and summary data (B) in 
experiments (n = 6) where neurons were treated with CNQX (40 μM, 120 min) with or without 
rapamycin (100 nM, 30 min pretreatment) before harvesting; *p < 0.05 relative to control. The 
BDNF band (∼14 kDa) represents mature BDNF. (C-D) BDNF expression in linearized somatic 
and dendritic segments and mean (+SEM) expression BDNF in somatic and dendritic 
compartments normalized to average control values, in neurons treated with CNQX (40 μM, 3 h) 
with or without rapamycin (100 nM, 30 min pretreatment). (E) AMPAR blockade significantly 
enhanced BDNF expression in dendrites (*p < 0.05, n = 30 neurons) compared with untreated 
control neurons (n = 33). This effect was blocked by pretreatment with rapamycin (100 nM; n = 
31 neurons), which had no effect on BDNF expression on its own (n = 29 neurons). Somatic 











































Figure 2.8: Sparse mTORC1 activation enhances synaptic efficacy in a cell-autonomous 
fashion. (A) Experimental rationale: Low-efficiency transfection using calcium phosphate yields 
individual transfected neurons surrounded by nontransfected cells. During recordings from 
RhebQ64L(+) cells, mTORC1 signaling is enhanced postsynaptically, while presynaptic 
mTORC1 activity is normal (red insert). (B-C) Example images (B) and mean (+SEM) 
normalized PS6 expression (C) in transfected neurons. Expression of RhebQ64L (n = 14 cells) 
significantly (*p < 0.05 vs EGFP alone by t test) enhanced PS6 levels compared with 
transfection with EGFP alone (n = 14 cells). PS6 fluorescence intensity indicated by color look-
up table. Scale bar, 40 μm. (D-E) Representative recordings of sEPSCs (D) and mean charge 
transfer (E) of RhebQ64L-expressing neurons (n = 17) or neighboring nontransfected neurons (n 
= 16), as well as EGFP-expressing neurons (n = 19) in low Ca2
+ 
(0.5 mM) extracellular solution. 
Quantificative analysis of spontaneous activity was performed by measuring the total charge 
transfer in 20 s relative to nontransfected cells. Postsynaptic expression of RhebQ64L was 
sufficient to induce an increase in spontaneous activity of nontransfected presynaptic neurons. *p 
< 0.01, one-way ANOVA, Tukey–Kramer post hoc. (F–H) Effects of altered mTORC1 signaling 
on cell growth pathways in hippocampal neurons. (F) Representative images of cultured 
hippocampal neurons cotransfected with GFP as well as either TSC1/2 or RhebQ64L. Scale bar, 
10 μm. (G-H) After 24 h, neither TSC1/2 (n = 21) nor RhebQ64L overexpression (n = 16) has 
any effect on soma size or spine density when compared with cells expressing EGFP alone (n = 
71). In contrast, 5 d of TSC1/2 expression yields significantly diminished soma size (n = 47) 
while prolonged RhebQ64L expression (n = 27) results in significantly enhanced soma size 
compared with control EGFP-expressing cells (n = 30); again, no significant change in spine 





























Figure 2.9: Postsynaptic mTORC1 activation drives enhancement of presynaptic function 
via BDNF release. (A-B) BDNF and MAP2 expression in linearized somatic and dendritic 
segments (A), and mean (+SEM) expression (B) of MAP2 and BDNF in somatic and dendritic 
compartments normalized to average control values, in neurons cotransfected with RhebQ64L 
and EGFP or neurons transfected with EGFP alone. While BDNF expression in dendrites was 
significantly (*p < 0.05, relative to EGFP alone) enhanced by expression of RhebQ64L (n = 22) 
compared with control neurons expressing EGFP alone (n = 22), somatic expression from these 
same cells was unchanged. MAP2 expression did not differ between groups. Scale bar: A, 10 
μm. (C–E) Representative recordings (C) and mean (+SEM) mEPSC frequency (D) and 
amplitude (E) in nontransfected neurons (n = 9) or neurons transfected with RhebQ64L as well 
as EGFP (n = 7) with or without treatment with TrkB-fc (1 μg/ml applied immediately post-
transfection: RhebQ64L(−) with TrkB-fc, n = 6; RhebQ64L(+) with TrkB-fc, n = 10). Cells were 
transfected at DIV 21–25 and then used for recordings 24 h later. Postsynaptic enhancement of 
mTORC1 signaling via expression of RhebQ64L was sufficient to increase mEPSC frequency 
compared with cells expressing EGFP alone, and this effect was blocked by scavenging 
extracellular BDNF with TrkB-fc. Neither RhebQ64L expression nor treatment with TrkB-fc had 
any effect on mEPSC amplitude. *p < 0.05, relative to EGFP alone. (F) Average MK801 
blockade of RhebQ64L (n = 11), EGFP (n = 11), and nontransfected (n = 10) neurons. MK801 
(20 μM) was applied to the bath (0 Mg2+, with CNQX and bicuculline) for 5 min, followed by 
200 extracellular stimulations (0.33 Hz), while voltage-clamping the cell at −70 mV to record 
NMDAR-mediated currents. The amplitude of each response was measured and expressed 
relative to the amplitude of the first response. The mean for each response is plotted in small 
circles and fitted by a double-exponential curve (untransfected: τ1 = 8.64, τ2 = 175.8; EGFP: τ1 
= 3.92, τ2 = 157.33; RhebQ64L: τ1 = 2.93, τ2 = 96.97). (G) Average percentage response of the 
second through eleventh stimulation relative to the first EPSC. Expression of RhebQ64L in the 
postsynaptic neuron was sufficient to increase the rate of MK801 blockade and extracellular 
incubation of TrkB-fc with RhebQ64L expression blocked the increase. *p < 0.01, one-way 
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Transynaptic signaling by BDNF as an immediate consequence of acute 
mTORC1 activation in dendrites 
 
3.1 Abstract 
 Spatially constrained protein synthesis within and around synaptic sites on dendrites 
provides an essential layer of control by which individual neurons can uniquely adapt to ongoing 
branch-specific changes in the pattern of afferent inputs. Further understanding of specific 
molecular mechanisms involved in regulating local translation of dendritic mRNAs in response 
to altered activity is currently an area of great interest.  In particular the mammalian target of 
rapamycin complex 1 (mTORC1) has been implicated as an important regulator of local protein 
synthesis, with well-characterized roles in long lasting forms of synaptic plasticity and memory 
formation. Here we report that mTORC1 is activated by the lipid second messenger phosphatidic 
acid (PA) in hippocampal neurons, with subsequent fast acting and profound effects on synaptic 
function. Transient application of exogenous PA drives mTORC1 activation in hippocampal 
neurons, stimulates synthesis of BDNF, and also drives a protein-synthesis dependent increase in 
the frequency, but not amplitude of spontaneous mEPSCs. Experiments utilizing either cell 
specific or transient inhibition of BDNF synthesis suggest that de novo BDNF translation in the 
postsynaptic compartment underlies retrograde signaling driven by dendritic mTORC1 




neurological and psychiatric disorders, a more thorough mechanistic understanding of translation 
regulation in dendrites has the potential to yield greater insight into the synaptic etiology of 
syndromes characterized by debilitating cognitive impairment. 
 
3.2 Introduction 
 The regulation of localized translation at synaptic sites in dendrites has emerged as vital 
mechanism whereby neurons alter the protein landscape in spatially defined regions of the cell in 
response to particular types of stimuli (Liu-Yesucevitz et al., 2011).  The ever widening range of 
cellular events believed to utilize this feature suggests that it may be more commonplace than 
once imagined, and is likely of particular use in brain regions with well defined stratified circuits 
such as in the hippocampus, where cells are equipped with dendritic arbors that display a high 
degree of functional compartmentalization (Branco and Hausser, 2010).  Recent studies suggest 
mRNAs transcripts representing over 2500 genes are localized outside the cell body in the CA1 
region of the hippocampus (Cajigas et al., 2012), revealing a broad range of alterations in cellular 
function that might depend on changes in dendritic translation.  
 One signaling pathway that has been shown to play an important role in regulating local 
protein synthesis in dendrites is that of the mechanistic target of rapamycin (mTOR). When 
bound to the regulatory protein raptor, mTOR forms a complex (mTORC1) known to regulate 
protein synthesis at the level of translation initiation (Ma and Blenis, 2009). mTORC1 is 
believed to regulate protein synthesis via phosphrylation of several components of the 
translational machinery, including the S6 kinases (S6Ks), the inhibitory eIF4E-binding proteins 
(4E-BPs), and the eIF4G initiation factors. Recent work however, suggests that 4E-BP is 




selective regulation of a subset of mRNA transcripts that contain 5′ terminal oligopyrimidine 
(TOP) motifs (Thoreen et al., 2012).  In mammalian central neurons, multiple dendritically 
localized mRNA transcripts have been shown to be under mTORC1-dependent translational 
control, changes in which can elicit profound effects on cellular structure and function (Raab-
Graham et al., 2006; Lee et al., 2011; Liao et al., 2012).  
 From a clinical perspective, harnessing mTORC1‟s influence over synapse development 
and plasticity has emerged as a potential point of therapeutic intervention (Ehninger and Silva, 
2011). Several monogenic forms of intellectual disability (ID) and Autism Spectrum Disorders 
(ASD) involve mutations in proteins that normally serve to inhibit mTORC1 signaling in vivo.  
As such, disorders including Tuberous Sclerosis, PTEN Hamartoma syndrome, and 
Neurofibramatosis Type 1 all share a common molecular phenotype of hyperactive mTORC1 
signaling (Kelleher and Bear, 2008). Despite this clear genetic link, it has been difficult to 
determine the precise relationship between dysregulated mTORC1 signaling and the abnormal 
social and cognitive phenotypes observed in patients with ASD and ID.  Previous reports have 
demonstrated that mTORC1 is vital for regulating proper circuit development (Nie et al., 2010; 
Normand et al., 2013), and mTORC1 signaling has been implicated in multiple forms of synaptic 
plasticity including Long Term Potentiation (Tang et al., 2002; Cammalleri et al., 2003; Stoica et 
al., 2011) and mGluR-dependent long term depression (Hou and Klann, 2002; Antion et al., 
2008), highlighting the multifaceted role for this signaling pathway in multiple cell types and 
developmental stages in the brain.  
 Outside of an emerging consensus regarding a role for mTORC1-dependent regulation of 
de novo protein-synthesis in synaptic plasticity, there is much less agreement with respect to the 




example, recently published studies examining the effects of conditional deletion of PTEN or 
mutations in either component of the tuberous sclerosis complex, have described incongruous 
effects of mTOR hyperactivation with respect to basic synapse function, including descriptions 
of no change in fEPSP input/output curve (Wang et al., 2006), deficits in fEPSP Input/output 
curve (Fraser et al., 2008), increases in mEPSC amplitude but not frequency (Tavazoie et al., 
2005, Weston et al., 2012), increases in mEPSC frequency but not amplitude (Bateup et al, 2011, 
Luikart et al., 2011), no change in mEPSC characteristics at all (Sperow et al., 2012), increases 
in presynaptic function (Weston et al. 2012), decreases in presynaptic release (von der Brelie et 
al., 2006), and no change in inhibitory neurotransmission (Luikart et al., 2011), versus profound 
effects on inhibitory synapse function (Bateup et al., 2013). Given that the extent of genetic 
manipulations utilized in these studies ranged from days to months, it is possible that variability 
in the duration of mTORC1 hyperactivation may possibly account for the inconsistent findings. 
mTORC1 is embedded in a rich network of interacting biochemical signals, and chronic 
dysregulation of this pathway may potentially recruit feedback mechanisms that result in cellular 
phenotypes which may not accurately reflect the nature of the initial insult (Rodrik-Outmezguine 
et al., 2011).  
 With these issues in mind, we sought to elucidate the immediate consequences of 
upregulated mTORC1 signaling on synapse form and function. To address this question, we used 
exogenous application of the lipid second messenger phosphatidic acid (PA), which has been 
shown to activate mTORC1 signaling in non-neuronal cells (Fang et al., 2001; Lim et al., 2003). 
Treatment with PA produced rapid activation of mTORC1 signaling in cultured hippocampal 
neurons, with subsequent profound effects on network function. These network effects were not 




presynaptic vesicle release at excitatory terminals. Cell specific elimination of BDNF expression 
revealed that this protein functions as a retrograde signal in response to acute mTORC1 
activation, acting to increase presynaptic efficacy. Understanding this change in basal synapse 
function in response to enhanced mTORC1 activity is important, given that several monogenic 
disorders resulting in intellectual disability and Autism-like phenotypes share a common feature 
of dysregulated mTORC1 activation at the synapse (Hoeffer and Klann, 2010).   
 
3.3 Results 
Phosphatidic acid (PA) is a lipid second messenger believed to activate mTORC1‟s 
kinase activity by binding directly to the FRB domain on mTOR itself and stabilizing the 
complex with its binding partner raptor (Veverka et al., 2008; Toschi et al., 2009). Consistent 
with observations from experiments using non-neuronal cell lines (Fang et al., 2001; Yoon et al., 
2011; You et al., 2012), western blots of lysates prepared from hippocampal neuron cultures 
revealed that PA rapidly induced sustained phosphorylation of the immediate downstream 
mTORC1 effectors 4E-BP1 and p70S6K (Figure 3.1A-B). The timing of kinase activity at these 
two downstream targets appear slightly staggered, with levels of phosphorylated p70S6K rising 
dramatically within the first 15 minutes after mTORC1 stimulation with PA, and p-4EBP1 levels 
showing peak activation 30 minutes after PA treatment (Normalized p-4EBP1 15 min post-PA, 
120.18±5.82% of Time 0, n=3; Normalized p-4EBP1 30 min post-PA, 111.69±2.99% of Time 0, 
n=3; Normalized p-p70S6K 15 min post-PA, 107.84±7.26% of Time 0, n=3; Normalized p-
p70S6K 30 min post-PA, 125.42±18.07% of Time 0, n=3). We observed persistent increases in 
mTORC1 kinase activity after activation with PA (100M), with significantly elevated levels of 




PA, 124.89±5.28% of Time 0, n=3; Normalized p-p70S6K 120 min post-PA, 129.84±9.30% of 
Time 0, n=3). As an additional metric of PA-induced changes in mTORC1 kinase activity 
(Figures 3.1C-D), we also found robust phosphorylation of ribosomal protein S6 at S235/236 in 
the cell bodies and dendrites of hippocampal neurons as assessed via immunocytochemistry 
(Normalized p-S6 Intensity Vehicle Control, 100±7.21%, n=13; Normalized p-S6 Intensity PA 
60min, 177.28±25.99%, n=19). Expression of tubulin (Figure 3.1A) and microtubule associated 
protein 2 (MAP2) did not change significantly as a consequence of exposure to PA (Figure 
3.1D).  
Using PA as a tool to acutely activate mTORC1 signaling in neurons, we next examined 
the consequences of such activation on dendritic BDNF expression. Previous work from our lab 
and others has identified BDNF as a unique target of mTORC1-dependent translational 
regulation in dendrites (Henry et al., 2012; Liao et al., 2012). In hippocampal neurons, this 
dendritic synthesis of BDNF plays a vital role in the homeostatic regulation of excitatory 
synapses, acting as a retrograde signal to enhance the efficacy of presynaptic terminals (Jakawich 
et al., 2010; Lindskog et al., 2010; Henry et al, 2012). Acute mTORC1 activation (60 min PA, 
100M) enhanced dendritic BDNF staining intensity in hippocampal dendrites, while having no 
effect on dendritic MAP2 expression in these same neurons (Figure 3.2A-B). Coincident 
blockade of protein synthesis (with 40μM anisomycin, 30 min prior to PA) or mTORC1 (with 
300nM rapamycin, 30 min prior to PA) completely suppressed this effect, suggesting that 
treatment with PA drives new synthesis of BDNF via activation of mTORC1 (Normalized 
BDNF Intensity Vehicle Controls, 100±15.17%, n=25; Normalized BDNF Intensity PA 60min, 
220.03±29.21%, n=25; Normalized BDNF Intensity PA+Aniso, 93.92±13.92%, n=25; 




statistically insignificant, effect of Anisomycin and Rapamycin on dendritic BDNF intensity 
when administered alone, suggesting a very limited role for steady-state BDNF synthesis under 
baseline conditions (Normalized BDNF Intensity Aniso alone, 77.89±11.33%, n=25; Normalized 
BDNF Intensity Rap alone, 86.76±22.38%, n=25). Similar effects were observed in western blots 
of hippocampal neuron lysates from cells treated with PA alone or in combination with 
Rapamycin (Figure 3.2C-D). PA elicited a time-dependent increase in BDNF expression, with an 
initial peak at 15min post PA treatment and significantly elevated levels observed up to 60min 
post treatment (Normalized BDNF expression PA 15min, 156.13±28.25% of time 0, n=3; 
Normalized BDNF expression PA 30min, 152.67±20.39% of time 0, n=3; Normalized BDNF 
expression PA 60min, 134.69±23.05% of time 0, n=3). This increase in BDNF expression was 
also mTORC1-dependent, as concurrent rapamycin (300nM) treatment completely eliminated 
PA-induced BDNF expression (Normalized BDNF expression PA+Rap 15min, 121.37±25.32% 
of time 0, n=3; Normalized BDNF expression PA+Rap 30min, 104.13±20.80% of time 0, n=3; 
Normalized BDNF expression PA+Rap 60min, 101.94±9.52% of time 0, n=3). As a final readout 
of PA-induced changes in BDNF expression, we took advantage of a recently developed 
fluorescent reporter of local BDNF synthesis in dendrites (Figure 3.2E-F). The reporter consists 
of the entire long Bdnf 3′ UTR (sequence „A*B‟), alongside a myristoylation peptide (myr), 
destabilized d1GFP protein, and a nuclear localization sequence (nls), which in total prevents 
substantial intracellular movement of reporter-based fluorescence away from the area in which it 
was synthesized (Liao et al., 2012). BDNF transcripts with long 3‟UTR have been previously 
shown to display preferential localization to the distal regions of dendrites (An et al., 2008), and 
as such the myr-d1GFP-nls–A*B reporter has been utilized recently as an effective readout of 




cultures transfected with the BDNF-A*B reporter showed enhanced GFP fluorescence intensity 
in the distal regions of dendrites (located 100-200m away from cell bodies), compared to 
transfected neurons treated with vehicle (Normalized reporter intensity vehicle control, 
100±17.53%, n=21; Normalized reporter intensity PA 45min, 195.07±28.99% of control, n=16). 
In total, these experiments clearly indicate that synthesis of BDNF is an immediate consequence 
of acute activation of mTORC1 in hippocampal neurons.   
mTORC1 signaling, long known to play an important role in regulating cell size and 
metabolism (Laplante and Sabatini, 2012), has been previously linked to changes in spine 
density and morphology after prolonged periods of hyperactivity (Tavazoie et al., 2005; Kwon et 
al., 2006; Fraser et al., 2008; Luikart et al., 2011; Xiong et al., 2012; but see Sperow et al., 2012; 
Bateup et al., 2012). To investigate potential changes in spine morphology after acute mTORC1 
activation, we transfected mature hippocampal neurons (DIV 21 or older) with eGFP, then 
treated with PA or vehicle 24 Hrs later (Figures 3.3A-C). We found no change in soma size or 
spine density after 90 minutes of enhanced mTORC1 activity (soma size vehicle control, 
335.07±31.73m
2
, n=8; Soma size PA 90 min, 323.61±27.96m
2
, n=10; Spine density vehicle 
control, 19.7±1.14 spines per 25m, n=20; Spine density PA 90min, 20.41±0.97 spines per 
25m, n=27), indicating that cell growth pathways were not significantly recruited by this 
transient activation. Additionally, we found no change in spine length or head width as a 
consequence of PA treatment (Spine length vehicle control, 2.57±0.052m, n=852; Spine length 
PA 90min, 2.56±0.04um, n=1344; Head width vehicle control, 1.07±0.02um, n=852; Head width 
PA 90min, 1.06±0.01um, n=1344), suggesting little if any impact on the morphological 




In contrast to the effects on spine morphology, cell attached recordings from 
hippocampal neurons in culture revealed a profound impact on cell spiking behavior after 
treatment with PA, potentially suggesting an increase in overall network function (Figure 3.4A). 
Whole cell current clamp recordings revealed no difference between control and PA-treated 
neurons in the number of action potentials elicited by a series of depolarizing current steps (Max 
# evoked spikes control, 5.57±0.96, n=14; Max # evoked spikes PA45min, 6.25±0.99, n=12), 
suggesting that PA-induced change in spike behavior do not reflect mTORC1-dependent changes 
in intrinsic excitability (Figure 3.4B-D). In agreement with results indicating no effect of 
transient mTORC1 activation on spine head width, we found no change in the amplitude of 
spontaneous mEPSCs after 45 or 90 minutes treatment with PA (mEPSC Amplitude control, 
12.22±0.53pA; mEPSC Amplitude PA 90 min, 12.57±0.52pA), suggesting that acute mTORC1 
activation is not sufficient to alter excitatory postsynaptic function (Figure 3.4E). In contrast, we 
found that transient pharmacological upregulation of mTORC1 activity via PA treatment resulted 
in a rapid increase in mEPSC frequency (mEPSC frequency control, 1.58±0.33Hz; mEPSC 
frequency PA 90 min, 4.43±0.58Hz). This time-dependent increase in mEPSC frequency 
induced by PA was dependent on protein synthesis, mTORC1 activation, and BDNF release, as 
the increase in mEPSC frequency was blocked by concurrent application of anisomycin (40M), 
Rapamycin (300nM) and an extracellular scavenger of released BDNF, TrkB-fc (1g/ml) 
(Figure 3.4G-H). While recent reports suggest that increases in network activity in mouse models 
featuring enhanced mTORC1 activity may reflect selective changes in inhibitory synapse 
function (Bateup et al., 2013), we found no changes in the frequency or amplitude of 
spontaneous mIPSCs in hippocampal cultures after treatment with PA (mIPSC amplitude 




frequency control, 0.97±0.12Hz, n=16; mIPSC frequency PA 45min, 1.29±0.13Hz, n=20), 
suggesting that altered inhibitory neurotransmission is not an immediate consequence of 
increased mTORC1 signaling (Figures 3.4I-J). To confirm that the observed changes in mEPSC 
frequency reflect bona fide changes in presynaptic function, we examined the effect of PA on 
syt-lum uptake at vglut1-positive excitatory synapses (Figure 3.5A-B). The results of these 
experiments mirrored the observed changes in synaptic physiology, as transient mTORC1 
activation induced a significant increase in syt-lum uptake that was blocked by anisomycin, 
rapamycin, and TrkB-Fc (Prop syt uptake Control, 0.40±0.04, n=52; Prop syt uptake PA 45min, 
0.58±0.03, n=91; Prop syt uptake PA+Rap, 0.33±0.03, n=34; Prop syt uptake PA+Aniso, 
0.44±0.06, n=30; Prop syt uptake PA+TrkB-fc, 0.28±0.04, n=30). 
mTORC1 is believed to regulate translation by phosphorylating components of the 
translation machinery itself, including the primary targets 4EBP1 and p70S6K (Hay and 
Sonenberg, 2004). In light of recent findings suggesting unique synaptic and behavioral 
consequences resulting from disruption of p70S6K (Bhattacharya et al., 2012) or 4E-BP1 
(Gkogkas et al., 2013), we were interested in determining whether either of these signaling 
components were uniquely responsible for mediating the effects of transient mTORC1 activation 
on synapse function (Figure 3.6A-C). To selectively disrupt individual elements of the signaling 
network downstream of mTORC1 activation, we utilized newly developed pharmacological 
agents including PF-4708671, a selective inhibitor of p70S6K (Pearce et al., 2010), as well as 
4EGI-1, a compound that disrupts the interaction between eukaryotic initiation factors 4E and 4G 
(Hoeffer et al., 2011). While the amplitude of spontaneous excitatory currents was not affected 
by inhibition of downstream mTORC1 targets (mEPSC amplitude control, 13.38±0.50pA, n=19, 




14.09±0.63pA, n=7; mEPSC amplitude PA+p70S6Ki, 12.29±0.87pA, n=13) co-application of 
either of these agents alongside PA disrupted the potentiating effects of PA on mEPSC frequency 
(mEPSC frequency control, 1.75±0.34Hz, n=19; mEPSC frequency PA 45min, 4.72±0.84Hz, 
n=14; mEPSC frequency PA+4EGi, 2.97±0.61Hz, n=7; mEPSC frequency PA+p70S6Ki, 
2.68±0.73Hz, n=13), suggesting that transient mTORC1 activation via application of PA utilizes 
both 4EBP1 and p70S6K to mediate effects on presynaptic function. 
The preceding results demonstrate that acute mTORC1 activation drives rapid protein 
synthesis-dependent increases in dendritic BDNF expression and rapid translation-dependent 
enhancement of presynaptic function that requires BDNF, suggesting a potential causal 
relationship between the two. To evaluate this possibility, we examined the specific role of 
postsynaptic BDNF release using sparse transfection of BDNF shRNA, which has been 
previously demonstrated to effectively knock down BDNF expression (Jakawich et al., 2010). 24 
hrs post-transfection, neurons were exposed to PA for 45 min, and postsynaptic mEPSC 
recordings were made from shRNA-expressing neurons (identified by RFP, expressed by an 
independent cassette in each shRNA plasmid) or untransfected control neurons (Figure 3.7A). 
We found that whereas acute mTORC1 activation with PA resulted in robust increases in 
mEPSC frequency, but not mEPSC amplitude, in non-transfected neurons or neurons transfected 
with a scrambled control shRNA (Figure 3.7B-D), PA had no effect in BDNF shRNA expressing 
neurons (untransfected vehicle, 1.04±0.27Hz, n=7; scrambled siRNA vehicle, 0.81±0.22Hz, n=4; 
BDNF siRNA vehicle, 0.69±0.07Hz, n=8; untransfected PA 45min, 6.42±2.01Hz, n=6; 
scrambled siRNA PA 45 min, 5.56±1.10Hz, n=3; BDNF siRNA PA 45 min, 1.79±0.40Hz, n=9). 
These results indicate that a postsynaptic source of BDNF is required for the retrograde 






 These results highlight a unique mechanism of trans-synaptic communication initiated by 
acute mTORC1-dependent signaling in dendrites. Though mTORC1 has been shown to play an 
important role in multiple forms of synaptic plasticity, studies examining effects of mTORC1 
hyperactivation on basal synapse form and function have produced markedly different results. 
Here we have shown that acute mTORC1 activation using the lipid second messenger 
phosphatidic acid (PA) elicits strong increases in network activity in dissociated hippocampal 
cultures that is not mediated by alterations in intrinsic excitability or inhibitory 
neurotransmission.  Instead, we find that transient increases in mTORC1 signaling produce a 
dramatic increase in release probability from apposed postsynaptic terminals. This effect 
emerges rapidly, likely within 30 minutes of mTORC1 activation, based on comparing the time 
course of mTORC1 activation to the time needed for functional changes to appear after PA 
treatment. Finally, we show that these changes in presynaptic function depend fundamentally on 
synthesis of BDNF in the postsynaptic cell for use as a retrograde signal.   
 Initial observations that PA is necessary for mTOR activation came from studies 
examining mitogenic stimulation of mTORC1 signaling (Fang et al., 2001). Subsequent 
functional and structural evidence indicate that PA binds to the FKBP12-rapamycin-binding 
(FRB) domain of mTOR at R2109, where it is believed to directly compete with the binding of 
the FKBP12-rapamycin complex itself (Veverka et al., 2008; Toschi et al., 2009). In support of 
this, cancer cell lines with high rates of internal synthesis of PA display resistance to rapamycin-
mediated inhibition of mTORC1 signaling (Chen et al., 2003), which is line with our finding that 




presynaptic function (300nM, vs 100nM as has been used previously in our lab to inhibit 
mTORC1 activity). Additional work in non-neuronal cells suggests that PA stimulates mTOR‟s 
kinase activity by promoting the stabilization between mTOR and its binding partner raptor 
(Toschi et al., 2009), or by enhancing mTORC1 autophosphorylation at S2481 via displacement 
of FK506 binding protein 38 (FKBP38)-mediated inhibition (Yoon et al., 2011). We find that in 
cultured hippocampal neurons, application of PA-containing vesicles rapidly stimulated 
mTORC1 signaling (Figure 3.1). Our observation that PA-induced increases in phosphorylation 
of downstream mTORC1 targets were apparent within 15 min (Figure 3.1), is similar to the 
timecourse of S6K activity previously observed after exogenously applied PA in Neutrophils and 
Monocytes (Frondorf et al., 2010). It is important to note that PA can bind to multiple targets 
besides mTOR, including Arf, Raf and NSF (Ktistakis et al., 2003). Additionally, PA has been 
shown exert a direct influence on vesicle release in chromaffin cells (Bader and Vitale, 2009) 
and at ribbon synapses in the CNS (Schwarz et al., 2011). While we cannot completely rule out a 
contribution of off-target effects, we remain confident that the enhancement in excitatory 
synapse function we observe after PA treatment is due to mTORC1-induced synthesis of BDNF 
as a retrograde signal. We support this claim with the following observations: 1) The PA-induced 
changes in excitatory synapse function we report here exactly mirror previously reported changes 
in synapse function observed after transient genetic upregulation of mTORC1 signaling via 
overexpression of Rheb-GTPase (Henry et al., 2012); 2) Our reported PA-induced increases in 
presynaptic function, assessed using an array of live-cell imaging and electrophysiology 
approaches, were completely blocked when PA was co-applied with anisomycin, rapamycin, or a 
scavenger of extracellular BDNF, TrkB-fc (Figures 3.4 and 3.5); and 3) postsynaptic knockdown 




(Figure 3.7).  In total, the results of these experiments are most parsimonious with a model in 
which PA activates mTORC1 and leads to the release of BDNF from dendrites as a transynaptic 
signal to enhancement presynaptic function.  
 We use a number of approaches to demonstrate BDNF expression is enhanced as a result 
of acute mTORC1 activation with PA. Though mTORC1 undoubtedly targets a number of other 
transcripts for translation control under such conditions as well, our data suggests that the 
synaptic and network level changes we observe after acute mTORC1 activation (Figure 3.4) are 
due to the dendritic synthesis and release of BDNF as a retrograde messenger to enhance 
presynaptic function. Of the numerous BDNF mRNA isoforms that exist in rat neurons, there is 
evidence for unique trafficking and subcellular localization depending on the configuration of 
alternatively spliced 5‟UTR exons (Chiaruttini et al., 2008) or polyadenylation of the 3‟UTR (An 
et al., 2008). We find a marked increase in levels of dendritic BDNF as assessed via 
immunocytochemistry (Figure 3.2A-B) as well as with a fluorescent reporter under control of the 
long 3‟UTR variant of BDNF mRNA (Figure 3.2E-F). These findings raise the interesting 
possibility that acute activation of mTORC1 yields increased translation of particular BDNF 
mRNA species. Given the recent observation that specific transcripts mediate local BDNF 
synthesis in the hippocampus after pilocarpine-induced status epilepticus (Baj et al., 2013), it 
will be of central interest for future studies to elucidate the mechanisms by which mTORC1 
signaling targets particular transcript isoforms to induce protein synthesis-dependent changes in 
synapse function.  
 An important open question is how BDNF secretion is regulated after mTORC1-
dependent synthesis. Previous studies have established that dendritic BDNF release is Ca2
+
-




response to backpropagating action potentials (Kuczewski et al., 2008). More recently, work 
from Chapman and colleagues suggests that particular sets of BDNF-containing vesicles are 
trafficked in a segregated manner out into dendritic or axonal compartments (Dean et al., 2012). 
It will be of interest for future work to further establish how this sorting mechanism operates in 
tandem with localized synthesis of BDNF to be utilized as a retrograde signal. Regardless, these 
data are interesting in light of the well-characterized role of BDNF in stimulating new protein 
synthesis via mTORC1 activation (Schratt et al., 2004). While our previous work demonstrated 
that blockade of excitatory input can elicit mTORC1-dependent synthesis of BDNF in the 
presence of extracellular scavengers of BDNF (Henry et al., 2012), the possibility remains that 
dendritically synthesized BDNF might exert an additional autocrine signaling effect to 
continuously stimulate mTORC1 activity after its initial engagement. This type of autocrine 
activity for BDNF release has been observed previously at developing presynaptic terminals in 
the hippocampus (Cheng et al., 2011). Such a mechanism might be useful for the continued 
propagation of a plasticity-inducing event that requires an external signal to break the positive 
feedback cycle, as has been observed recently at synapses in the hypothalamus (Yang et al., 
2011).   
 Though the effects of chronic mTORC1 upregulation on basal characteristics of synapse 
form and function have been extremely varied, our findings mirror that of several recent 
publications. Specifically, we find that acute activation of mTORC1 signaling after PA treatment 
mirrors the effects of more prolonged activation reported previously with respect to increases in 
mEPSC frequency (Luikart et al., 2011; Bateup et al., 2011), and increases in presynaptic release 
probability (Wang et al., 2006; Weston et al., 2012). Additionally, we found no change in 




effects seen after hyperactivation of mTORC1 signaling resulting from mutations in PTEN or 
TSC1/2 (Luikart et al., Bateup et al., 2011; Sperow et al.2012). Our results differ from previous 
reports describing changes in inhibitory synapse connectivity (Bateup et al., 2013), increases in 
spine density (Fraser et al., 2008), and increases in mEPSC amplitude (Tavazoie et al., 2005). 
One potential source of this discrepancy may be the amount of time during which mTORC1 
activity is aberrantly upregulated. A recent report indicates that mTORC1 signaling follows a 
biphasic trajectory in the context of gustatory learning, with peaks of activity at 15 and 180 min 
post-learning, which may indicate some degree of feedback or non-linearity within the pathway 
in vivo (Belelovsky et al., 2007). There are additional indications that particular consequences of 
mTORC1 activation on cell function proceed at different time scales. For instance, our previous 
work demonstrated that somatic hypertrophy in cultured hippocampal neurons is observed after 5 
days, but not after 1 day of genetic mTORC1 hyperactivation (Henry et al., 2012). This may also 
suggest that the synaptic functional abnormalities we report here actually precede changes in cell 
morphology. Given the essential role played by synaptic activity in shaping neuronal 
connectivity during development (Bleckert and Wong, 2011), it is conceivable that early shifts in 
excitatory synapse function resulting from mTORC1 hyperactivation may drive the subsequent 
changes in spine density and circuit structure that have been observed after longer periods of 
mTORC1 hyperactivation (Nie et al., 2010; Luikart et al., 2011; Weston et al., 2012; Normand et 
al., 2013). With its common role in several monogenic neurodevelopmental disorders, additional 
insight into the consequences of mTORC1 upregulation on synapse form and function will 
provide a crucial link between cellular and behavioral abnormalities observed in patients with 
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Figure 3.1: Fast activation of neuronal mTORC1 via exogenous phosphatidic acid. (A) 
Representative Western blots depicting phosphorylated p70S6K (Thr389) and 4EBP1 (Thr37/46) 
following treatment with PA (100M, n=3 exps) or vehicle for the indicated times. (B) Mean 
(SEM) expression of p-p70S6K and p-4EBP1in neurons subject to treatment with PA. 
Exogenous PA rapidly enhanced mTORC1 activity, as evidence by significant, time-dependent 
increases in phosphorylation of its immediate downstream targets p70S6K and 4EBP. (C) Full-
frame examples of MAP2 and phosphorylated ribosomal protein S6 (Thr 235/236) staining in 
neurons treated with vehicle (n = 13) or phosphatidic acid (PA; 100 μM) for 60 min (n = 19). 
PS6 fluorescence intensity indicated by color look-up table; scale bar equals 40 μm.  (D) Mean 
(+SEM) normalized MAP2 and PS6 expression in neurons treated as indicated. Application of 
PA activates mTORC1 signaling as indicated by enhanced PS6 staining. *p < 0.05 (t-test), 











Figure 3.2: Enhanced BDNF synthesis is an immediate consequence of short-term 
mTORC1 activation. (A-B) BDNF and MAP2 expression in linearized dendritic segments (A), 
and mean (+ SEM) expression of MAP2 and BDNF (B) in dendritic compartments normalized to 
average control values, in neurons treated with PA (100 μM, 60 min; n = 25) or vehicle (n=25). 
BDNF expression in dendrites was significantly (*p < 0.05, relative to vehicle controls) 
enhanced by treatment with PA compared to vehicle treated controls. This effect was blockaded 
by pre-treatment with anisomycin (40 μM, 30 min prior to PA; n=25) or rapamycin (200 nM, 30 
min prior to PA; n = 25). MAP2 expression did not differ between groups. Scale bar represents 
10 μm in (A). (C) Representative western blots depicting changes in expression of BDNF or 
tublulin after treatment with PA (100M) ± Rapamycin (300nM) for the indicated times. (D) 
Mean (SEM) expression of BDNF in cultured neurons subject to treatment with PA (n=3 
experiments). Exogenous PA rapidly enhanced BDNF expression in an mTORC1 dependent 
manner, as the increased expression was blocked by rapamycin. (E). Representative images of 
hippocampal neurons expressing myr-d1GFP-nls-A*B treated with either vehicle or PA (100M, 
45 min). Scale bar, 10 µm. (F) Mean (+SEM) GFP fluorescence in dendrites of hippocampal 
neurons treated with PA (n=16) or vehicle (n=21). Sampled dendritic regions were located 100-







































Figure 3.3: Acute mTORC1 activation does not affect spine morphology. (A)  Representative 
full frame images and dendritc sub-regions of cultured hippocampal neurons transfected with 
GFP then treated with PA or vehcile for 90min at DIV 21-24. Scale bar, 10m. (B-C) Box-plot 
summaries of soma area and spine density (spines per 25m of dendrite) in cells treated with 
vehicle (n=20 cells) or PA (n=27 cells). (D-E) Cumulative distributions of spine length and spine 
head width (both in micrometers) from cells treated with vehicle (black traces, n=852 spines) or 























Figure 3.4: PA enhances network activity via increases in excitatory neurotransmission. (A) 
Cell attached recordings of hippocampal neurons in dissociated cultured treated with vehicle or 
PA (100M, 45 min). Inset: enlarged region of recording (red box) showing individual spikes in 
a burst. (B) Whole-cell current clamp recordings showing example action potential traces from 
vehicle-treated control neurons (black) or cell treated with PA (red,). APs were evoked by 
injecting 1 s depolarizing current steps in the presence of excitatory and inhibitory synaptic 
blockers (CNQX 10M, APV 50M, Bicuculine 10M). (C-D) Mean (± SEM) and maximum 
number of action potentials evoked by a series of depolarizing current steps in vehicle treated 
(n=14) or PA treated (n=12) cells.  (E-F) Cumulative histogram of amplitude (pA) and inter-
event interval (msec) of mEPSCs recorded from neurons treated with vehicle or 100 μM PA for 
45 or 90 min. Inset, mean (+ SEM) mEPSC amplitude and frequency in neurons after treatment 
with PA (100 μM) or vehicle. (G) Representative recordings in neurons treated with PA 
(100mm, 45 min) with or without 30 min pretreatment with rapamycin (200 nM), anisomysin (40 
μM) or TrkB-fc (1 μg/ml). (H) Timecourse of mean (+SEM) mEPSC amplitude and frequency of 
spontaneous mEPSCs at 45m or 90m exposure to PA with or without pretreatment, as indicated 
above. Sample sizes for the indicated groups: Vehicle (n = 7), PA 45 min (n = 9), PA45min + 
rapamycin (n = 9), PA45min +anisomycin (n = 5), PA45min +TrKB-fc (n = 6), PA90min (n = 
6), PA90min + rapamycin (n = 6), PA90min + anisomycin (n = 9), PA90min+ TrkBfc (n = 3), 
rapamycin alone (n = 7), anisomycin alone (n = 7), TrkB-fc alone (n = 6). Acute activation of 
mTORC1 signaling with PA enhances mEPSC frequency in a protein synthesis, mTORC1, and 
TrkB dependent manner. (I) Representative recordings of pharmacologically isolated (TTX 
1M, CNQX 10M, APV 50M) spontaneous miniature inhibitory currents in cells treated with 
vehicle or PA. (J). Mean (+SEM) mIPSC amplitude and frequency of cultured neurons treated 






























Figure 3.5: Enhanced presynaptic release emerges quickly after mTORC1 activation. (A-B)  
Representative examples (A) and mean (+ SEM) syt-lum uptake (B) from experiments where the 
indicated groups were treated with PA (100 μM, 90 min) in the presence or absence of 
rapamycin (200 nM, 30 min prior), anisomycin (40 μM, 30 min prior) or TrkB-Fc (1 μg/ml, 30 
min prior).  Sample sizes for the indicated groups: vehicle control (n=52), PA alone (n=91), 
PA+rapamycin (n=34), PA+anisomycin (n=41), or PA+TrkB-Fc (n=30 images). PA treatment 
induced a significant (*p < 0.05, relative to vehicle control) increase in syt-lum uptake that was 
blocked by inhibiting protein synthesis, mTORC1, or by scavenging extracellular BDNF. Scale 





























Figure 3.6: Functional effects of PA are sensitive to inhibitors of 4E-BP1 and p70S6K. 
Representative recordings (A) and mean (+ SEM) mEPSC amplitude (B) and frequency (C) in 
vehicle-treated control neurons (n = 19), as well as cells treated with PA alone (n = 14), or in 
combination with a pharmacological inhibitor of p70S6K (n=13) or a compound which disrupts 
the interaction between eukaryotic initiation factors 4E and 4G (4EGi, n=7). The decrement in 
PA-induced increases in mEPSC frequency after co-treatment with either inhibitor suggests that 
acute activation of mTORC1 does not act preferentially through phosphorylation of p70S6K or 





























Figure 3.7: Postsynaptic BDNF expression is necessary for PA-induced changes in synaptic 
function. (A) Experimental timeline: Dissociated hippocampal cultures were tranfsteced with 
shRNA against BDNF or scrambled control via calcium phosphate.  24 hr post transfection, cells 
were treated with 100 μM PA for 45 minutes before recording. (B-D) Representative recordings 
(B) and mean (+SEM) mEPSC amplitude (C) and frequency (D) in control nontransfected 
neurons (n = 7), as well as cells expressing BDNF shRNA (n = 8), or scrambled control shRNA 
(n = 4). The top panel in (B) contains representative traces from vehicle treated group, while the 
lower panel contains traces from cells subject to treatment with PA (100 μM, 45 min; n=6, 9, 3). 
Cells were transfected at DIV 15 then used for recordings 24 hrs later.  Postsynaptic BDNF 
knockdown blocked the increase in mEPSC frequency observed after PA treatment *p < 0.05 
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Phospholipase D1 mediates a unique route to mTORC1 activation during 
synaptic homeostasis but not long term potentiation 
 
4.1 Abstract 
 mTOR-dependent translational control is vital to several forms of long lasting synaptic 
plasticity, including long term potentiation and mGluR-dependent long term depression. We 
have recently reported that dendritic mTORC1 also plays a role in regulating synaptic 
homeostasis, where it serves to modulate presynaptic function via synthesis of a retrograde 
signal.  The means by which these varied types of synaptic stimuli all recruit mTOR-dependent 
protein synthesis yet lead to widely varied functional outcomes is unclear. Here we report that 
PLD-mediated hydrolysis of the lipid second messenger phosphatidic acid is a crucial component 
of the signaling pathway that relays homeostatic signals to postsynaptic mTORC1 after loss of 
excitatory input. We also find that this PLD/PA mediated activation of mTORC1 is a point of 
divergence between homeostatic and Hebbian forms of synaptic plasticity. PLD signaling is 
necessary for mTORC1 activation after AMPAR blockade but not during LTP, which mirrors the 
pattern of intracellular PA synthesis detected under each condition. This dissociation between 
LTP and HSP also holds true at the functional level, as inhibition of PLD signaling, or genetic 




observed after AMPAR blockade but not the postsynaptic potentiation which is a central feature 
LTP.    
 
4.2 Introduction 
 The execution of long lasting changes in the strength of excitatory synapses is believed to 
be a central mechanism by which neuronal networks relay and encode information. A supply of 
newly synthesized proteins is vital for maintaining prolonged changes in synapse function. While 
altered gene expression via transcriptional regulation in the cell nucleus undoubtedly plays a 
vital role in mediating common forms of long-lasting plasticity, recent years have witnessed a 
growing appreciation for localized changes in the synaptic proteome served by dendritic 
translation (Sutton and Schuman, 2006). The mechanistic target of rapamycin complex 1 
(mTORC1) is a critical regulator of translation initiation (Ma and Blenis, 2009) and is known to 
be necessary for several unique forms of synaptic plasticity, including Long term potentiation 
(Tang et al., 2002; Cammalleri et al., 2003; Vickers, et al., 2005), mGluR-dependent long term 
depression in the hippocampus (Hou and Klann, 2004) and VTA (Mameli et al., 2007), 
homeostatic adaptation to synaptic inactivity (Penney et al., 2012; Henry et al., 2012), and the 
antidepressant action of acute NMDAR blockade (Li et al., 2010). Given the apparent ubiquity of 
mTORC1 signaling in such phenomenologically distinct forms of synaptic plasticity, the 
question remains as to how mTOR-dependent changes in protein synthesis implement the 
expression of such markedly different functional outcomes. 
 mTOR signaling is embedded in an extremely complex network of interacting signaling 
components (Zoncu et al., 2011) and our understanding of this multifaceted pathways is under 




unique mechanism for regulating mTOR activity via internal synthesis of phosphatidic acid 
(Chen and Fang, 2002; Foster 2009). Phosphatidic acid (PA) is a lipid second messenger that 
was originally discovered to play important role in relaying mitogenic signals to mTOR during 
cell growth and proliferation (Fang et al., 2001). PA binds directly to mTOR on its FKBP12-
Rapamycin Binding (FRB) domain and is thought to strengthen its association with its binding 
partner raptor, thus increasing mTOR‟s catalytic activity (Veverka et al., 2008; Toschi et al., 
2009). In post-mitotic cells such as neurons, it is possible that this mitogenic signaling 
mechanism could have been co-opted for an alternative purpose in mediating synaptic plasticity. 
This possibility is supported by previous work from our lab in which we have utilized acute 
application of PA to potently drive mTORC1 kinase activity in hippocampal neurons.  
 Here we report that intracellular synthesis of phosphatidic acid (PA) by Phospholipase-D 
(PLD) signaling is an integral step in mTORC1 activation in response to AMPAR blockade, but 
not in response to multiple forms of chemically induced LTP. Pharmacological blockade of 
PLD1/2 eliminates mTORC1 kinase activity in response to loss of excitatory input, but not after 
glycine or forskolin based cLTP. Similarly, well-characterized alterations in synapse function 
associated with homeostatic plasticity and LTP are differentially sensitive to elimination of 
PLD1/2 function. Overexpression of PLD1, but not PLD2, recapitulates these effects and is 
sufficient to drive changes in mTORC1 kinase activity, increase levels of dendritic, but not 
somatic, BDNF expression, and enhance the frequency of spontaneous mEPSCs. Lastly, we 
utilize a pharmacogenetic strategy to replace endogenous mTOR with point mutants which no 
longer bind internally synthesized PA. Inhibition of intracellular PA/mTOR interaction renders 
neurons insensitive to AMPAR blockade with respect to altered mTORC1 signaling or functional 




remain identical to cells with normal mTOR function. These results further establish mTORC1 
as a central hub which meditates multiple forms of synaptic plasticity, and identifies PLD1/PD 
signaling as a unique entry point in the context of homeostatic adaptation to synaptic inactivity. 
 
4.3 Results 
Intracellular Synthesis of PA is critical for mTOR signaling during HSP 
 Intracellular synthesis of the lipid second-messenger phosphatidic acid (PA) has emerged 
as an important signal in mitogenic activation of mTORC1 signaling (Foster et al., 2009), but 
little is known about a potential role for PA in relaying synaptic signals to mTOR in mammalian 
central neurons. To visualize PA synthesis in dissociated hippocampal neurons, we transfected 
cells with GFP-Spo20-PABD at DIV 16-18 and performed live-imaging experiments 2-3 days 
later. The GFP-Spo20-PABD plasmid contains the PA-binding domain of the yeast N-
ethylmaleimide-sensitive factor attachment protein receptor (SNARE) protein Spo20 fused to 
EGFP (Zeniou-Meyer et al., 2007). Similar to previous findings in COS-7 (Frondorf et al., 2010) 
and PC12 cells (Zeniou-Meyer et al., 2007), we find that GFP-Spo20-PABD fluorescence is 
largely limited to the cell nucleus under basal conditions (Figure 4.1A). However, after 
subjecting neurons to AMPAR blockade (CNQX, 40M) we observed a steady, time-dependent 
increase in PA-related fluorescence intensity in discrete regions around the soma and extending 
out into the distal regions of the dendrites by 2Hrs post-treatment (Figure 4.1A). In additional 
experiments we utilized a secondary fluorescence-based sensor of intracellular PA synthesis 
(Figure 4.1B). This reporter contained the C-terminal PA-binding module of human Raf1 fused 
to EGFP (GFP-Raf1-PABD). Previous characterizations of this reporter indicate that it can 




(Schwarz et al., 2011). Similar to our findings using GFP-Spo20-PABD, we observed the 
presence of discrete regions of intracellular clustering of the GFP-Raf1-PABD reporter after 
subjecting neurons to a brief period of AMPAR blockade (CNQX, 40M, 3Hrs). These clustered 
regions of fluorescence intensity did not appear in cells treated with a vehicle control, indicating 
low or extremely transient levels of intracellular PA synthesis under baseline conditions (Figure 
4.1B).  
 Together, our reporter data suggest that intracellular synthesis of PA may be a 
mechanism utilized by neurons to activate mTORC1 signaling in the context of homeostatic 
adaptation to synaptic inactivity. Given previous findings that mTORC1 activity is required 
during other well-studied forms of plasticity such as LTP (Tang et al., 2002; Cammalleri et al., 
2003), we also wanted to examine a potential role for intracellular PA synthesis in LTP. Using a 
glycine-based chemical LTP (cLTP) paradigm which has been previously used to induce long-
lasting, mTOR-dependent changes in synaptic strength in dissociated cultures (Lu et al., 2001), 
we found no difference in the distribution of the GFP-Raf1-PABD reporter between cells subject 
to a cLTP paradigm vs vehicle-treated controls (Figure 4.1B).  The markedly different responses 
of the GFP-Raf1-PABD reporter to cLTP and AMPAR blockade raised the possibility that these 
two forms of plasticity differ in the means by which mTORC1 signaling is engaged, with 
intracellular synthesis of PA acting as an important point of divergence. Intracellular PA can 
arise from multiple sources, including lysophosphatidic acid (LPA), diacylglycerol (DG) and 
phosphatidylcholine (Foster 2009). Previous reports suggest that the primary source of 
intracellularly generated PA in cancer cells is via hydrolysis of phosphatidylcholine by 
phospholipase-D (Jenkins and Frohman, 2005). To explore a role for phospholipase-D (PLD) 




developed small molecule inhibitor of PLD, 5-fluoro-2-indolyl des-chlorohalopemide (FIPI), 
which inhibits both PLD1 and PLD2 activity and blocks intracellular PA accumulation at 
subnanomolar concentrations (Su et al., 2009). We found that pretreatment with FIPI either 
completely eliminated or severely reduced the number of GFP-Raf1-PABD puncta after 
treatment with CNQX (Figure 4.1B). 
 To examine the effect of PLD signaling on mTORC1 activation during different forms of 
synaptic plasticity, we performed immunocytochemical analysis of phosphorylated ribosomal 
protein S6 (p-S6) at S235/236, a commonly used readout of mTORC1 kinase activity (Henry et 
al., 2012). We observed significant increases in somatic p-S6 intensity after both a glycine 
(cLTP1, 227.73±17.43% over control, n=39) and forskolin-based (cLTP2, 275.19±15.60% over 
controls, n=40) stimulation paradigm (Figure 4.1C-E). Synaptic deprivation via AMPAR 
blockade (CNQX, 40M, 3Hr) also produced a significant increase in S6 phosphorylation 
(CNQX, 127.75±6.63% above control, n=73) as we have reported previously (Henry et al., 
2012). Interestingly, co-application of the PLD1/2 inhibitor FIPI (100nM, 30 min pre-treatment) 
had no effect on increased p-S6 levels induced by glycine (cLTP1+FIPI, 235.08±20.74% above 
control, n=40) or forskolin (cLTP2+FIPI, 295.28±24.08% above controls, n=37), but completely 
eliminated CNQX-induced increases in mTORC1 kinase activity (CNQX+FIPI, 102.93±5.50% 
of control, n=71). Cells treated with FIPI alone showed no significant difference in p-S6 levels 
compared to controls, suggesting minimal contribution of steady state PLD signaling to baseline 
levels of mTORC1 activity. Together these data suggest that PLD/PA signaling is uniquely 
engaged in mediating an intracellular response to AMPAR blockade and is an essential signaling 
component leading to mTORC1 activation during homeostatic plasticity, but not during the 





PLD signaling mediates Functional Changes during HSP 
 We next used whole-cell patch-clamp electrophysiology to examine a potential role for 
PLD signaling in the functional changes that emerge at excitatory synapses during homeostatic 
plasticity or LTP. Previous efforts from our lab and others have revealed an adaptive, mTORC1-
dependent increase in presynaptic function that emerges after subjecting synapses to postsynaptic 
deprivation of AMPAR-mediated inputs (Penney et al., 2012, Henry et al., 2012). We replicate 
those effects here (Figure 4.2A-C), demonstrating a homeostatic increase in mEPSC frequency 
that emerges roughly 3 Hrs after subjecting cells to AMPAR blockade (Control, 1.27±0.14Hz, 
n=22; CNQX, 3.61±0.38Hz, n=9). Notably, this effect was completely blocked by co-application 
of the PLD1/2 inhibitor FIPI (Figure 4.2C), though FIPI had no effect on mEPSC frequency on 
its own (CNQX+FIPI, 1.43±0.17Hz, n=14; FIPI Alone, 1.61±0.22Hz, n=18). A similar 
requirement for PLD signaling was observed for homeostatic changes in presynaptic function 
engaged by blockade of L-type voltage gated calcium channels (Figure 4.2D-F). As reported 
previously (Henry et al., 2012), Nifedpine (10M, 2Hr) elicits an mTORC1-dependent increase 
in mEPSC frequency when applied for >3Hrs. This increase in presynaptic function was blocked 
by concurrent treatment with FIPI (Control, 3.75±0.81Hz, n=6; Nifedpine, 11.88±2.82 Hz, n=8; 
Nifedipine+FIPI, 2.34±0.524Hz, n=6; FIPI Alone, 3.521±1.09Hz, n=6), indicating a similar 
mechanism at work to that utilized during AMPAR blockade. In mammalian central neurons, 
this adaptive increase in presynaptic function after AMPAR blockade depends on the mTORC1-
dependent synthesis of BDNF as a retrograde signal (Henry et al., 2012). In line with a role for 
PLD/PA signaling operating upstream of mTORC1 in mediating this effect, 




blockade (Figure 4.2G-H), which was completely blocked by co-application of FIPI (Control, 
100±10.98%, n=63; CNQX, 200.67±26.43% of control, n=75; CNQX+FIPI, 63.12±7.15% of 
control, n=70; FIPI Alone, 75.10±10.47% of control, n=56). The homeostatic increase in 
postsynaptic function after seen AMPAR blockade (Figure 4.2A-C), which previous reports have 
indicated is mTORC1-independent and may depend on intracellular Retinoic acid signaling 
(Aoto et al., 2008; Wang et al., 2011; Henry et al, 2012), is unaffected by concurrent PLD1/2 
blockade (Control, 12.80±0.42pA, n=22; CNQX, 15.82±1.35pA, n=9; CNQX+FIPI, 
14.90±0.62pA, n=14; FIPI Alone, 13.06±0.70pA, n=17), suggesting that this pathway is 
uniquely involved in mediating adaptive changes in presynaptic function during loss of 
excitatory input.  
 Similar to previous reports (Lu et al., 2001) we found that a glycine-based cLTP stimulus 
produced a significant increase in both the amplitude and frequency of spontaneous mEPSCs 
when assessed 2Hrs after stimulation (Figure 4.3A-D). Though the increase in mEPSC frequency 
was slightly attenuated by co-application of the mTORC1 inhibitor rapamycin (100nM, 30min 
pre-treatment), event frequency remained markedly elevated above controls levels (Control, 0.90 
±0.24Hz, n=12; Glycine, 4.76±1.35Hz, n=11; Glycine+Rap, 3.20±0.88Hz, n=8), indicating the 
non-mTOR dependent nature of this functional change. In contrast, glycine-induced increases in 
mEPSC amplitude were completely blocked by co-application of rapamycin (Control, 
12.87±0.55pA, n=12; Glycine, 16.80±0.77pA, n=11; Glycine+Rap, 13.05±0.64pA, n=8), which 
is in line with a role for de novo translation of additional AMPARs in this form of plasticity. 
Interestingly, we found a dissociation between the requirement for mTORC1 activity and 
PLD1/2 signaling in the potentiation of excitatory synapses during LTP (Figure 4.3A-D). In 




blockade (Figure 4.2A-C), co-application of FIPI had no effect on glycine-induced increases in 
mEPSC amplitude (Glycine+FIPI, 15.77±1.03pA, n=11, P<0.05 compared to control), 
suggesting that PLD1/2 signaling is not necessary for mTORC1-dependent changes in 
postsynaptic function at excitatory synapses during chemically-induced LTP.  
 
PLD1 contributes to PA-induced activation of mTORC1 
 There are two PLD genes expressed in the mammalian brain, PLD1 and PLD2, each of 
which show unique localization profiles and activation criterion. Given that PA, the product of 
PLD activity, is a transient messenger which signals within a very limited spatial range of the 
membrane compartment from which it is generated, unique sites of PLD-mediated PA synthesis 
could have feasibly have markedly different functional consequences (Cockcroft 2001). To 
examine if PLD1 and PLD2 exhibit unique subcellular localization patterns in the mammalian 
CNS, we expressed HA-tagged human PLD1 (hPLD1) or PLD2 (hPLD2) in dissociated 
hippocampal cultures and assessed HA localization via immunocytochemistry 24-48 Hrs later 
(Figure 4.4A). In previously published reports using non-neuronal cells, overexpressed HA-
PLD1 was primarily localized to late endosomes or the golgi complex, while overexpressed HA-
PLD2 was found mainly along the plasma membrane (Du et al., 2004). We observed a similar 
pattern of HA staining in neurons expressing hPLD1 or hPLD2, with HA-tagged hPLD1 
localized to discrete intracellular puncta, and hPLD2 localized to the plasma membrane (Figure 
4.4A). 
 Using phosphorylated ribosomal protein S6 as a readout of mTORC1 activity, we found 
significantly elevated levels of somatic p-S6 in cells expressing hPLD1, compared to cells 




overexpression (Figure 4.4A-B). In contrast, neurons expressing either human or rat versions of 
PLD2 showed no significant change in somatic p-S6 levels compared to GFP expressing controls 
(GFP, 100±11.53%, n=29; hPLD1, 286.90±37.27% of control, n=19; hPLD2, 139.69±19.91% of 
control, n=26; rPLD2, 88.71±9.63% of control, n=25). Given recent reports that PLD1 signaling 
influences dendrite arborization during neuronal development (Zhu et al., 2012) we wanted to 
assess any potential changes to excitatory synapse morphology that result from PLD 
manipulations in mature cells (Figure 4.4C-D). We found that the density of dendritic spines was 
unaffected as a result of 24hrs of overexpression of PLD1 or PLD2 (GFP, 23.19±1.6 
spines/25m, n=16; hPLD1, 24.18±1.11 spines per 25m, n=17; hPLD2, 24.86±1.87 spines per 
25m, n=14). To characterize the effects of PLD overexpression on excitatory synapse function, 
we recorded mEPSCs from dissociated hippocampal neurons expressing hPLD1 or hPLD2 at 
DIV21-23 (Figure 4.54E-G). Similar to our previous results using overexpression of Rheb-
GTPase to constitutively drive mTORC1 signaling (Henry et al., 2012), neurons expressing 
hPLD1 displayed a significant increase in mEPSC frequency compared to cells expressing GFP 
alone (Figure 4.4E-G). Cells expressing hPLD2 were not significantly different from GFP 
controls with respect to mEPSC frequency (GFP, 0.54±0.10Hz, n=13; hPLD1, 2.12±0.44Hz, 
n=11; hPLD2, 0.43±0.08Hz, n=8). The amplitude of spontaneous mEPSCs did not change as a 
function of PLD1 or PLD2 overexpression (GFP, 20.58±1.99pA, n=13; hPLD1, 22.16±2.42pA, 
n=11; hPLD2, 21.72±2.71pA, n=8). Previous efforts in our lab have also shown that genetic 
upregulation of mTORC1 activity by Rheb overexpression is sufficient to enhance BDNF levels 
in the dendrites of cultured hippocampal neurons (Henry et al., 2012). Given recent reports that 
PLD1 is required for Rheb-mediated activation of mTORC1 (Sun et al., 2008); we next asked 




GFP-expressing control cells, neurons expressing hPLD1 exhibited significantly higher BDNF 
intensity in the dendritic, but not somatic, subcompartment (Figure 4.5H-I). No such change in 
dendritic BDNF expression was observed in neurons expressing human or rat PLD2 (GFP 
dendrites, 100±12.99%, n=23; hPLD1 dendrites, 141.72±11.36% of control, n=38; hPLD2 
dendrites, 103.65±9.74% of control, n=26; rPLD2 dendrites 111.81±10.97% of control, n=25). 
Somatic BDNF intensity was not significantly increased as a result of PLD1 or PLD2 
overexpression (GFP soma, 100±6.24%, n=23; hPLD1 soma, 84.26±4.04% of control, n=38; 
hPLD2 soma, 78.67±4.346% of control, n=26; rPLD2 soma, 95.54±5.69% of control, n=25). 
Collectively, these results suggest that overexpression of PLD1, but not PLD2, is sufficient to 
increase intracellular levels of PA, which acts as a potent activator of mTORC1 signaling leading 
to increased BDNF expression as a retrograde signal.  In line with our previous work, this 
dendritically released BDNF acts to enhance the efficacy of opposed presynaptic terminals, here 
reflected as an increase in the frequency of spontaneous mEPSCs. 
 
PA binding to mTOR is essential for homeostatic adaptation 
 Previous work has established that the positively charged Arg2109 residue in the FRB 
domain of mTOR is vital for the binding of PA to mTOR (Fang et al., 2001).  This site exhibits a 
high degree of evolutionary conservation (Rodriguez Camargo et al., 2012), suggesting an 
important role for PA/mTOR signaling across multiple species. Substituting this positively 
charged Arginine residue with Alanine severely impairs the hydrophobic interaction between 
mTOR and PA. We took advantage to this fact to develop a pharmacogenetic approach with the 
aim of reducing intracellular PA binding to mTOR in a select group of neurons in culture. 




binding domain (S2035T), which eliminates binding between mTOR and the rapamycin-FKB12 
complex, thus rendering neurons expressing this mutant insensitive to rapamycin-induced 
inhibition of mTORC1 function (Brown et al., 1995). An additional set of cells were made to 
express a mutant form of mTOR carrying both the S2035T and R2109A point mutations, which 
renders these cells insensitive to both rapamycin and PA. All neurons were co-transfected with 
GFP as a cell fill and treated with rapamycin (100nM) to eliminate endogenous mTOR signaling, 
resulting in a one condition in which a small group of cells were left with intact mTOR activity 
due to rapamycin resistance, and a second group of cells with intact mTORC1 signaling but 
significantly reduced PA binding (Figure 4.5A). Using levels of p-S6 staining intensity as a 
readout of mTORC1 kinase activity, we found that disruption of PA-mTOR binding had no 
impact on mTORC1 activation during LTP (Figure 4.5B-5C). In contrast, while neurons 
expressing the rapamycin-resistant (S2035T) mTOR point mutant showed significant increases 
in somatic p-S6 intensity after AMPAR blockade (CNQX, 40M, 3Hrs), cells in which 
PA/mTOR binding was disrupted showed no change in somatic p-S6 intensity after loss of 
excitatory input compared to controls (S2035T Control 100±9.35%, n=37; S2035 cLTP, 
217.87±27.77% of control, n=22; S2035 CNQX, 283.32±72.10% of control, n=15; 
S2035T/R2109A Control, 100±13.78% of control, n=26; S2035T/R2109A cLTP, 
250.13±72.23% of control, n=22; S2035T/R2109A CNQX, 114.42±15.62% of control, n=16). 
This indicates that binding of PA to mTOR‟s FRB domain is critical for increases in mTORC1 
kinase activity engaged during homeostatic adaptation to synaptic inactivity, but not during 
chemically induced LTP.  
 To assess the impact of reduced PA/mTOR binding on synaptic plasticity, we assessed 




of postsynaptic and presynaptic function, respectively. We utilized an identical strategy to that 
described for the proceeding set of experiments (Figure 4.5A), in which rapamycin was used to 
eliminate endogenous mTORC1 function under conditions of rapamycin and/or PA resistant 
mTOR mutant expression. In keeping with our previously published results (Jakawich et al., 
2011; Henry et al., 2012), „control‟ neurons expressing the rapamycin-resistant version of mTOR 
(S2035T Control) showed a significant increase in mEPSC frequency in response to AMPAR 
blockade (Figure 4.6A-B). In contrast, under conditions in which the postsynaptic neuron 
expressed a form of mTOR which was resistant to PA binding (R2109A), treatment with CNQX 
no longer had any effect on mEPSC frequency compared to vehicle treated controls (S2035T 
Control, 0.66±0.12Hz, n=26; S2035 CNQX, 1.92±0.32Hz, n=14; S2035T/R2109A Control, 
1.14±0.31Hz, n=9; S2035T/R2109A CNQX, 0.98±0.15Hz, n=16). Similar results were obtained 
after subjecting cells to L-type voltage gated Calcium channel blockade (Figure 4.6C-D): 
Nifedipine-induced increases in mEPSC frequency were completely blocked under conditions of 
reduced intracellular PA/mTOR binding (S2035T Control, 0.35±0.08Hz, n=6; S2035 Nifedpine, 
1.53±0.35Hz, n=9; S2035T/R2109A Control, 0.44±0.15Hz, n=8; S2035T/R2109A Nifedpine, 
0.73±0.19Hz, n=11). While PA/mTOR binding appears to be essential for homeostatic increases 
in presynaptic function during AMPAR or VGCC blockade, the same was not true for cLTP-
induced increases in postsynaptic function (Figure 4.6E-F). Indeed, we found largely identical 
levels of postsynaptic potentiation when assessed 2Hrs post cLTP stimulation in cells with or 
without impaired postsynaptic PA/mTOR binding (S2035T Control, 15.86±1.13pA, n=12; 
S2035T cLTP, 21.90±1.80pA, n=9; S2035T/R2109A Control, 16.71±0.76pA, n=10; 




intracellular PA/mTOR binding in the postsynaptic domain for the expression of functional 
changes at excitatory synapses during homeostatic plasticity but not LTP.   
 
4.4 Discussion 
 Here we report that PLD-mediated hydrolysis of the lipid second messenger PA is a 
crucial component of the signaling pathway which relays homeostatic signals to postsynaptic 
mTORC1 after loss of excitatory input (Figure 4.7). Critically, our data reveal that this PLD/PA 
mediated activation of mTORC1 is a point of divergence between homeostatic and Hebbian 
forms of synaptic plasticity. We find that PLD signaling is necessary for mTORC1 activation 
after AMPAR blockade but not during LTP, which mirrors the pattern of intracellular PA 
synthesis detected under each condition (Figure 4.1). This dissociation between LTP and HSP 
also holds true at the functional level, as inhibition of PLD signaling, or genetic disruption of 
PA/mTOR interaction eliminates the well-defined presynaptic enhancement observed after 
AMPAR blockade but not the postsynaptic potentiation which is a central feature LTP.  
 
How is PLD/PA signaling engaged? 
 Steady state levels of PA are believed to be quite low under normal conditions; with 
some estimates showing baseline levels of intracellular PA roughly 5% of that shown for its 
precursor, phosphatidylcholine (Fang et al., 2003). While there is evidence to support a role for 
constitutive regulation of mTORC1 and mTORC2 complex integrity by steady-state levels of PA 
(Toschi et al., 2009), more recent work suggests that actively synthesized PA may directly 
stimulate mTORC1, but not mTORC2,  kinase activity by displacing the inhibitory FK506 




autophosphorylation (Yoon et al., 2011a). In non-neuronal cells, recent reports have 
demonstrated that PLD/PA signaling plays an important role in signaling nutrient availability to 
mTOR. Specifically, amino acid availability is believed to act as a signal which causes the Rag-
dependent translocation of mTOR (Sancak et al., 2008) and hVps34-dependent translocation of 
PLD1 (Yoon et al., 2011b) to the late endosomal/lysosomal membrane. It is after this amino-acid 
induced translocation occurs that Rheb activates PLD1-induced synthesis of PA to activate 
mTORC1 signaling. Besides Rheb, PLD1 can also be activated by protein kinase C, select Rho-
GTPases, and members of the ADP-ribosylation factor (Arf) family (Ktistakis et al., 2003). 
Interestingly, recent work has implicated postsynaptic action of the RhoGTPase Cdc42 in the 
expression of presynaptic homeostasis at the drosophila NMJ (Pilgram et al., 2011). Further 
experiments are needed to explore the possibility that neurons utilize PLD/PA signaling as a 
mechanism similar to that implemented by mitotic cells in relaying nutrient signals to mTOR, or 
if instead an alternative manner of activating PLD signaling is utilized, perhaps involving a 
member of the RhoGTPase family, during synaptic homeostasis.  
 
How do unique types of activation lead to different function outcomes? 
 The increased postsynaptic strength observed during LTP (Figure 4.3) and presynaptic 
enhancement which emerges after AMPAR blockade (Figure 4.2, Henry et al., 2012), are both 
mTORC1-dependent phenomena. Given mTOR‟s prominent role in orchestrating protein 
translation necessary for many forms of synapse plasticity and learning (Hoeffer and Klann, 
2010), we were interested to uncover an upstream point of divergence by which mTOR is 
activated in these two forms of plasticity. While our data suggest that PLD/PA signaling is 




signal during synaptic homeostasis (Figure 4.2E, Figure 4.5), it remains unclear how this route to 
mTOR activation results in this unique synaptic phenotype. It is possible that these two different 
mTORC1-dependent functional outcomes arise as a consequence of mTOR‟s action at unique 
sets of dendritically localized transcripts. If this is indeed the case, a possible explanation is that 
mTORC1 acts to regulate the translation of mRNAs in close proximity to the stimulated 
complex, and the spatial locale of cLTP or PLD/PA-induced mTOR activation occurs in 
subcellular regions with unique compositions of potential mRNA targets. Previous work has 
identified mTOR distribution at the cell nucleus (Kim and Chen, 2000), at late 
endosomes/lysosomes (Sancak et al., 2008; Flinn et al., 2010), along the golgi apparatus (Nartia 
et al., 2011) as well as in the endoplasmic reticulum (Drenan et al., 2004). It is conceivable that 
stimulation of mTORC1 signaling at the late endosome/lysosome would potentially lead to the 
translation of specific mRNA transcripts, and hence produce different functional outcomes, than 
would be observed when mTOR is activated in another subcellular compartment such as the 
endoplasmic reticulum. The complex ER network in neuronal dendrites contains rich sites of 
polyribosome accumulation, and acts as a critical region of local translation for membrane-bound 
proteins such as AMPARs during LTP (Cui-Wang et al., 2012), a form of plasticity which is 
known to be mTORC1-dependent (Tang et al., 2002). Additionally, there is growing evidence 
for mRNA localization at late endosomes/lysosomes (Gibbings and Voinnet, 2010), though little 
is known about the potential cadre of uniquely localized transcripts that might occupy this 
subcellular locale in neurons. Further experiments will be necessary to determine if activation of 
mTORC1 at distinct subcellular compartments can explain the unique aspects of PLD/PA-







Isoform specific effects on mTORC1 activation and synapse function 
 Our experiments involving overexpression of either PLD1 or PLD2 reveal an interesting 
degree of specificity with respect to the influence each of these isoforms exerts over neuronal 
mTORC1 activation and synapse function. The finding that overexpression of PLD1, but not 
PLD2, causes an increase in mTORC1 activation (Figure 4.4C) was somewhat surprising given 
previous work showing that overexpression of either PLD isoform is sufficient to activate 
mTORC1 signaling in non-neuronal cell lines (Fang et al., 2003; Chen et al., 2003). Part of this 
discrepancy could be a result of the different ways in which post-mitotic cells such as neurons 
make use of signaling pathways which normally serve a role in mitogenic signaling. 
Additionally, PLD1 and PLD2 are known to exhibit markedly different patterns of subcellular 
localization, with PLD1 present at late endosomes/ lysosomes (Todo et al., 1999) or the golgi 
apparatus (Freyberg et al., 2001), and PLD2 occupying lipid raft sites along the plasma 
membrane (Colley et al., 1997). Our finding that PLD1 overexpression dramatically increases 
dendritic BDNF expression and mEPSC frequency (Figure 4.5) mirrors our previously reported 
effects on BDNF expression and presynaptic function after overexpression of a constitutively 
active version of Rheb GTPase (Henry et al., 2012). This is perhaps not surprising, given 
previous reports that Rheb, mTOR, and PLD1 share a similar subcellular localization (Todo et 
al.,1999; Sancak et al., 2008) and that Rheb directly binds to and activates PLD1 (Sun et al., 
2008). If PLD1 is directly implicated in certain aspects of Rheb-induced changes in synaptic 




neurodevelopmental disorders which share upregulated mTORC1 signaling as a common 
phenotype, including PTEN hamartoma syndrome and Tuberous sclerosis. 
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Figure 4.1: PLD-dependent generation of PA during homeostatic plasticity but not cLTP 
(A) Hippocampal neuron expressing the fluorescent PA reporter GFP-Spo20-PABD in culture 
(left). Right, expanded section of dendrite highlighted in left panel under baseline conditions, and 
after 60 or 120 minutes of exposure to CNQX (40M). (B) Example images of neurons 
expressing an alternate fluorescent reporter of PA synthesis, GFP-Raf1-PABD, under control 
conditions or after treatment with glycine, CNQX, or CNQX + FIPI. Intracellular accumulation 
of PA-associated GFP fluorescence was regularly observed after CNQX, but not glycine 
treatment. FIPI significantly reduced the number of PA-positive punta after CNQX treatment. 
(C-D) Representative images (C-D) and mean (+ SEM) fluorescence intensity (E-F) of MAP2 
and phosphorylated ribosomal protein S6 (p-S6) signal in somatic regions under baseline 
conditions, or under conditions of cLTP or AMPAR blockade with or without concurrent 
inhibition of PLD signaling (FIPI, 100nM, 30 min pretreatment). FIPI blocks enhanced 









































Figure 4.2: PLD signaling is required for adaptive presynaptic compensation (A-C) 
Representative recordings (A) and mean (+SEM) mEPSC amplitude (B) and frequency (C) 
recorded from cells treated with vehicle control or CNQX (40M, 3Hr) with or without the 
PLD1/2 inhibitor FIPI (100nM, 30m pretreatment). Summary graphs presented on left and 
cumulative probability distribution shown on right. (*p<0.05 relative to vehicle controls). PLD is 
necessary for CNQX-induced in mEPSC frequency but not amplitude. (D-F) Representative 
recordings (D) and mean (+SEM) mEPSC amplitude (E) and frequency (F) recorded from cells 
treated with vehicle control or Nifedipine (10uM, 2Hr) with or without the PLD1/2 inhibitor FIPI 
(100nM, 30m pretreatment). Summary graphs presented on left and cumulative probability 
distribution shown on right. (*p<0.05 relative to vehicle controls). (G-H) Examples images of 
BDNF and MAP2 expression in linearized dendritic segments (G), and mean (+SEM) expression 
(H) of MAP2 and BDNF in dendritic compartments normalized to average control values, in 
neurons treated with CNQX (40mM, 3Hr) with or without the PLD1/2 inhibitor FIPI (100nM, 30 
min pre-treatment). BDNF expression in dendrites was significantly enhanced by AMPAR 
blockade compared with control neurons. This effect was completely blocked by concurrent 










































Figure 4.3: Altered postsynaptic function after cLTP does not require intact PLD signaling 
(A-D) Representative recordings (A), population distribution (B) and mean (+SEM) mEPSC 
amplitude (C) and frequency (D) recorded from cells treated with vehicle control or Glycine 
based cLTP stimulus (100M glycine) with or without the PLD1/2 inhibitor FIPI (100nM, 30m 
pretreatment). Summary graphs presented on left and cumulative probability distribution shown 
on right in C and D. (*p<0.05 relative to vehicle controls). PLD signaling is not necessary for 



























Figure 4.4: PLD1 overexpression is sufficient to activate mTORC1 and drive changes in 
synapse function. (A-B) Representative images (A) and mean intensity (+SEM,B) of somatic p-
S6 staining in neurons expressing HA-tagged hPLD1, hPLD2, or GFP control. Expression of 
hPLD1, but not hPLD2 or rPLD2, significantly (*p<0.05 relative to GFP expressing control 
neurons) increases p-S6 staining. (C) Representative dendritic sub-regions of cultured 
hippocampal neurons expressing GFP alone or in combination with hPLD1 or hPLD2. (D) Mean 
(+SEM) number of spines per 25m in groups as indicated. Spine density was unaffected by 
overexpression of either PLD isoform. Scale bar = 10m in (B). (E-G) Representative recordings 
(E) and mean (+SEM) mEPSC amplitude (F) and frequency (G) recorded from cells expressing 
hPLD1, hPLD2 or GHFP control. Summary graphs presented on left and cumulative probability 
distribution shown on right. (*p<0.05 relative to vehicle controls). Overexpression of hPLD1, 
but not hPLD2, is sufficient to elevate mEPSC frequency after 24 Hrs compared to GFP 
expressing controls. (H-I) GFP and BDNF expression in somatodendritic segments (H), and 
mean (+SEM) expression (I) of BDNF in somatic and dendritic compartments normalized to 
average GFP control values, in neurons cotransfected with GFP as well as hPLD1 or hPLD2. 
BDNF expression in dendrites was significantly (*p<0.05, relative to GFP alone) enhanced by 
expression of hPLD1 compared with control neurons expressing GFP alone, while neurons 
expressing hPLD2 showed no difference in dendritic BDNF levels compared to control. hPLD1 
or hPLD2 overexpression did not increase somatic BDNF intensity compared to controls. Scale 


































Figure 4.5: PA binding to mTOR is necessary for enhanced mTORC1 kinase activity 
during synaptic homeostasis but not cLTP. (A) Schematic of experimental design: Neurons 
were transfected with GFP as well as one of two mutant versions of mTOR (S2035T = 
Rapamycin resistant; S2035T/R2109A = Rapamycin and PA resistant). Cultures were then 
treated with rapamycin (100nM) to eliminate endogenous mTORC1 activity. (B) Full frame 
example images of GFP and p-S6 staining in neurons expressing GFP alongside either mTOR 
point mutant, under conditions of AMPAR blockade (CNQX, 40M, 3Hr), cLTP (Forskolin-
based stimulus, 50M), or vehicle control. (C) Mean (+SEM) somatic intensity of p-S6 staining 
in groups as indicated. Inhibition of PA/mTOR interaction (via R2109A mutation) eliminates 
increased mTORC1 kinase activity in the context of AMPAR blockade, but not during cLTP. 


























Figure 4.6: PA binding to mTOR is necessary for altered synapse function during synaptic 
homeostasis but not cLTP. (A-B) Representative recordings (A) and mean (+SEM) mEPSC 
frequency (B) recorded from cells expressing GFP as well as Rap-resistant (mTOR S2035T) or 
PA-resistant (mTOR R2109A) mTOR point mutants under treatment conditions as indicated. 
Summary graphs presented on left and cumulative probability distribution shown on right. 
(*p<0.05 relative to vehicle controls).  Inhibition of PA/mTOR interaction (via R2109A 
mutation) eliminates increased mEPSC frequency after AMPAR blockade. (C-D) Representative 
recordings (C) and mean (+SEM) mEPSC frequency (D) recorded from cells expressing GFP as 
well as Rap-resistant (mTOR S2035T) or PA-resistant (mTOR R2109A) mTOR point mutants 
under treatment conditions as indicated. Summary graphs presented on left and cumulative 
probability distribution shown on right. (*p<0.05 relative to vehicle controls).  Inhibition of 
PA/mTOR interaction (via R2109A mutation) eliminates increased mEPSC frequency after L-
type VGCC blockade. (E-F) Representative recordings (E) and mean (+SEM) mEPSC amplitude 
(F) recorded from cells expressing GFP as well as Rap-resistant (mTOR S2035T) or PA-resistant 
(mTOR R2109A) mTOR point mutants under treatment conditions as indicated. Summary 
graphs presented on left and cumulative probability distribution shown on right. (*p<0.05 
relative to vehicle controls).  Inhibition of PA/mTOR interaction (via R2109A mutation) has no 






































Figure 4.7: Model: PLD/PA signaling is an upstream point of divergence during the 
activation of mTORC1 in unique forms of synapse plasticity PLD1-mediated synthesis of PA 
is essential for mTORC1 activation, and subsequent release of BDNF as a retrograde signal, as 
an adaptive response to loss of excitatory input via CNQX treatment. Not such role is found for 
PLD1/PA signaling in the context of mTORC1 activation during cLTP, whose functional effects 
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Activity-dependent proteasome trafficking underlies state-dependent 
expression of synaptic homeostasis 
 
5.1 Abstract 
 Precisely tuned regulation of pre and post-synaptic communication depends on the ability 
to adjust synaptic protein levels via coordinated protein synthesis and degradation mechanisms. 
Recent work has demonstrated activity-dependent proteasome recruitment into dendritc spines in 
response to synaptic stimulation, indicating that remodeling the synaptic landscape via active 
degradation is likely an important aspect of postsynaptic functional plasticity. In axons, where 
the abundance of proteasomes is dramatically lower than in dendrites, the redistribution of the 
proteasome to appropriate synaptic terminals could be a critical mechanism governing protein 
degradation in the presynaptic compartment. Indeed, we report here that intrinsic firing governs 
activity-dependent proteasome trafficking to and from synaptic terminals in axons of cultured 
hippocampal neurons, and this dynamic proteasome localization is critical for trans-synaptic 
signaling to homeostatically adjust presynaptic neurotransmitter release. Using epitope- and 
fluorescently-tagged subunits of the 19S proteasome, we find that increasing neuronal firing 
rates enriches prtoteasome accumulation at synaptic terminals, whereas inhibiting neuronal firing 
results in a dramatic redistribution away from synaptic terminals to non-synaptic areas. This 
altered localization is due, at least in part, to an activity-dependent active sequestration 
mechanism at presynaptic terminals, as revealed by live monitoring of fluorescence persistence 




activity dependent phosphorylation of the Rpt6 subunit of the 19S proteasome is necessary and 
sufficient for axonal proteasome redistribution, and that this altered localization plays a critical 
role in establishing retrograde homeostatic changes in presynaptic function after loss of 
postsynaptic drive which are selectively implemented at active boutons. Together, our data 
reveal dynamic redistribution of the proteasome as a novel mechanism whereby the activity-




 The synaptic proteome is vastly complex space, with connections between particular cells 
types consisting of unique combinations of pre and postsynaptic constituents that are highly 
dynamic in space and time (O'Rourke et al., 2012). Given recent interest in the synapse as a 
primary locus of disruption for a range of neurological and psychiatric disorders including 
schizophrenia, Autism Spectrum Disorders, and Intellectual Disability (Bayés et al., 2011), it is 
vital to understand the mechanisms by which synapse form and function are modified in the 
healthy and diseased brain. Accumulating evidence suggests that precisely tuned regulation of 
pre- and post-synaptic communication depends on the ability to adjust synaptic protein levels via 
coordinated protein synthesis and degradation mechanisms (Cajigas et al., 2010). Considerable 
work has been devoted to understanding how these processes modify synapse function on an 
individual basis, but specific examples of cooperative synthesis and degradation operating in a 
specific form of synaptic plasticity are rare.  
 In the mammalian hippocampus, there is evidence that UPS-dependent degradation 




that emerge in the context of long-term potentiation (LTP) at excitatory synapses. These 
processes appear to operate in tandem but on distinct sets of proteins, such that pharmacological 
inhibition of either de novo protein synthesis or activity of the ubiquitin proteasome system 
(UPS) blocks the expression of synaptic potentiation, but simultaneous inhibition of both 
processes restores LTP to control levels (Fonseca et al., 2006). Additional work has shown that 
expression of LTP at CA3-CA1 synapses in the hippocampus requires proteasome dependent 
degradation operating in concert with mechanistic target of rapamycin (mTOR)-dependent 
protein synthesis (Karpova et al., 2006). This is notable, given that hyperactivated mTORC1 
signaling is a common feature of several neurodevelopmental disorders, including PTEN 
Hamartoma syndrome, Tuberous Sclerosis, and Neurofibramatosis type 1 (Hoeffer and Klann, 
2009). Though mTORC1-dependent protein translation is likely pivotal for the altered 
postsynaptic function observed in the context of LTP (Tang et al., 2002; Cammalleri et al., 2003; 
Ma et al., 2011) and mGluR-LTD (Hou and Klann, 2004; Banko et al., 2006), recent work has 
also characterized a novel role for mTORC1 involving the enhancement of presynaptic function 
via a postsynaptically synthesized retrograde signal (Penney et al., 2012; Henry et al., 2012). 
Strikingly, this phenomenon was observed in the context of adaptive synaptic compensation after 
loss of excitatory input, as well as after transient genetic or pharmacological upregulation of 
mTORC1 function. While BDNF was identified as the retrograde signal which is released after 
acute mTORC1 activation (Henry et al., 2012), the precise mechanisms responsible for 
maintaining the subsequent long-lasting enhancement in presynaptic function are unknown.  
 Though transcription-dependent, cell-wide changes in both pre- and postsynaptic proteins 
are well documented during crucial developmental periods and in the context of activity 




et al., 2008), accumulating evidence suggests that the synaptic proteome can also be regulated in 
spatially discrete regions of the cell in response to more subtle changes in input. Initial insights 
into locally regulated protein synthesis in the mammalian CNS came from the discovery of 
polyribosomes in the distal dendrites of dentate granule cells (Steward and Levy, 1982). These 
core components of the translation machinery were later shown to relocalize from dendritic 
shafts into spines after stimuli that induce LTP (Ostroff et al., 2001). More recently, several 
groups have demonstrated a similar form of activity-dependent redistribution of the proteasome 
into dendritic spines in response to strong synaptic stimulation (Bingol and Schuman, 2006; 
Bingol et al., 2010).  
 In axons, where the abundance of the UPS is lower than in dendrites, the redistribution of 
proteasomes to particular synaptic terminals could be a critical mechanism governing protein 
degradation in the presynaptic compartment, but thus far no such mechanism has been 
demonstrated.  We report here that intrinsic firing governs activity-dependent proteasome 
redistribution to and from synaptic terminals in axons of cultured hippocampal neurons, and this 
dynamic relocalization is critical for trans-synaptic signaling to homeostatically adjust 
presynaptic neurotransmitter release. Using epitope- and fluorescently-tagged subunits of the 
19S proteasome, we find that increasing neuronal firing rates enriches proteasome accumulation 
at synaptic terminals, whereas inhibiting neuronal firing results in a dramatic redistribution away 
from synaptic terminals to non-synaptic areas. This altered localization is due, at least in part, to 
an activity-dependent active sequestration mechanism at presynaptic terminals, as revealed by 
live monitoring of fluorescence persistence after synaptic photoactivation of GFP-tagged 
proteasomal subunits. Moreover, we find that activity dependent phosphorylation of the Rpt6 




and that this altered localization plays a critical role in the selective expression of enhanced 
presynaptic release after postsynaptic mTORC1 activation or loss of postsynaptic drive. 
Together, our data reveal dynamic redistribution of the proteasome as a novel mechanism 
whereby the activity-dependent “state” of synaptic compartments determines the specific forms 
of plasticity they can exhibit. 
 
5.3 Results 
 Postsynaptic mTORC1 activation drives state-dependent changes in presynaptic function 
Previously, we have established that mTORC1 signaling participates in a unique, trans-
synaptically mediated form of plasticity involving the dendritic synthesis and release of BDNF 
as a retrograde signal (Henry et al., 2012). In our previous efforts we utilized overexpression of a 
constitutively active form of Rheb-GTPase to activate mTORC1 signaling. To assess 
consequences of mTORC1 activation under less physiologically unrealistic conditions, we 
expressed WT Rheb in cultured hippocampal neurons and assessed levels of mTORC1 activation 
24 Hrs later (Figure 5.2A). Similar to our previously reported findings, RhebWT expression 
enhanced mTORC1 kinase activity, as assessed via changes in the phosphorylation of ribosomal 
protein S6 (eGFP Controls, 100±13.16%, n=28; RhebWT, 266.78±28.85, n=29). In line with 
previous reports of BDNF as a target of mTORC1-mediated translational regulation (Henry et 
al., 2012; Liao et al., 202), we found enhanced BDNF expression in neurons expressing RhebWT 
compared to neurons expressing eGFP alone. Notably, this effect was limited to dendritic 
subcompartments, and no difference in BDNF intensity was observed in somatic regions 
between groups (eGFP dendritic BDNF Intensity, 100±16.48%, n=35, RhebWT dendritic BDNF 




somatic BDNF Intensity, 91.45±5.21%, n=32). Voltage-clamp recordings of miniature 
spontaneous excitatory postsynaptic currents (mEPSCs) revealed alterations in synaptic function 
as a consequence of enhanced dendritic BDNF release (Figure 5.1B). Neurons expressing 
RhebWT exhibited enhanced mEPSC frequency compared to cells expressing GFP alone. This 
effect was dependent on dendritically released BDNF, as application of the extracellular BDNF 
scavenger TrkB-fc (1g/ml) completely eliminated increases spontaneous release as a 
consequence of Rheb expression (eGFP Control, 1.52±0.17Hz, n=25; RhebWT, 2.44±0.44Hz, 
n=27; eGFP + TrkB-fc, 1.51±0.19Hz, n=10; RHebWT+TrkB-fc, 1.29±0.15Hz, n=12). The 
amplitude of spontaneous excitatory currents was unchanged as a consequence of postsynaptic 
mTORC1 activation via RhebWT overexpression (eGFP Control, 13.95±0.66pA, n=25; 
RhebWT, 14.03±0.65pA, n=27; eGFP + TrkB-fc, 13.51±1.12pA, n=10; RHebWT+TrkB-fc, 
15.31±1.05pA, n=12).  
 We next assessed the impact of mTORC1-dependent retrograde signaling on evoked 
glutamatergic neurotransmission. First, we directly visualized evoked glutamate release by 
imaging activity-dependent changes in vglut1-pHluorin fluorescence at presynaptic terminals 
identified by co-expression of mCherry-tagged synaptophysin (mCh-Syn). As previously 
reported (Voglmaier et al., 2006), basal vglut1-pHluorin fluorescence at presynaptic terminals 
was low due to effective quenching by the acidic environment of synaptic vesicles, allowing for 
optical detection of action potential-triggered synaptic vesicle fusion when the lumen of the 
vesicle is exposed to the neutral extracellular space. To induce action potentials across the 
network, we applied field stimulation via parallel platinum-iridium electrodes under conditions 
where individual pulses each faithfully produced an action potential, verified by a characteristic 
cell wide Ca2
+




application of the lipid second messenger phosphatidic acid (PA) to acutely activate mTORC1 
signaling (as seen in Chapter 3). In control (vehicle-treated) neurons, a 10-s train of action 
potentials delivered at 10 Hz induced a clear increase in vglut1-pHluorin fluorescence at 
presynaptic terminals, but following acute mTORC1 activation with PA (100 μM; 45 min), this 
evoked vesicle fusion was markedly enhanced (Figure 5.1C). Scavenging extracellular BDNF 
with TrkB-fc (1 μg/ml) during PA application prevented this enhancement of evoked release, 
suggesting that acute mTORC1 activation drives increases in evoked glutamate release in a 
manner dependent on BDNF release (Vehicle Control peak DF = 0.79±0.05, n=567; PA peak DF 
= 1.68±0.10, n=802; PA+TrkB-fc peak DF = 0.96±0.02, n=652; TrkB-fc Alone peak DF = 
0.84±0.02, n=750). As another means of assessing evoked neurotransmitter release, and to 
examine if mTORC1-dependent changes in evoked release are evident in a preparation where 
intrinsic hippocampal circuitry is preserved, we examined paired-pulse facilitation (PPF, 
negatively correlated with release probability) at CA3-CA1 synapses in acute hippocampal slices 
prepared from P18-24 rats. Following preparation and recovery, slices were treated with PA (100 
μM; 45 min), either alone or coincident with the protein synthesis inhibitor anisomycin (40 μM), 
the mTORC1 inhibitor rapamycin (300 nM), or the Trk receptor inhibitor k252a (300 nM). 
Relative to control (vehicle-treated) slices, acute mTORC1 activation with PA resulted in 
significantly diminished PPF (Figure 5.1D), consistent with an increase in release probability at 
these synapses. This effect of PA required new protein synthesis, mTORC1 activation, and Trk 
receptor activation (Figure 5.1D), suggesting that the diminished PPF that accompanies 
mTORC1 activation in slices, shares core mechanistic features with the retrograde regulation of 
presynaptic function by dendritic mTORC1 observed in cultured hippocampal neurons. 




5.1D). Taken together, these results demonstrate that postsynaptic mTORC1 activation exerts 
retrograde control over evoked neurotransmitter release, as it does over spontaneous 
neurotransmitter release. To verify a role for de novo synthesis of BDNF in PA-induced 
enhancement of presynaptic function, we used magnetofection to rapidly deliver siRNA targeting 
BDNF to specifically block new BDNF synthesis without loss of existing BDNF expression 
(Figure 5.2E). BDNF siRNA was visible inside neurons immediately following magnetofection 
(Figure 5.2B), and as expected, a time-dependent decrease in basal levels of BDNF expression 
ensued (Figures 5.2C-D). Importantly, we found that dendritic BDNF expression was similar 
between neurons receiving BDNF siRNA and those receiving a non-targeting control siRNA 
90min following magnetofection (Relative change in BDNF Intensity- Control siRNA 90 min, 
0±6.09%, n=33; Relative change in BDNF Intensity- BDNF siRNA 90 min, -3.09±4.54%, n=21; 
Relative change in BDNF Intensity- Control siRNA 48 Hr, 4.16%, n=32; Relative change in 
BDNF Intensity- BDNF siRNA 48Hr, -41.69±4.34%, n=21). In contrast, BDNF siRNA 
magnetofection completely suppressed the increase in dendritic BDNF expression induced by 
PA treatment (BDNF Intensity Vehicle-treated control siRNA, 100±9.51%, n=55; BDNF 
Intensity PA-treated control siRNA, 181.12±12.70% of control, n=62; BDNF Intensity Vehicle-
treated BDNF siRNA, 100±13.01%, n=49; BDNF Intensity PA-treated BDNF siRNA, 
90.91±5.91% of control, n=60) suggesting a relatively specific effect on new BDNF synthesis 
due to limited BDNF turnover over this interval. We next explored the functional consequences 
of suppressing new BDNF synthesis. Whereas PA treatment induced robust increases in mEPSC 
frequency in neurons receiving control siRNA magnetofection (Figure 5.1F), this effect was 
completely blocked in neurons receiving BDNF siRNA magnetofection (Vehicle -treated control 




siRNA, 1.52±0.19Hz, n=5; PA-treated BDNF siRNA, 2.36±0.47Hz, n=7). These results indicate 
that de novo BDNF synthesis is required for retrograde changes in presynaptic function driven 
by mTORC1 activation. Taken together, our findings reveal that dendritic mTORC1 locally 
regulates the function of opposed presynaptic terminals by controlling BDNF synthesis in 
dendrites. 
 Our previous characterization of locally-mediated homeostatic plasticity driven by 
AMPAR blockade uncovered an unexpected yet critical role for presynaptic spike activity in the 
expression of adaptive increases in spontaneous vesicle release (Jakawich et al., 2010). We 
replicate those findings here, using changes in vglut-pH fluorescence to assess a potential 
requirement for neuronal spiking in the expression of homeostatic shifts in evoked vesicle 
release after loss of excitatory input (Figure 5.3A-D). In line with our previous findings, we find 
that loss of excitatory input via AMPAR blockade (CNQX, 40M, 3Hr) results in a substantial 
increase in vglut1-pH fluorescence intensity evoked from a 10s 10Hz stimulus train (Figure 
5.3A-2D). However, we also find that simultaneous application of the voltage-gated Na+-
channel blocker TTX completely eliminates CNQX-induced increases in evoked 
neurotransmission, without eliciting significant effects on presynaptic function when applied 
alone (Vehicle Control peak DF = 1.51±0.11, n=262; CNQX peak DF = 2.31±0.27, n=120; 
CNQX+TTX peak DF = 1.15±0.05, n=349; TTX Alone peak DF = 1.60±0.08, n=343). We next 
examined a potential role for ongoing spike activity in the presynaptic changes which emerge 
after acute mTORC1 activation with PA (Figure 5.1D-F). Using changes in the frequency of 
mEPSCs as a readout of presynaptic function, we found that application of PA (100M, 45min) 
significantly enhanced the frequency of spontaneous mEPSCs. However, when PA was applied 




changes in mEPSC frequency were completely ablated (Vehicle Controls, 1.48±0.27Hz, n=9; 
PA, 4.89±1.17Hz, n=11; PA+TTX, 1.16±0.31Hz, n=13; TTX Alone, 2.21±0.72Hz, n=8). 
Comparable increases in postsynaptic function, using changes in mEPSC Amplitude as a 
readout, were not observed as a consequence of PA or TTX treatment (Vehicle Controls, 
17.67±1.54pA, n=9; PA, 16.19±0.76pA, n=11; PA+TTX, 14.04±0.99pA, n=13; TTX Alone, 
15.39±0.96pA, n=8). Together these data clearly indicate an important role for ongoing spike 
activity in the expression of altered presynaptic function driven by acute mTORC1 activation or 
loss of excitatory input.  
 
Critical role for presynaptic UPS function during homeostatic plasticity 
 Active protein turnover driven by UPS-dependent degradation has been implicated in 
several forms of synaptic plasticity, and recent work indicates that protein breakdown might act 
in concert with new protein synthesis to dynamically shape the synaptic proteome. To examine a 
potential role for proteasomal degradation in synaptic homeostasis after loss of excitatory input, 
we subjected neurons to pharmacological blockade of UPS function using Lactacystin (Lac, 
10M), and assessed changes in spontaneous synaptic current after blockade of AMPA receptors 
(CNQX, 40M 3Hrs, followed by washout). Similar to our previous results (Jakawich et al., 
2010; Henry et al., 2012), we found that transient loss of synaptic drive elicits a robust 
compensatory increase in both the amplitude and frequency of spontaneous mEPSCs (Figure 
5.4A). Interestingly, while the change in mEPSC amplitude was unaltered by concurrent 
blockade of UPS function with Lac (Control, 13.10±0.69pA, n=11; CNQX, 15.16±0.61pA, 
n=14; CNQX+Lac, 14.06±0.66pA, n=9), we found that homeostatic increases in mEPSC 




(Control, 2.9±0.67Hz, n=11; CNQX, 4.47±0.85Hz, n=14; CNQX+Lac, 1.53±0.51Hz, n=9). To 
verify that this Lac-sensitive change in mEPSC frequency reflects an alteration in presynaptic 
function, we performed live imaging experiments with cultured hippocampal neurons expressing 
vglut-pH-mCH (Figure 5.4B). In line with our previous results (Figure 5.3), brief loss of 
excitatory input (CNQX, 40M, 3 Hr) elicits a compensatory increase in the peak levels of 
fluorescence intensity evoked by a 10Hz, 10s field stimulus (Control peak DF = 1.34±0.06, 
n=628; CNQX peak DF = 2.31±0.27, n=120). Concurrent inhibition of proteasome function via 
pre-treatment of Lactacystin (10M) or MG132 (10M) completely eliminated this CNQX-
induced increase in presynaptic function (CNQX+MG132 peak DF = 1.38±0.07, n=400; 
CNQX+Lac peak DF = 1.71±0.18, n=57). Collectively, these data indicate that UPS function is 
vital for the emergence of presynaptic functional homeostasis after loss of excitatory input.  
 We next examined whether UPS function is necessary in the pre- or postsynaptic 
compartment for the expression of presynaptic homeostasis. To perturb proteasome activity in 
specific synaptic compartments, we expressed a WT or mutant version of ubiquitin carrying a 
K48R point mutation. The formation of polyubiquitinated chains at this K48 residue serves as a 
canonical signal for proteasome mediated degradation, and overexpression of K48R ubiquitin 
thus acts as a dominant negative to eliminate UPS function without altering other aspects of 
ubiquitin-mediated signaling. We first performed whole cell voltage clamp recordings of 
spontaneous excitatory currents from neurons expressing WT or K48R ubiquitin. Recording 
from sparsely transfected cultures assures manipulation of postsynaptic UPS function, while 
presynaptic proteasome activity remains normal in the vast majority of synapses impinging on 
the recorded neuron (Figure 5.4C). Compared to neurons expressing GFP alone, expression of 




increased in response to CNQX treatment (GFP Vehicle, 0.53±0.13Hz, n=16; GFP CNQX, 
1.77±0.55Hz, n=14; K48R vehicle, 0.41±0.11Hz, n=10; K48R CNQX, 1.61±0.59Hz, n=12).  In 
contrast to our previously reported role for postsynaptic mTOR (Henry et al., 2012), these data 
suggest that postsynaptic UPS function is dispensable for presynaptic alterations during synaptic 
homeostasis. The same was not true under conditions of presynaptic UPS inhibition, however. 
Here, we expressed WT or K48R ubiquitin alongside vglut-pH-mCH to assess changes in 
presynaptic function directly after loss of excitatory input (Figure 5.4D). Compared to neurons 
expressing WT ubiquitin, cells exhibiting impaired UPS function in the presynaptic domain 
displayed no compensation in evoked neurotransmission after AMPAR blockade (WT Vehicle 
Peak DF, 1.26±0.09, n=442; WT CNQX Peak DF, 1.85±0.12, n=496; K48R Vehicle Peak DF, 
1.13±0.04, n=238; K48R CNQX Peak DF, 1.14±0.04, n=792), suggesting that proteasomal 
degradation is required presynaptically for homeostatic changes to emerge in this synaptic 
compartment.  
 A critical feature of this form of synaptic homeostasis induced by loss of excitatory input 
is the postsynaptic synthesis and release of BDNF as a retrograde signal (Jakawich et al., 2010; 
Henry et al., 2012). The finding that postsynaptic UPS function is nonessential for the expression 
of presynaptic changes under such conditions suggests that BDNF release operates upstream of 
the proteasome. As such, the effects of exogenous BDNF application on presynaptic function 
should be sensitive to inhibition of UPS function. Similar to previous reports, we find that acute 
application of BDNF  (250ng/ml, 2Hrs), significantly increases presynaptic function, using 
changes in mEPSC frequency (Vehicle Control, 2.27±0.71Hz, n=7; BDNF, 5.98±1.27Hz, n=7), 
a-syt antibody uptake and evoked changes in vglut-pH fluorescence intensity (Vehicle Control 




(Figure 5.4E-3F, 5.5A). Notably, we found that pharmacological inhibition of proteasome 
activity completely blocked BDNF-induced increases in presynaptic release as assessed via 
changes in mEPSC frequency (Lact Alone, 1.92±0.17Hz, n=5; BDNF + Lac, 2.88±0.83Hz, n=7; 
MG132 alone, 2.07±0.42Hz, n=6; BDNF+MG132, 2.49±1.04Hz, n=7), proportion of a-syt 
uptake or evoked changes in vglut-pH intensity (BDNF + Lac, 1.18±0.04Hz, n=715; 
BDNF+MG132, 1.18±0.05, n=305), indicating that UPS activity is essential for BDNF-induced 
changes in presynaptic function. 
 Our previous work shows that activation of postsynaptic mTORC1 via genetic 
upregulation of Rheb or application of the lipid second messenger PA is sufficient to drive 
dendritic synthesis of BDNF, resulting in a state-dependent enhancement in presynaptic efficacy 
(Figures 5.1, 5.3). Critically, this change in presynaptic function after acute activation of 
mTORC1 signaling operates through an identical pathway to that utilized during homeostatic 
increases in presynaptic function after loss of excitatory input (Henry et al., 2012).  To assess, 
whether the effects of acute mTORC1 activation on presynaptic function are also sensitive to 
proteasome inhibition, we performed whole cell recordings in cultured neurons subject to UPS 
blockade with MG132 or Lactacystin, then exposed to PA containing vesicles (100M, 45 min) 
to acutely drive increased mTORC1 kinase activity (Figure 5.5B). In line with a conserved 
pathway shared between CNQX-driven presynaptic homeostasis and the effects of acute 
mTORC hyperactivation, we found that proteasome inhibition eliminated increased mEPSC 
frequency after PA treatment (Vehicle control, 1.0±0.15Hz, n=10; PA, 3.20±0.74Hz, n=10; 
PA+MG132, 1.71±0.42Hz, n=12; PA+Lac, 0.60±0.15Hz, n=10). Nether PA administered alone, 




currents (Vehicle control, 15.97±0.76pA, n=10; PA, 15.51±0.99pA, n=10; PA+MG132, 
14.08±0.83pA, n=12; PA+Lac, 15.91±1.03pA, n=10). 
 
Activity-dependent redistribution of the presynaptic UPS 
 Recent work has demonstrated the striking phenomenon of proteasomal sequestration at 
synaptic regions in dendritic spines in response to strong neuronal depolarization or NMDA 
receptor stimulation (Bingol and Schuman, 2006; Bingol et al., 2010). Given the dual necessity 
for presynaptic UPS function and ongoing spike activity for adaptive presynaptic homeostasis 
after loss of excitatory input, we next examined the possibility that altered neuronal activity 
could impact proteasome distribution in axons, and whether this altered localization could impact 
the expression of functional homeostasis. To assess a potential contribution of neuronal activity 
to presynaptic localization of the UPS, we expressed a FLAG-tagged subunit of the 19S 
regulatory cap of the proteasome (FLAG-Rpt3) alongside mCherry-synaptophysn (mCH-Syn) to 
label presynaptic terminals. Neurons were treated with the GABA-A blocker Bicuculine or the 
voltage-gated sodium channel blocker TTX to increase or decrease neuronal activity for 2 hours, 
respectively (Figure 5.6A). After this brief period of activity manipulation, we found a 
remarkable increase in the intensity of FLAG signal at mCH-Syn positive regions in neurons 
treated with Bicuculine.  Conversely, in cells subject to action potential blockade with TTX, we 
observed a significant loss of proteasome-related fluorescence signal at synaptic boutons 
(Nomalized Control FLAG-Rpt3 Intensity, 100±22.17%, n=12 images; Normalized Bicuculine 
FLAG-Rpt3 Intensity, 176.10±50.72% of control, n=11 images; Normalized TTX FLAG-Rpt3 
Intensity, 56.82±12.86% of control, n=12 images). In a separate set of experiments, we assessed 




loss of synaptic input with CNQX (Figure 5.7A). While AMPAR blockade (CNQX, 40M, 
3Hrs) did not significantly change proteasome-related fluorescence signal at presynaptic 
boutons, concurrent blockade of action potentials with TTX produced a similar loss of 
synaptically localized proteasome during CNQX as we previously observed during TTX 
treatment alone. This suggests that AMPAR blockade with CNQX does not completely block 
spiking activity in dissociated cultures, as reported previously (Jakawich et al., 2010), and 
provides potential insight into the mechanism responsible for why action blockade eliminates 
CNQX-induced presynaptic homeostasis. 
        The proceeding set of experiments provided an analysis of steady state presynaptic 
proteasome localization under different activity manipulations, but did not provide information 
regarding the timing of proteasome relocalization during activity manipulations. To assess 
activity-dependent proteasome redistribution in real time, we performed live-imaging 
experiments of GFP-tagged proteasome subunits (GFP-Rpt6) under conditions of activity 
blockade with TTX (1M). We observed a progressive loss of proteasome-related GFP signal in 
synaptic boutons over the course of a 30 min exposure to TTX (Figure 5.6C, Yellow box). 
Interestingly, we found a similar increase in extrasnaptically localized GFP signal in the same set 
of axons over the course of action potential blockade (Figure 5.6C, red box).  This suggests 
intrinsic spiking activity drives the relocalization of the UPS into and out of synaptic regions in 
axons. Strikingly, brief depolarization (60mM K+, 5 min) resulted in an immediate reversal of 
GFP-Rpt6 localization, such that synaptic proteasome levels were comparable to pre TTX levels 
and extrasynaptic regions were largely devoid of UPS-related fluorescence signal (Relative 




-22.39±5.45%; 5 min post-60mM K+, 22.29±5.42%; Relative change in extrasynaptic GFP 
Fluorescence 15 min-post TTX, 16.43±8.03%, n=32; 30 min post-TTX, 23.50±11.66%).  
        Though the preceding experiments provide compelling evidence for activity-dependent 
redistribution of the UPS in axons, it is unclear whether this relocalization proceeds as a course 
of microtubule based cargo transport or instead occurs due the paired action of free proteasomal 
diffusion and active sequestration, as has been suggested to occur in dendritic spines (Bingol and 
Schuman, 2006). To address the mechanisms behind altered UPS localization in axons, we 
performed live imaging experiments in neurons expressing mCH-Syn as well as the 19S 
proteasome subunit Rpt6 fused to photoactivatable GFP (PAGFP-Rpt6). In one set of 
experiments we targeted extrasynaptic regions for photoactivation and monitored movement of 
Rtp6-associated fluorescence throughout the axon. The example experiment shown in Figure 
5.8A is representative of our repeated observations, wherein extrasynaptic photoactivation elicits 
a brief rise in fluorescence intensity in the targeted extrasynaptic region, which then rapidly 
spreads into nearby regions of the axon, displaying both retrograde and anterograde patterns of 
movement. We found striking differences in the longevity of fluorescence intensity in 
extrasynaptic regions compared to synaptic regions of interest over the course of the imaging 
session. After photoactivation, PAGFP signal intensity rapidly diminishes back down to baseline 
levels in extrasynaptic regions, indicating movement of Rpt6 away from this region of the axon 
(Figure 5.8B, black trace). In contrast, after invasion of nearby synaptic regions, Rpt6-PAGFP 
intensity tends to remain steady for much longer periods of time, here failing to reach baseline 
levels within the 200s imaging session (Figure 5.8B, blue and red traces). This suggests the 
existence of an active tethering mechanism at work to preserve proteasome localization at 




experiments supports this notion (Figure 5.8C), with striking differences in the decay rates 
between extrasynaptic and synaptic regions. To examine whether this tethering mechanism at 
synaptic boutons could be influenced by neuronal spike activity, we performed similar sets of 
experiments but targeted synaptic, rather than extrasynaptic, regions for photoactivation and 
monitored loss of PAGFP-Rpt6 fluorescence over time (Figure 5.8D). Compared with vehicle-
treated control cells, neurons subject to increased spike activity for a period of 2 Hrs (Bicuculine, 
10M) showed a dramatic increase in the longevity of PAGFP fluorescence intensity remaining 
at boutons after photoactivation (Figure 5.8E-5.8F), indicating that sequestration of proteasomes 
at presynaptic regions in the axon is subject to modulation via changes in spike output.  
  
Phosphorylation of the 19S Rpt6 subunit is critical for activity-driven UPS redistribution 
and presynaptic functional homeostasis 
 How do changes in spike activity lead to altered proteasome longevity at presynaptic 
terminals? Recent work has identified a serine residue on the Rpt6 subunit of the 19S cap, 
phosphorylation of which influences the synaptic localization of the proteasome at postsynaptic 
regions in dendritic spines (Bingol et al., 2010). Phosphorylation of Rpt6 at S120 is regulated by 
neuronal activity, and overexpression of Rpt6 point mutants at this site can have profound effect 
on postsynaptic function (Djakovic et al., 2012). Given the strong influence spike activity exerts 
over proteasome localization in axons and retention rates at presynaptic boutons, we next 
examined whether manipulations of the Rpt6 phosphorylation at S120 could impact UPS 
localization and synapse function presynaptically.  We first examined how overexpression of 
phosphor-dead (S120A) or phospho-mimetic (S120D) Rpt6 mutants alters retention rates of 




mCh-Syn to label presynaptic regions, as well as either WT, S120A or S120D Rpt6 fused to 
PAGFP (Figure 5.9A). Representative examples of time-dependent loss of PAGFP intensity for 
each group can be seen in Figure 5.9B. Fluorescence decay rates differed markedly as a 
consequence of S120 phosphorylation status (Figure 5.9C). Compared to cells expressing WT-
Rpt6, S120A-Rpt6 overexpression significantly increased the speed of UPS-related fluorescence 
loss after photoactivation at presynaptic boutons (WT-Rpt6 time to reach ½ max, 57.8±8.29s, 
n=15 boutons; S120A-Rpt6 time to reach ½ max, 37.62±3.11s, n=13). This effect was 
bidirectional, as overexpression of the phosphomimetic S120D Rpt6 point mutant resulted in a 
significant increase in the longevity of photoactivated proteasomes at synapses (S120D-Rpt6 
time to reach ½ max, 90.21±12.55s, n=14 boutons). In line with our previous data in which 
activity manipulations exert similar influence over UPS retention rates ad steady state levels at 
presynaptic boutons, we found that manipulation of Rpt6S120 phosphorylation was also 
sufficient to alter steady state levels of the proteasome at synaptic regions. Here, we expressed 
HA-tagged Rpt6 variants (WT, S120A, S120D) with mCH-Syn to assess proteasome localization 
at presynaptic regions (Figure 5.10). We found that alterations in S120 phosphorylation exert 
effects on steady-state UPS localization in axons that mirror those seen after activity 
manipulation with Bicuculine or TTX, such that the S120A mutation reduces HA-tagged Rpt6 
localization, and the S120D mutation increases HA-tagged Rpt6 levels at mCH-Syn positive 
regions in axons (Normalized control HA Intensity, 100±17.68%, n=30; Normalixzed S120A 
HA Intensity, 58.34±11.68% of control, n=30; Normalized S120D HA Intensity, 151.78±32.66% 
of control, n=20). Operating under the assumption that exogenously expressed Rpt6 mutants 
become incorporated into endogenous proteasomes, overexpression of S120A or S120D-Rpt6 




complex. To examine this, we expressed WT, S120A or S120D-Rpt6 alongside mCh-Syn, and 
assessed intensity of co-expressed FLAG-tagged Rpt1 signal at presynaptic boutons (Figure 
5.9D). Similar to our findings with altered localization of HA-tagged Rpt6 mutants alone (Figure 
5.10), we found that expression of S120A-Rpt6 resulted in a significant decrease in presynaptic 
FLAG-Rpt1 signal, while expression of S120D-Rpt6 caused a significant increase in presynaptic 
FLAG-Rpt1 signal compared to neurons expressing WT-Rpt6 (Normalized control FLAG 
Intensity, 100±12.74%, n=26; Normalixzed S120A FLAG Intensity, 60.23±9.66% of control, 
n=20; Normalized S120D FLAG Intensity, 153.69±27.83% of control, n=9). Together these data 
indicate that phosphorylation of the 19S Rpt6 subunit at S120 exerts a powerful influence over 
presynaptic UPS localization and retention rates at boutons. 
 Under conditions of baseline Rpt6 phosphorylation, increased neuronal activity via 
GABA-A receptor inhibition (Bicuculline, 10M, 2Hr) results in elevated co-localization of 
FLAG-tagged Rpt3 at presynaptic boutons (Figure 5.6A-B). If the activity-dependent 
phosphorylation of Rpt6 at S120 is important from this redistribution of the UPS after enhanced 
spike output, then overexpression of the phospho-dead S120A Rpt6 mutant should block this 
change in presynaptic proteasomal accumulation. In neurons expressing GFP-tagged WT Rpt6, 
we repeat our earlier described observation of enhanced localization of UPS components at 
presynaptic terminals after treatment increased spiking activity (Figure 5.11A-B). However, 
under conditions of S120A-Rpt6 overexpression, GFP fluorescence intensity in mCH-Syn 
positive regions was indistinguishable between neurons treated with Bicuculine and vehicle-
treated controls, suggesting that phosphorylation of Rpt6 at S120 is a necessary component of 
the mechanism by which proteasome distribution is regulated by neuronal activity. The 




as functional UPS-mediated degradation for the expression of functional homeostasis at 
presynaptic terminals after loss of excitatory input. However, thus far a direct link between 
proteasome localization and adaptive changes in presynaptic function has not been made. As 
such, we next utilized overexpression of S120A-Rpt6 to shift the distribution of proteasomes 
away from synaptic boutons and examined what, if any, effect the resultant lack of UPS activity 
in presynaptic regions would have on CNQX-mediated changes in vesicle release (Figure 5.12C-
D). In line with our earlier observations, evoked changes in vglut-pH intensity were dramatically 
enhanced after a brief period of AMPAR blockade (CNQX, 40M, 3Hrs) in neurons expressing 
WT-Rpt6 (WT-Rpt6 Vehicle Peak DF, 1.23±0.07, n=248 boutons; WT-Rpt6 CNQX Peak DF, 
2.51±0.14, n=287 boutons). Conversely, neurons expressing the phospho-dead S120A-Rpt6 
point mutant showed significantly reduced changes in evoked neurotransmission after synaptic 
deprivation (S120A-Rpt6 Vehicle Peak DF, 1.23±0.09, n=237 boutons; S120A-Rpt6 CNQX 
Peak DF, 1.75±0.12, n=331 boutons). The slight, but statistically significant compared to 
controls, increase in vglut-pH fluorescence intensity which remains in S120A expressing cells 
(Figure 5.12D) is likely due to a failure of the S120A-Rpt6 mutant subunit to incorporate in all 
endogenous proteasome complexes. We observe a similar dependence on Rpt6 S120 
phosphorylation for the expression of functional changes in spontaneous neurotransmission after 
AMPAR blockade (Figure 5.12). When expressing WT-Rpt6, neurons live labeled with an 
antibody against the lumenal domain of synaptotagmin show increased spontaneous vesicle 
release at excitatory synapses in response to CNQX treatment (Proportion of a-syt uptake in WT-
Rpt6 controls, 0.26±0.05, n=23; proportion of a-syt uptake in WT-Rpt6 CNQX, 0.46±0.07, 
n=23; proportion of a-syt uptake in S120A-Rpt6 controls, 0.19±0.06, n=27; proportion of a-syt 




AMPAR blockade are driven by dendritically released BDNF (Jakawich et al., 2010; Henry et al, 
2012), the effects of acute BDNF on presynaptic function should also be sensitive to altered 
distribution of the UPS in axons. We took advantage of the relatively fast-acting effects of 
exogenously applied BDNF to assess within-synapse changes in evoked neurotransmission in 
cells expressing WT or S120A-Rpt6. We collected vglut-pH responses to two identical stimuli, 
one administered prior to BDNF treatment and another 30 min after BDNF exposure (Figure 
5.11E). Under conditions of WT-Rpt6 expression, acute BDNF treatment (250ng/l, 30 min) 
produced a dramatic increase in evoked vlgut-pH fluorescence intensity (WT-Rpt6 Vehicle, 
68.02±6.69% of max response to stim 1, n=139 boutons; WT-Rpt6 BDNF, 179.39±9.26% of 
max response to stim 1, n=217). However, driving proteasome distribution away from synaptic 
boutons by overexpression of S120A-Rpt6 completely eliminated BDNF-induced increases in 
evoked neurotransmission (S120A-Rpt6 Vehicle, 67.53±7.50% of max response to stim 1, n=35;  
S120A-Rpt6 BDNF, 51.59±2.47% of max response to stim 1, n=365), signaling that activity 
dependent phosphorylation of Rpt6 acts an important precondition for this form of plasticity.  
 Our previous results suggest that the mechanisms responsible for altered proteasome 
localization at presynaptic terminals are sensitive to baseline rates of spike activity, such that 
action potential inhibition with TTX drives an altered distribution away from synaptic boutons 
(Figure 5.6). If phosphorylation of Rpt6 at S120 is an important component of this mechanism, 
then overexpression of the phosphomimentic S120D point mutant of Rpt6 should obviate the 
requirement of neuronal activity for increased UPS localization at synapses. In neurons 
expressing GFP-tagged WT Rpt6, we replicate our earlier finding of diminished proteasome 
localization of at presynaptic terminals after a brief period of spike blockade with TTX (Figure 




intensity in mCH-Syn positive regions was not statistically different between neurons treated 
with TTX and vehicle-treated controls (Normalized GFP intensity WT-Rpt6 Control, 
100±16.09%, n=13; Normalized GFP intensity WT-Rpt6 TTX, 59.79±10.67% of control, n=21; 
Normalized GFP intensity S120D-Rpt6 Control, 100±19.93%, n=16; Normalized GFP intensity 
S120D-Rpt6 TTX, 98.37±21.46%, n=19). This supports the notion that neuronal activity drives 
altered proteasome localization through a process involving the phosphorylation of Rpt6 at S120, 
and that mimicking phosphorylation at this site is sufficient to bypass the need for enhanced 
spike activity in driving the UPS to synaptic terminals. We have shown that state-dependent 
presynaptic homeostasis can be blocked by pharmacological disruption of neuronal spiking 
(Figure 5.3). As such, driving proteasomes to synaptic boutons via overexpression of S120D-
Rpt6 should render functional changes in presynaptic release impervious to TTX blockade of 
CNQX-induced adaptation. We assessed changes in evoked neurotransmission under conditions 
of simultaneous AMPAR blockade and spike inhibition in neurons expressing S120D-Rpt6 
(Figure 5.13C-D), and found that these synapses exhibited equivalent levels of augmented 
presynaptic release under conditions of AMPAR blockade alone or AMPAR blockade paired 
with spike inhibition (S120D-Rpt6 Vehicle Peak DF, 0.89±0.05, n=515 boutons; S120D-Rpt6 
CNQX Peak DF, 1.65±0.08, n=622; S120D-Rpt6 CNQX+TTX Peak DF, 1.76±0.08, n=571; 
S120D-Rpt6 TTX ALone Peak DF, 1.24±0.09, n=208). Critically, these results are not due to 
more generalized changes in vesicle pool dynamics, as overexpression of S120A-Rpt6 or 
S120D-Rpt6 does not alter the recycling pool or total release pool of vesicles (Figure 5.14), as 
assessed using previously established methods (Kim and Ryan, 2010).  
 





Presynaptic UPS and synapse function  
 Previous reports suggest that manipulations of UPS function can impact presynaptic 
release properties, wherein inhibition of protesome activity on its own is sufficient to increase 
neurotransmitter release (Willeumier et al., 2006; Rinetti and Schweizer, 2010). While we do not 
find similar changes in presynaptic release driven by manipulations of UPS function alone, our 
work adds to a growing body of evidence indicating that proteasomal degradation can fine tune 
presynaptic function. Our finding of an activity-dependent role for UPS-mediated degradation in 
axons shares some commonality with recent reports of activity-dependent “presynaptic 
silencing”, wherein prolonged depolarization leads to an increase in proteasome enzymatic 
activity at presynaptic terminals (Jiang et al., 2010). However, rather than enhanced presynaptic 
UPS activity eliciting an increase in presynaptic efficacy as we observe here, Jiang et al. report a 
decrease in the number of active synapses and reduced size of the recycling pool. It is possible 
that these divergent findings are a result of the different methods of enhancing neuronal activity, 
using pharmacological silencing of GABA-A receptors or field stimulation in the experiments 
described here versus several hours of exposure to a high K+ solution (Jiang et al., 2010).  It 
seems likely that these different functional outcomes arise in response to the degradation of 
unique sets of presynaptic proteins in each condition. While chronic depolarization with a high 
K+ solution has been shown to lead to the degradation of Rim-1 and Munc13-1 (Jiang et al. 
2010), the target of UPS-mediated degradation which mediates our observed increase in 
presynaptic function remains unidentified.  
 Previously verified presynaptic targets of activity-dependent proteasomal degradation 




Spangler et al., 2013), components of the vesicle release machinery including syntaxin 1 (Chin et 
al., 2002), synaptophysin (Wheeler et al., 2002), UNC-13 (Aravamudan and Broadie, 2003; 
Speese et al., 2003), and SNAP-25 (Sharma et al., 2011) as well as presynaptic voltage-gated ion 
channels such as Cav2.2 (Waithe et al., 2011; Marangoudakis et al., 2012). It will be of crucial 
interest for future work to identify the target of presynaptic degradation in the type of plasticity 
we describe here. Given the nature of the change in presynaptic function we observe, wherein 
degradation of a presynaptic protein results in an increase in synaptic release, it is sensible to 
assume that the target is a protein which normally serves to constrain vesicle release. Such a 
mechanism would share similar features to previously reported instances of the UPS operating in 
the context of synaptic plasticity through the degradation of proteins that normally serve to 
constrain synapse strength (Zhao et al., 2003), including the R subunit of PKA (Hegde et al., 
1993) and the CREB repressor, CREB1b (Upadhya et al., 2004). Potential candidate targets of 
presynaptic degradation which could fit such a model include Slp4-A, which inhibits vesicle 
release via an interaction with the small GTPase Rab27 (Fukada 2003), and tomosyn, a 
syntaxin1-binding protein that has been shown to exert an inhibitory effect on vesicle fusion 
(Fujita et al., 1998;  Yizhar et al., 2004; Gracheva et al., 2007). 
 The mechanisms by which specific proteins are targeted for degradation are complex, and 
subject to a high degree of activity-dependent modification (Hegde, 2010). Attachment of an 
ubiquitin protein to a degradation target occurs in a multistep process, involving the action of E1, 
E2 and E3 classes of enzymes. However, specificity of substrate targeting is achieved primarily 
via action of the E3 ubiquitin ligase. Thus, the identity of the specific presynaptic proteins 
targeted for proteasomal degradation here could potentially be linked to the identity of the 




subdomains in neurons. Among the identified examples include SCRAPPER, which targets 
RIM1 (Yao et al., 2007), Siah, which targets synaptophysin, β-catenin, α-synuclein, and 
synphilin-1 (Waites et al., 2013), Phr1, which targets DLK (Lewcock et al., 2007), and staring, 
which is believed to regulate degradation of syntaxin 1 (Chin et al., 2002). It will be important 
for future studies to investigate a potential role for these or other as yet unidentified E3 ligases in 
mediating the type of state-dependent presynaptic compensation we describe here.  
 
Activity dependent relocalization of the proteasome 
 Studies performed in yeast (Russell et al., 1999) and mammalian cells lines (Brooks et 
al., 2000) suggest that the proteasome occupies a predominantly nuclear subcellular localization 
under baseline conditions in many cells types. However, biochemical analyses of proteasome 
activity in specific neuronal subcellular compartments have indicated that UPS-mediated 
degradation is higher in synaptic regions than in the nucleus (Upadhya et al., 2006), which 
suggests a role for activity-dependent redistribution. Previous work in neuronal cells suggests 
that activation of PKC or treatment with the GABA-A receptor blocker Bicuculline causes the 
translocation of the 20S proteasome from the nucleus into the cytoplasm and dendritic 
subdomains (Shen et al., 2007). Notably, deletion of the cocaine-regulated protein NAC1 has 
been found to prevent proteasome translocation after Bicuculine but has no effect on PKC-
mediated relocalization. These data provided an initial indication that neurons utilize multiple 
mechanisms of proteasomal redistribution, one of which may involve direct phosphorylation of 
the proteasome itself (Glickman and Raveh, 2005).  
 In vitro studies suggest that phosphorylation of the Rpt6 subunit of the 19S regulatory 




This work has been supported by findings in neuronal cultures, wherein phosphorylation of Rpt6 
at S120 has also been reported to enhance proteasome activity (Djakovic et al, 2009, Bingol et 
al., 2010). The findings described here add to the complexity of activity dependent regulation of 
proteasome function, by demonstrating that phosphorylation of the 19S regulatory subunit Rpt6 
at S120 also plays an important role in the redistribution of proteasomes into presynaptic regions. 
A similar role for Rpt6 phosphorylation has recently been demonstrated in activity-dependent 
postsynaptic redistribution (Djakovic et al., 2012). Given the importance of phosphorylation of 
Rpt6 in guiding redistribution of the proteasome to presynaptic terminals, an important 
remaining question regards the identity of the upstream kinase at work. To date, both PKA and 
CaMKII have been shown to phosphorylate Rpt6 at S120 (Zhang et al., 2007; Djakovic et al., 
2009), though only CAMKII has been directly implicated in activity-dependent phosphorylation 
of Rpt6 resulting in altered synaptic function (Djakovic et al., 2012). Interesting recent evidence 
suggests that phosphorylation of Rpt6 at S120 in the amygdala by CaMKII, but not PKA, is 
critical for the formation of long-term fear memories (Jarome et al., 2013), though from these 
data it is not possible to ascertain whether this depends predominantly on either pre- or 
postsynaptic phosphorylation of Rpt6.  
 
Interaction between UPS and BDNF signaling in expression of functional changes 
 Phosphorylation of Rpt6, while clearly important for activity-dependent proteasome 
redistribution in axons, cannot fully account for the functional changes we observe after AMPAR 
blockade. Overexpression of the phospho-dead S120A point mutant of Rpt6, while sufficient to 
significantly alter proteasome localization at presynaptic terminals (Figure 5.10D) and rates of 




own when compared to cells expressing Rpt6WT (Figure 5.12D). Similar results were observed 
in cells expressing the phospho-mimetic S120D mutation of Rpt6, wherein increased localization 
of proteasomes to synaptic boutons was not sufficient to exert changes on presynaptic function 
on its own (Figure 5.10, Figure 5.14). A crucial component of the changes in presynaptic 
function we observe after AMPAR blockade or treatment with PA is the synthesis and release of 
BDNF from the postsynaptic compartment as a retrograde signal (Henry et al., 2012). In line 
with this model, we find that a brief (2Hr) treatment with BDNF results in a marked increase in 
neurotransmitter release (Figure 5.4E-F, 5.5B, 5.12F), an effect which has been reported 
previously in hippocampal cultures (Lessmann and Heumann, 1998; Jakawich et al., 2010) and 
slices (Gottschalk et al., 1998) and has been shown to depend on intact presynaptic TrkB 
receptor signaling (Li et al., 1998). We build upon this work, demonstrating that this effect can 
be inhibited by blocking presynaptic UPS function (Figure 5.4) or inhibiting synaptic proteasome 
localization (Figure 5.11). However, it is not clear how BDNF signaling interacts with 
presynaptically localized UPS to result in enhanced neurotransmitter release. BDNF activation of 
TrkB can elicit changes in cellular function through three major routes, which include the 
MAPK/ERK, PI3K, and PLC signaling pathways (Patapoutian and Reichardt, 2001). It is 
conceivable that the activity of one of these pathways may exert an influence on the target 
specificity or activation properties of presynaptically localized UPS. The most well characterized 
peptidase actions of the 20S proteasome include trypsin-like, chymotrypsin-like, and 
peptidyIgIutamyl-peptide hydrolyzing (PGPH) activity (Coux et al., 1996). Manipulations of 
specific peptidase actions can have unique effects on cell function, as, for example, inhibition of 
chymotrypsin-like, but not trypsin-like or PGPH activity, induces neurite outgrowth in Neuro2A 




in specific neuronal subcompartments have identified that MAPK signaling enhances 
chymotrypsin-like activity in synaptosomal, but not nuclear, fractions from mouse brain 
homogenates (Upadhya et al., 2006). An intriguing, though as yet untested, possibility is that 
BDNF/TrkB-mediated activation of presynaptic MAPK signaling leads to an increase in 
presynaptic chymotrypsin activity, which in turn mediates enhanced vesicle release through the 
degradation of a specific protein or sets of proteins.  
 
Altered longevity at boutons vs active trafficking 
 Our data does not appear to support a role for activity-dependent redistribution of the 
proteasome as a consequence of active transport of cargo along microtubules.  Instead, it appears 
more likely that the presynaptic terminal somehow acts as diffusion sink similar to the proposed 
role of the postsynaptic density of excitatory synapses in tethering AMPA receptors (Bressloff 
and Earnshaw, 2007). Our photoactivation data (Figure 5.8) shows that photoactivated 
proteasome subunits travel from the site of photoactivation to nearby synaptic regions quite 
rapidly. This movement is much faster than what would be expected for microtubule based 
transport of cytosolic proteins in the axon, which have been reported to travel at speeds of ~2-
8mm/day (Brown, 2003). Additionally, previous work examining microtubule based trafficking 
of cytosolic proteins tagged with PA-GFP have identified a distinct anterograde bias to this type 
of transport in axons (Scott et al., 2011), an effect which is clearly not seen after photoactivation 
of PAGFP-Rpt6 in our experiments (Figure 5.8A). Rather than relying on microtubule-based 
transport, our data suggest a model wherein proteasomes are able to diffusely move through the 
axon, and are eventually captured and retained at presynaptic boutons in response to activity. Our 




that it is likely to be specific for proteasomes in which the S120 residue on the Rpt6 regulatory 
subunit is phosphorylated, based on the fact that expression of phospho-memetic or phospho-
dead point mutants of Rpt6 are sufficient to exert profound changes on proteasome localization 
and functional adaptation to AMPAR blockade (Figure 5.9-5.12). If it is indeed the case that 
phosphorylated proteasome are captured and retained at presynaptic terminals, the question 
remains as to the mechanism by which proteasomes are sequestered. In keeping with notion that 
proteasomes become bound to the actin cytoskeleton in spines in response to strong synaptic 
stimulation (Bingol and Schuman, 2006), recent evidence shows that phosphorylation at S120 of 
the 19S RPT6 subunit enhances proteasome resistance to detergent extraction, suggesting 
increased association with cytoskeleton or scaffolding proteins (Djakovic et al., 2012). Our data 
is parsimonious with a similar model in which proteasomes diffuse throughout axons and 
become tightly associated with actin-rich boutons upon activity dependent phosphorylation of 
the Rpt6 subunit. Further experiments will be necessary to determine if proteasome redistribution 
to presynaptic regions depends on an interaction with the actin cytoskeleton, or perhaps with 
another as yet unidentified scaffolding protein. 
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Figure 5.1: Postsynaptic mTORC1 activation enhances presynaptic presynaptic release via 
synthesis of BDNF as a retrograde signal. (A) Representative images of BDNF and MAP2 
expression in linearized dendritic segments, and mean (+ SEM) fluorescence intensity of MAP2 
and BDNF signal in somatic and dendritic compartments normalized to average control values, 
in neurons treated with expression eGFP alone (n = 35 images) or in combination with RhebWT 
(n= 35 images). BDNF expression in dendrites was significantly (*p < 0.05 by Student‟s t-test, 
relative to eGFP controls) enhanced in neurons expressing RhebWT for 24 Hrs, relative to 
neurons expressing eGFP alone for the same duration. Scale bar represents 10m in A. (B) 
Representative recordings and mean (± SEM) mEPSC amplitude and frequency in control 
nontransfected neurons (n = 25), as well as cells expressing RhebWT (n = 30).The top panel in 
(B) contains representative traces from vehicle treated group, while the lower panel contain 
traces from cells subject to treatment with the BDNF scavenger TrkB-fc (1g/ml; n=12 and 10). 
Scavenging extracellular BDNF eliminates RhebWT induced increases in mEPSC frequency. (C) 
Example images of synapses expressing vglut1-pHluorin (vglut-pH) at baseline (left panel) as 
well as immediately after termination of a 10Hz, 10s stimulus train (right panel).  Treatment with 
phosphatidic acid enhanced the changes in vglut-pHluorin fluorescence intensity, compared to 
cells treated with vehicle in response to an identical stimulus train. Scale bar represents 10mm in 
(C). (D) Timecourse of relative change in vglut-pHluorin fluorescence in response to a 10Hz 10s 
stimulus train, recorded from cells treated with vehicle, PA, TrkB-fc or TrkBfc + PA.  Black bar 
represents onset of 10s stimulus train. Grey: Vehicle control (n = 566 synapses). Red: PA (n = 
802 synapses). Green: PA+TrkB-fc (n = 652 synapses). Blue: TrkB-fc alone (n = 750 synapses). 
Right, mean (± SEM) change in vlgut-pHluorin fluorescence intensity from baseline recorded at 
the termination of a 10Hz, 10s AP train evoked by field stimulus. Evoked changes in vglut-
pHluorin fluorescence intensity were significantly enhanced by treatment with PA, and this 
effect was blocked by pre-treatment with the BDNF scavenger TrkB-fc. (*p<0.05, one-way 
ANOVA, Tukey–Kramer post hoc) (E) Paired-pulse facilitation (PPF) in acute hippocampal 
slices.  Treatment with phosphatidic acid (100 mM, 45 min) significantly diminished (*p < 0.05, 
relative to vehicle controls) the degree of facilitation induced by paired pulses at 50, 100 and 200 
ms intervals.  Pre-treatment with anisomycin, rapamycin, as well as the Trk receptor antagonist 
K252a, blocked this effect.  Lower panel, inhibitors have no effect on their own relative to 
vehicle treated controls. Grey Circles: Control (n = 38 slices); Red Circles: PA (n = 10); Green 
closed Triangles: PA+Aniso (n = 7 slices); Blue closed triangles: PA+ K252a (n = 8 slices); 
Orange closed diamonds: PA+ Rap (n = 6 slices); Green open Triangles: Aniso Alone (n = 3 
slices); Blue open Triangles: K252a alone (n = 9 slices); Orange open Diamonds: Rap alone (n = 
8 slices). Scale bar represents 10ms and 100mV. (F) BDNF expression in linearized dendritic 
segments (K), and mean (+ SEM) expression BDNF in dendritic compartments normalized to 
average control values, in neurons subject to magnetofection plus or minus PA (100 μM, 90 
min). In neurons transfected with control siRNA, treatment with PA (n = 62) significantly 
enhanced BDNF expression in dendrites (*p < 0.05) compared to vehicle treated cells (n = 
55).  In neurons transfected with BDNF siRNA, PA application (n = 60) failed to alter dendritic 
BDNF expression relative to vehicle (n = 49).  Scale bar in (F) = 10 μm. (G) Representative 
recordings and mean (+ SEM) mEPSC frequency (N) in neurons subject to magnetofection plus 
or minus PA (100 μM, 90 min). Treatment with PA significantly enhanced mEPSC frequency in 




vehicle treated neurons (n = 8).  In neurons transfected with BDNF siRNA, no differences were 




















































Figure 5.2: RhebWT overexpression enhances mTORC1 activity in culture, and 
progressive loss of endogenous BDNF after siRNA magnetofection. (A-B)  Example images 
(A) and mean (+SEM) normalized p-S6 expression in transfected neurons. Expression of 
RhebWT (n=29 cells) significantly (*p<0.05 vs EGFP alone by t test) enhanced p-S6 levels 
compared with transfection with EGFP alone (n= 28 cells). PS6 fluorescence intensity indicated 
by color look-up table. Scale bar, 10m in (A). (B) Representative DIC and fluorescein images 
in cells subject to magnetofection as indicated then quenched with 0.04% Trypan blue. Trypan 
blue quenches extracellular fluorescein signal, indicating that magnetofection rapidly delivers 
fluorescein-conjugated siRNA into cells immediately after transfection. (C) Representative 
images of straightened somadendritic regions of cultured neurons subject to magnetofection with 
control or anti BDNF siRNA. Scale bar represents 10mm in (C).  (D) Mean (+ SEM) expression 
of BDNF, normalized to average control values at identical time points, in neurons treated as 
indicated. While BDNF fluorescence was unaffected by magnetofection of anti-BDNF siRNA at 
90 min (n = 21) compared to control siRNA transfected cells (n =33), BDNF levels were 
significantly (*p < 0.05, relative to control) reduced by anti-BDNF siRNA magnetofection after 
48 Hrs (n=21) relative to neurons transfected with control siRNA (n=32). (E) Experimental 
timeline: Dissociated hippocampal cultures were transfected with siRNA against BDNF or non-
targeting control via magnetofection.  30 min post transfection, cells were treated with 
phosphatidic acid for 90 minutes then either used for whole-cell recordings or fixed and 









Figure 5.3: Shared state-dependency of presynaptic enhancement driven by acute 
mTORC1 activation or loss of excitatory synaptic inputs. (A-C) Example images (A) of axon 
terminals coexpressing mCherry-synaptophysin (mCh-Syn, top) as well as vglut-pHluorin (vglut-
pH, bottom). Bottom, representative examples of synapses expressing vglut-pH after termination 
of a 10 Hz 10 s stimulus train. Treatment with the AMPAR blocker CNQX (40M, 3 h) enhances 
the changes in vglut-pHluorin fluorescence intensity, compared with cells treated with vehicle in 
response to an identical stimulus train. Scale bar represents 25m. B, Relative change in vglut-
pHluorin fluorescence over time in response to a 10 Hz 10 s stimulus train, recorded from cells 
treated with vehicle, CNQX, CNQX plus TTX, or TTX alone. Black bar represents onset of 10 s 
stimulus train. Black, Vehicle control (n=262 synapses). Red, CNQX (n=120 synapses). Green, 
CNQX plus TTX (n=349 synapses). Blue, TTX alone (n=343 synapses). Evoked changes in 
vglut-pHluorin fluorescence intensity were significantly enhanced by treatment with CNQX, and 
this effect was blocked by concurrent spike blockade with TTX. (*p<0.05, one-way ANOVA, 
Tukey–Kramer post hoc compared to vehicle controls at peak fluorescence levels at immediate 
termination of stimulus train). (D) Representative recordings in neurons treated with PA (100m, 
45 min) with or without 30 min pretreatment with TTX (1M). (E-F) Mean (+SEM) mEPSC 
Amplitude (E) and Frequency (F) plus cumulative histogram of amplitude and inter-event 
interval of mEPSCs recorded from neurons treated with vehicle or 100 μM PA for with or 
wthout concurrent spike blockade via TTX as indicated: Vehicle control (n=9), PA (n=11), 







Figure 5.4: The ubiquitin proteasome system operates presynaptically to mediate increased 
vesicle release after exposure to retrograde signal. (A) Representative mEPSC recordings and 
mean (+SEM) mEPSC amplitude and frequency made from hippocampal cultures after washout 
of CNQX (3Hrs, 40M) with or without Lactacystin (10M) as indicated: Control (n=15), 
CNQX (n=16), CNQX + Lac (n=12). (B) Representative images (top) of vglut1-pH peak 
fluorescence at the termination of a 10s, 10Hz field stimulus, after washout of CNQX (40M, 3 
Hrs) with or without concurrent inhibition of the ubiquitin proteasome system with MG132 
(10M, 30 min pre-treatment) or Lactacystin (10mM, 30 min pretreatment). (bottom) Relative 
change in vglut1-pHluorin fluorescence over time and mean peak change in fluorescence from 
baseline in response to a 10 Hz 10 s stimulus train. Control (n=841), CNQX (n=407), 
CNQX+MG132 (n=400), CNQX + Lac (n=57). (*p<0.05 relative to vehicle controls at peak 
fluorescence levels at immediate termination of stimulus train). (C) Postsynaptic inhibition of 
proteasome function via expression of dominant negative K48R ubiquitin point mutant (red cell). 
Representative recordings mean mEPSC frequency recorded from cells expressing GFP alone or 
in combination with K48R ubiquitin, after washout of CNQX (40M, 4Hr). Summary graphs 
presented on left and cumulative probability distribution shown on right. GFP (n=16), 
GFP+CNQX (n=14), K48R (n=10), K48R+CNQX (n=12). (D) Presynaptic inhibition of 
proteasome function via expression of dominant negative K48R ubiquitin point mutant (red cell) 
alongside vglut1-pH. Representative images of vglut1-pH peak fluorescence at the termination of 
a 10s, 10Hz field stimulus, after washout of CNQX (40M, 3 Hrs) in cells expressing eiether 
WT or K48R ubiquitin. (bottom) Relative change in vglut1-pHluorin fluorescence over time and 
mean peak change in fluorescence from baseline in response to a 10 Hz 10 s stimulus train. 
WT(n=442 synapses), WT+CNQX (n=496 synapses), K48R (n=238 synapses), K48R+CNQX 
(n=792 synapses). (*p<0.05 relative to vehicle controls at peak fluorescence levels at immediate 
termination of stimulus train). (E) Representative mEPSC recordings and mean (+SEM) mEPSC 
amplitude and frequency made from hippocampal cultures after washout of BDNF (2Hrs, 
250ng/ml) with or without Lactacystin (10M) or MG132 (10M). Control (n=7), BDNF (n=7), 
Control + Lac (n=5), BDNF+Lac (n=7), Control + MG132 (n=6), BDNF + MG132 (n=6). 
(*p<0.05 vs vehicle treated controls). (F) Representative images (top) of vglut1-pH peak 
fluorescence at the termination of a 10s, 10Hz field stimulus, after washout of BDNF 
(250ng/ml,2Hrs) with or without concurrent inhibition of the ubiquitin proteasome system with 
MG132 (10M, 30 min pre-treatment) or Lactacystin (10M, 30 min pretreatment). (bottom) 
Relative change in vglut1-pHluorin fluorescence over time and mean peak change in 
fluorescence from baseline in response to a 10 Hz 10 s stimulus train. Control (n=724), BDNF 
(n=808), BDNF+MG132 (n=305), BDNF+ LAc (n=715). (*p<0.05 relative to vehicle controls at 
peak fluorescence levels at immediate termination of stimulus train). Scale bar represents 10m 


















Figure 5.5: Pharmacological inhibition of proteasome function blocks presynaptic 
augmentation after BDNF exposure or acute mTORC1 activation. (A)  Representative 
examples and mean (+SEM) syt-lum uptake from experiments where the indicated groups were 
treated with BDNF Alone (250ng/ml, 2Hrs) or in combination with proteasome inhibitors as 
indicated. Control (87=x images), Lac (n= 40 images), MG132 (n= 29 images), BDNF (n=33 
images), BDNF + Lac (n=24 images), BDNF+MG132 (n=33 images). (*p<0.05, relative to 
control). (B) Representative recordings and mean mEPSC Amplitude and Frequency obtained 
from cells treated with PA (100M, 45 min) with or without proteasome inhibitors as indicated. 
Summary averages presented on left and cumulative probability distributions shown on left. 
Vehicle control (n=10), PA Alone (n=10), PA+MG132 (n=12), PA+Lac (n=10). (*p<0.05, one-















Figure 5.6: Neuronal activity drives synaptic redistribution of the proteasome in axons. (A) 
Effects of activity manipulation on presynaptic proteasome distribution. Top panel shows 
representative cell-attached recordings from cells under control conditions or after treatment with 
Bicuculine (10M) or TTX (1M) for 2Hrs. Lower panel contains representative images of 
axonal segments expressing Rpt3-FLAG and mCherry-Synaptophysin. (B) Group means of 
FLAG fluorescence intensity present in mCh-Syn positive regions under each condition: Control 
(n=12 images), Bic (n=11 images), TTX (n=12 images). Scale Bar represents 5m in B. 
(*p<0.05 compared to controls). (C) Representative images of axonal regions expressing 
mCherry-Syn (top panel) as well as Rpt6-GFP (lower 3 panels). Identical set of synapses 
displayed in each image, under conditions of baseline images (top), after 30 min of TTX 
exposure (middle) and after 5min 60mM K+ (bottom). Right, enlarged sections denoting 
extrasynaptic („shaft‟, red) or synaptic („bouton‟, yellow) regions of interest under each 
condition. (D) Timecourse of group averages (% change in fluorescence from baseline) for 
extrasynaptic (black square, n=32 ROIs across 8 axons) and synaptic (red circle, n=32 ROIs 
across 8 axons) regions after 30 minutes of TTX treatment (1M) followed by 5 min exposure to 
60 mM K+ (blue shaded region, normalized to values at 30 min post TTX). Scale bar represents 










Figure 5.7: Spike blockade eliminates association between HA-tagged proteasome subunit 
and marker of presynaptic boutons. Representative images of axonal segments expressing 
HA-Rpt6 as well as mCh-Syn, treated with CNQX alone (40M, 3Hr) or in combination with 
TTX (1M). Right, group means of % change in HA fluorescence (relative to vehicle treated 
controls) as indicated: Control (n=49 images), CNQX (n=55 images), CNQX+TTX (n=45 
images). Spike blockade redistributed proteasome localization away from synaptic regions in the 
axon, regardless of presence or absence of homeostatic challenge induced by AMPAR blockade. 


























Figure 5.8: Active retention of proteasomes at presynaptic boutons (A) Example images of 
timelapse experiment from cells expressing mCh-Syn as well as PA-GFP Rpt6. mCh-Syn signal 
alone (a1), and PAGFP signal before (a2), 0s (a3), 30s (a4), and 150s (a5) after a 5s 
photoactivation stimulus targeted in the extraynaptic region denoted in a2 (white square). Scale 
bar represents xx in A. (B) Timecourse of PAGFP fluorescence values (a.u.) taken from the 
experiment shown in A. Traces correspond to data obtained from ROIs centered around the 
extrasynaptic region shown in a2 (black line), as well as two synaptic regions as highlighted in 
a5 (red and blue lines). (C) Timecourse of collected PAGFP fluorescence decay group means in 
synaptic (n= 13) and extrasynaptic (n=6) regions, normalized to peak fluorescence after 
photoactivation. As peak fluorescence in synaptic regions routinely occurred with a temporal 
delay compared to extrasynaptically photoactivated regions (as in B), peak fluorescence values 
were time locked to compare relative decay rates. (D) Schematic of single-synapse experiment: 
Individual boutons expressing mCh-Syn and PA-GFP Rpt6 were targeted for photoactivation 
(yellow square), then monitored to track fluorescence decay over time. (E) Example images 
showing mCh-Syn signal (left) and gradual loss of PAGFP fluorescence from synaptic regions 
after photoactivation. (F) Timecourse of collected PAGFP fluorescence decay group means in 
neurons treated with Bicucline (10M for 2Hrs, n= 38) or vehicle treated controls (n=11), 
normalized to peak fluorescence after photoactivation. Treatment with Bicucline resulted in 





































Figure 5.9: Phosphorylation of Rpt6 at S120 alters synaptic localization of the proteasome 
in axons. (A) Schematic of single synapse photoactivation experiment. Neurons were transfected 
with mCH-Syn as well as PA-GFP tagged to WT, S120A or S120A Rpt6. Individual bouton 
were targeted for photoactivation (Yellow Square) then monitored to track loss of fluorescence 
over time. (B) Example images showing mCh-Syn signal (left) and gradual loss of PAGFP 
fluorescnece after photoactivation in cells expressing WT, S120A or S120D Rpt6. (C) 
Timecourse (left) and mean decay rates (right, quantified as time to reach ½ max) of PAGFP 
fluorescence decay in neurons expressing WT Rpt6 (n=15 synapses), S120A Rpt6 (n=13 
synapses) or S120D Rpt6 (n=14 synapses), normalized to peak fluorescence after 
photoactivation. (*p<0.05 compared to Rpt6WT controls) (D) Example images of axonal regions 
from neurons triple transfected with mCh-SYn, FLAG-Rpt1, as well as either Rpt6-WT, Rpt67-
S120A, or Rpt6-S120D. Right, group means of FLAG fluorescence intensity present in mCh-Syn 
positive regions under each condition as indicated: Rpt6WT (n=26 images), Rpt6-S120A (n=20 












Figure 5.10: HA-tagged Rpt6 WT and point mutants display unique distribution patterns 
in axons. (A) Example images of axonal regions from neurons transfected with mCh-SYn, as 
well as HA-tagged Rpt6-WT, Rpt6-S120A, or Rpt6-S120D. Right, group means of HA 
fluorescence intensity present in mCh-Syn positive regions under each condition as indicated: 
Rpt6WT (n=30 images), Rpt6-S120A (n=30 images), Rpt6 S120D (n=20 images). Scale Bar 









Figure 5.11: Serine to alanine point mutation in Rpt6 eliminates activity dependent 
redistribution and blocks enhanced presynaptic function after loss of excitatory input or 
exposure to BDNF. (A) Example images of axonal regions from neurons transfected with mCh-
SYn, as well as GFP-tagged Rpt6-WT or Rpt6-S120A. Cells were treated with Bicucline or 
vehicle after 48Hrs of expression then assessed for GFP colocalization with synaptic mCh-Syn 
signal. (B) Group means of GFP fluorescence intensity present in mCh-Syn positive regions 
under each condition as indicated: Rpt6WT Vehicle (n=10 images), Rpt6-WT Bicuculine (n=11 
images), Rpt6-S120A Vehicle (n=14 images), Rpt6-S120A Bicuculine (n=16 images). Scale Bar 
represents x in A. (*p<0.05 compared to vehicle treated controls for each group). (C) Schematic 
of experiment: Neurons were transfected with vglut1-pH as in combination with either Rpt6WT 
or Rp6-S120A. 48Hrs later, cells were subject to AMPAR blockade with CNQX (40M, 3Hr), 
then assessed for field-stimulus driven exocytosis. (D) Relative change in vglut1-pHluorin 
fluorescence over time and mean peak change in fluorescence from baseline in response to a 10 
Hz 10 s stimulus train for groups as indicated: Control (n=248 boutons), CNQX (n=287 
boutons), S120A (n=237 boutons), S120A + CNQX (n=331 boutons). (E) Experimental design 
for within-group assessment of the effect of acute BDNF treatment on vesicle release. Neurons 
expressing mCH-Syn and vglut1-pH were subject to a 10s, 10Hz field stimulus to assess initial 
release properties. Cells were then treated with BDNF (250ng/ml, 30min) and this same set of 
synapses was again stimulated using an identical spike train. (F) Example images of axonal 
segments depicting mCh-Syn signal, as well as peak evoked vglut1-pH fluorescence before and 
30 min after application of BDNF in neurons expressing Rpt6WT (left) and Rpt6-S120A (right). 
(G) Examples of averaged responses from a single set of boutons expressing Rpt6WT imaged 
before (black) and after (red) application of either BDNF (n=31 boutons) or vehicle (n=71 
boutons). (H) Collected group averages of peak vglut1-pH intensity at end of 10Hz stimulus 
(shown normalized to peak obtained by stimulus 1 as indicated: Rpt6 WT Vehicle (n=139 
boutons), Rpt6WT BDNF (n=217 boutons), Rpt6 S120A Vehicle (n=35 boutons), Rpt6 S120A 








Figure 5.12: Expression of Rpt6S120 eliminates homeostatic increases in spontaneous 
vesicle release. Representative examples and mean (+SEM) syt-lum uptake from experiments 
where the indicated groups were treated with CNQX Alone (40M, 3Hrs) or in combination with 
expression of Rpt6S120A as indicated: Control (n=23 images), Control+CNQX (n=23 images), 
S120A (n=27 images), S120A+CNQX (n=27 images). (*p<0.05, relative to control) Scale bar in 









Figure 5.13: A phosphomimetic mutation in Rpt6 is sufficient to drive the proteasome to 
synapses and render presynaptic compensation state-independent. (A) Example images of 
axonal regions from neurons transfected with mCh-SYn, as well as GFP-tagged Rpt6-WT or 
Rpt6-S120D. Cells were treated with TTX or vehicle after 48Hrs of expression then assessed for 
GFP colocalization with synaptic mCh-Syn signal. (B) Group means of GFP fluorescence 
intensity present in mCh-Syn positive regions under each condition as indicated: Rpt6WT 
Vehicle (n=14 images), Rpt6-WT TTX (n=21 images), Rpt6-S120D Vehicle (n=16 images), 
Rpt6-S120D TTX (n=19 images). Scale Bar represents 10m in A. (*p<0.05 compared to 
vehicle treated controls for each group). (C) Schematic of experiment: Neurons were transfected 
with vglut1-pH in combination with either Rpt6WT or Rp6-S120D. 48Hrs later, cells were 
subject to AMPAR blockade with CNQX (40M, 3Hr) and spike blockade with TTX (1M), 
then assessed for field-stimulus driven exocytosis. (D) Relative change in vglut1-pHluorin 
fluorescence over time and mean peak change in fluorescence from baseline in response to a 10 
Hz 10 s stimulus train for groups as indicated: S120D control (n=515 boutons), S120D CNQX 
(n=622 boutons), S120D CNQX+TTX (n=571 boutons), S120D TTX Alone (n=208 boutons). 









Figure 5.14: Expression of Rpt6 point mutants on its own does not alter vesicle pool 
characteristics. (A) Example experimental run to assess vesicle pool fractions.  Neurons were 
bafilomycin (1M) then given 900APs at 20Hz to determine the recycling pool fraction of total 
labeled vesicles (see Ryan paper). Nh4Cl was then added to reveal the total pool of pHluorin 
labeled vesicles (blue arrow). (B) Group averages reveal no significant difference in the size of 
total vesicle pool (presented as NH4Cl-induced peak fluorescence normalized to baseline 
fluorescence levels) between experimental groups as indicated: Rpt6WT (n=7 experiments), 
Rpt6 S120A (n=6 experiments), Rpt6 S120D (n=7 experiments). (C) Group averages reveal no 
difference in the size of the recycling pool of vesicles (presented as fraction of fluorescence 
plateau reached in presence of Bafilomycin compared to total after NH4Cl) as a result of 
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 Collectively, the data collected as part of this dissertation work suggest that postsynaptic 
mTORC1 signaling is responsive to changes in dendritic voltage or synaptic Ca2
+
 influx, and 
that blockade of AMPARs or L-type voltage gated Ca2
+
 channels with CNQX or Nifedipine is a 
sufficient stimulus to drive a homeostatic shift in presynaptic function via mTOR-dependent 
synthesis of BDNF as a retrograde signal (Chapter 2). Work from multiple labs has suggested 
that retrograde control of presynaptic function may be mediated by cell-adhesion proteins (Hu et 
al., 2012, Futai et al, 2007) particularly in the context of homeostatic adaptation to spike 
blockade (Vitureira et al., 2011). Our own findings add to a growing body of evidence which 
supports the notion that trans-synaptically mediated homeostasis induced by loss of excitatory 
input (i.e. AMPAR blockade) relies instead on retrograde signaling from the post to presynaptic 
compartment via a diffusible signal. The data presented here is in agreement with previous 
reports at mammalian central synapses that have identified this retrograde signal as BDNF 
(Jackawhich, et al., 2010; Lindskog et al., 2010), or Nitric oxide (Lindskog et al., 2010). A 
similar role for postsynaptic mTORC1 in the expression of presynaptic homeostasis was recently 
demonstrated at the fly NMJ (Penney et al., 2012), though the molecular identity of the 
retrograde signal at this synapse remains unknown. An interesting feature of the work from 




sufficient to induce rapid enhancement of presynaptic function. Our work at mammalian central 
synapses mirrors and extends these findings. Indeed, we report that this retrograde signaling 
mechanism appear to be an immediate effect of hyperactive mTORC1 signaling, as acute 
activation of mTORC1 with the lipid second messenger PA is sufficient to drive BDNF-
dependent increases in presynaptic release (Chapter 3). This is notable, as it suggests that 
mTORC1-induced retrograde signaling may be a conserved mechanism across multiple species 
and synapse types to dynamically match presynaptic release to the functional properties of the 
postsynaptic cell. Experiments conducted at the fly NMJ have led some to posit the existence of 
multiple proteins operating in the postsynaptic compartment to exert and inhibitory block on 
mTORC1-mediated release of a retrograde signal (Frank, 2013), including dystrophin (van der 
Plas et al., 2006),  Importin-13 (Giagtzoglou et al., 2009), and cv-c (Pilgram et al., 2011). Rather 
than identify postsynaptic inhibitors of mTORC1-mediated homeostasis, our work highlights a 
unique role for PLD1-mediated hydrolysis of the lipid second messenger PA in the activation of 
mTOR during activity blockade (Chapter 4). This combined pathway of PLD1-->PA-->mTOR 
activation appears to operate as a homeostatic sensor mechanism to detect shifts in postsynaptic 
activation, and, strikingly, is completely unnecessary for synaptically-driven mTORC1 activation 
during chemically-induced LTP. These findings suggest that unique means of mTOR activation 
have the potential to result in functional outcomes that are specific for the manner in which 
mTORC1 is activated. This could have important implications for our understanding of mTOR-
related neurodevelopmental disorders, in that it may be difficult to anticipate a stereotyped 
functional change at the level of the synapse in response to upregulated mTOR signaling after 
mutations in PTEN, TSC1/2 or NF1. FInally, we identify a novel presynaptic effector 




relocalization of the UPS interacts with retrograde BDNF signaling to drive changes in 
presynaptic release (Chapter 5). This finding situates state-dependent presynaptic homeostasis 
driven by loss of excitatory input as a form of plasticity which is brought about by the 
coordinated regulation of local translation and targeted degradation at synapses. There are a 
growing number of examples of similar types of co-operative synthesis and breakdown 
mechanisms at work in other forms of plasticity, including during mGluR-LTD (Hou et al., 
2006) and after NMDAR stimulation (Banerjee et al., 2009), though these appear to be instances 
of breakdown and synthesis operating in same synaptic compartment. The type of interaction we 
describe here is unique in that it involves coordination of degradation and translation in apposed 
synaptic compartments, linked by a retrograde signal.   
 
Defining the molecular players in a homeostatic circuit at excitatory synapses 
 One of the defining features of a homeostatic system is that it exhibits a constant output. 
The acceptable range of functional output is defined as the „set point‟, deviations from which 
trigger feedback mechanisms to return output levels to acceptable norms (Davis, 2006). In the 
case of global changes in synapse function induced by prolonged spike blockade with TTX 
(Ibata et al., 2008) or increased activity via CHR2 stimulation (Goold and Nicoll, 2011), it is 
believed that homeostatic sensors respond to abnormally high or low levels of somatic calcium 
influx and enact feedback mechanisms to return spike activity to within an acceptable range 
(Turrigiano et al., 2011). In these cases, somatically localized CamKIV and CamKK appear to 
act as components of a sensor mechanism which detects deviations in somatic calcium influx and 
implements feedback via changes in transcription. In the case of locally-mediated synaptic 




Stated more simply, what is the relevant „output‟ measure in dendrites, deviations from which 
trigger spatially restricted homeostatic adaptations?  It seems unlikely that a dendritic branch or 
individual synapse would be sensitive to changes in cell firing, though it is conceivable that 
back-propagating action potentials could signal this sort of information. An alternative 
possibility that is more parsimonious with the data presented here, is that dendrites contain 
sensor mechanisms which are sensitive to localized changes in voltage or Ca2
+
 influx. The 
nature of the homeostatic challenges implemented in our experiments lend support to this idea, 
as AMPAR blockade with CNQX and voltage-gated Ca2
+
-channel blockade with Nifedipine 
both undoubtedly alter steady state levels of dendritic Ca2
+
 influx and leave the dendritic arbor 
in a more hyperpolarized state than it would be under normal conditions. Work from Lu Chen‟s 
lab has identified retinoic acid (RA) as a componenet of a Ca2
+
-sensitive postsynaptic sensor 
crucial for implementing postsynaptic functional compensation in response to loss of excitatory 
input (Chen et al., 2012). Our finding that intracellular synthesis of PA is necessary for 
presynaptic homeostasis but not cLTP suggests that PLD1 might operate as a component of a 
similar Ca2
+
 sensing mechanism operating locally in dendrites.  Additional work is needed to 
clearly define the manner in which PLD1 respnds to changes in voltage or Ca2
+ 
influx. 
 Regarding effector mechanisms, our results suggest that degradation of an as yet 
unidentified presynaptic protein likely mediates the homeostatic changes induced by retrograde 
BDNF signaling (Chapter 5). Aside from this putative UPS target, the work described here does 
not provide additional insight into potential effectors in this homeostatic circuit. However, the 
type of plasticity we describe here has much in common with a commonly studied form of 
synaptic homeostasis characterized at the Drosophila NMJ (Frank, 2013). The genetic tractability 




homeostasis driven by loss of excitatory input is implemented at the molecular level. As 
previously discussed, forward genetic screens using a philanthotoxin based model of synaptic 
homeostasis at the fly NMJ has identified a number of presynaptic proteins which are vital for 
the expression of presynaptic homeostasis. Thus far, however, there have been no published hits 
for a protein which serves to dampen vesicle release under normal conditions, as would fit our 
proposed model. It would informative to use PhTx or GluAII-knockout based models of synaptic 
homeostasis at the fly NMJ to test for a potential role of presynaptic disinhibition mediated by 
degradation of a protein such as tomosyn or Slp4-A. The field of homeostatic plasticity has 
benefited immensely from the unique benefits provided by mammalian and invertebrate model 
systems, and ongoing shared effort between labs utilizing these approaches will be vital if we are 
to achieve a more complete understanding of the molecular players involved in state-dependent 
presynaptic homeostasis.  
 An intriguing possibility left untested by the experiments described here is that 
mTORC1-dependent retrograde signaling mechanisms may play a role in establishing coherence 
between pre and post-synaptic efficacy outside of the context of explicit deprivation of excitatory 
input. Evidence across multiple species and cell types demonstrates that fundamental aspects of a 
presynaptic terminal‟s function, such as release probability, are influenced by the identity and 
characteristics of the postsynaptic cell on which they make contact (Davis, 1995). In addition, 
one feature of the postsynaptic cell to which presynaptic contacts appear to be particularly 
sensitive is the relative degree of dendritic depolarization. Studies conducted at the drosophila 
neuromuscular junction (NMJ) indicate that experimentally-induced hyperpolarization of the 
postsynaptic membrane potential is sufficient to induce a compensatory increase in presynaptic 




between presynaptic release probability and the number of synapses on a given dendritic branch 
of a pyramidal neuron has supported the idea that presynaptic efficacy homeostatically adjusts to 
unique levels of background synaptic activity present in any given dendrite (Branco et al., 2008). 
This would seem to require a mechanism responsible for integrating information about changes 
in levels of dendritic depolarization, and dynamically implementing feedback mechanisms to 
adjust presynaptic inputs accordingly. Achieving balance in pre-and postsynaptic function 
appears to be of fundamental importance at several types of synapses, and may be one of the 
most basic and widespread uses of post to pre-synaptic retrograde signaling in the nervous 
system (Regehr et al., 2009). Our work suggests that dendritic mTORC1 may contribute to this 
type of trans-synaptic homeostasis via dendritic synthesis of BDNF as a retrograde signal, 
through an explicit requirement for mTOR in the type of steady-state pre and postsynaptic 
functional matching characterized by Branco and colleagues remains to be tested.  
 
mTORC1 dysregulation, E/I imbalance and the pathophysiology of ASD 
 Given its position as a central node in a rich signaling pathway with links to diverse cell 
functions including cell growth and division, it is perhaps unsurprising to find that dysregulated 
mTORC1 signaling has been implicated in multiple psychiatric and neurological conditions 
including Autism Spectrum Disorders (Hoeffer and Klann, 2010), epilepsy (Wong, 2010), Major 
Depressive Disorder (Duman et al., 2012), and neurodegenerative disorders including 
Alzheimer's Disease (Pei and Hugom, 2008). In the space which remains, my aim is to provide 
an account of how mTORC1 signaling contributes to the neuropathology of ASD, with particular 
emphasis on how disruptions in mTORC1-mediated homeostasis may contribute to the altered 





Dysreguated mTORC1 signaling in Autism Spectrum Disorders 
 Autism spectrum disorders (ASD) represent a heterogenous group of conditions with a 
triad of core diagnostic features including deficits in communication, impaired social interaction 
and a predisposition toward repetitive behaviors (Fombonne, 1999). Roughly 70% of autistic 
individuals also suffer from mental retardation. Recent advances in genomic approaches to 
understanding ASD have revealed a complex network of genes that may be responsible for the 
divergent phenotypic abnormalities present in human patients. Notably, a plurality of ASD-
related mutations appear to be in genes which serve functions in chromatin remodeling, 
metabolism, mRNA translation, and synaptic transmission, with potential functional convergence 
around the maintenance of neuronal and synaptic homeostasis (Hugeut et al., 2013). The study of 
monogenic forms of ASD has provided valuable opportunities to try and uncover synaptic and 
behavioral commonalities between multiple genetic heterogeneous forms of ASD. Interestingly, 
many of these single-gene disorders commonly related to autism result in overactive mTORC1 
signaling, leading some to posit that dysregulated translational control at synapses may be a 
common phenotype central to the emergence of aberrant cognitive and behavioral characteristics 
related to ASD (Kelleher and Bear 2008; Bourgeron, 2009; Hoeffer and Klann, 2010). Tuberous 
sclerosis complex and fragile X syndrome (FXS) are disorders with high rates of comorbidity 
with ASD. The proteins mutated in these disorders, TSC1/2 and FMRP respectively, normally 
act to inhibit mTORC1 activity.  In addition, the genetic mutations related to Neurofibromatosis 
Type 1 (NF1) and PTEN hamartoma syndrome also lead to overactive translation via 




mTORC1 also has an essential role in neuronal development and plasticity (Jaworski and Sheng, 
2006), again suggesting a potential link in the etiology of developmental disorders such as ASD.  
 
E/I Imbalance as general feature of ASD and Epilepsy 
 An important insight into a potential shared mechanism behind the sensory, cognitive, 
and social dysfunctions common in ASD arose from the observation that patients with ASD 
often exhibit characteristics of epilepsy (Tuchman and Cuccaro, 2011). Since the first reported 
cases of ASD by Leo Kanner in 1943, the clinical community has appreciated the high degree of 
co-morbidity between ASD and epilepsy (Kanner 1943). Roughly 50-70 percent of children with 
ASD exhibit epilepsy-elated sharp spike activity in MEG recordings during sleep (Lewine et al., 
1999). In addition, a recent meta-analysis surveying all published reports from 1963-2006 
showed a high degree of symptomatic overlap between the two disorders, with unique 
manifestations depending on the severity of the cognitive disability in ASD patients: 21.4% of 
ASD patients with co-morbid Intellectual disability also present with Epilepsy vs 8% observed in 
AD patients who carry no evidence of intellectual disability (Amiet et al., 2008).  
 The etiology of epilepsy is complex, with a diverse array of both genetic and 
environmental factors that can bias neuronal circuits toward aberrant synchronization resulting in 
seizures (Goldberg and Colter, 2013). However, increased mTORC1 signaling appears to be a 
commonly observed feature of many animal models of epilepsy, as seen after seizures induced 
by kainate (Zeng et al., 2009), Pilocarpine (Huang et al., 2010), and Pentylenetetrazole (Zhang 
and Wong, 2012). It is likely that seizure-related increases in neuronal activity drive mTOR 
signaling on their own, but observations from syndromic disorders characterized by unchecked 




development or progression of epileptogenesis. Indeed, animals models exhibiting loss of PTEN 
or TSC1/2 function reliably develop spontaneous seizures (Ogawa et al., 2007), which can be 
ameliorated by treatment with rapamycin (Zhou et al., 2009, Zeng et al., 2008). Recent evidence 
suggests that mTORC1 dysregulation need not be system-wide for seizures to develop, as the 
selective deletion of the inhibitory mTOR regulator PTEN from dentate granule cells is sufficient 
to induce Temporal Lobe epilepsy, likely stemming from morphological changes including the 
aberrant growth of basal dendrites, and spine density roughly double that of normal cells (Pun et 
al., 2012). This study is one of several that indicate mTOR-mediated changes in dentate granule 
cell development and migration, including abnormal mossy fiber sprouting (Buckmaster et al., 
2009), contribute to epileptogenesis. However, there is additional experimental support for a 
common synaptic basis of aberrant neuronal synchrony in conditions such as Tuberous Sclerosis 
that is mediated by elevated glutamatergic signaling (Wang et al., 2007). 
 There is considerable evidence for a positive relationship between the severity of 
cognitive impairment in ASD and prevalence of seizures (Giannotti et al., 2008; Parmeggiani et 
al., 2010), particularly for patients with Tuberous Sclerosis Complex (Jeste et al., 2008). In the 
past decade, these observations lead to the breakthrough conceptual advance that similarly 
unstable or noisy cortical networks may be a common feature to certain forms of epilepsy and 
ASD. Particularly, as originally proposed by Rubenstein and Merzenich (2003), it is possible that 
an imbalance in the ratio of excitatory and inhibitory tone in key brain regions which mediate 
sensory, language, or social behaviors could be a fundamental feature of ASD. This E/I 
imbalance was postulated to take the form of increased excitation, manifested via aberrantly high 
glutamatergic synaptic function or aberrantly low GABAergic synaptic function. A circuit-level 




chronically elevate firing activity of select populations of excitatory or PV+ inhibitory neurons in 
the mouse prefrontal cortex (Yizhar et al., 2011). Strikingly, a shift in E/I balance toward 
overexcitation resulted in deficits in episodic learning and social interactions, while comparable 
shifts toward increased inhibitory tone in the same brain regions produced no such effects.  
 There is evidence to support that this imbalance of excitation and inhibition in the brains 
of patients with ASD arises from disruptions in GABA mediated inhibition.  For instance, 
removal of MecP2 specifically from GABAergic interneurons reduces inhibitory quantal size, 
and phenocopies many fundamental aspects of Rett syndrome seen in global MecP2 mutant Mice 
(Chao et al., 2010). A fascinating recent study also suggests that loss of TSC1 in GABAergic 
purkinje neurons of the cerebellum is sufficient to recapitulates many common ASD-like 
phenotypes including repetitive behaviors and impaired social interactions (Tsai et al., 2012). 
Though inhibitory synapse dysfunction can undoubtedly contribute to the E/I imbalance 
observed in ASD, there is additional evidence to support genetic links to disrupted excitatory 
transmission. A plurality of mutations implicated in neurodevelopmental disorders such as ASD 
are found in proteins localized at excitatory synapses and are integral for glutamatergic signaling 
at the postsynaptic density (Ebert and greenberg, 2013; Huguet et al., 2013). A unique role for 
altered excitatory tone in ASD is bolseted by fascinating recent work from Zylka lab, which has 
advanced the hypothesis that genes associated with ASD, are on average 3.7x longer than the 
general population of genes expressed in cortical neurons. As such, mutations with alter the 
transcription elongation process or topoisomerase activity in particular could have a 
disproportionately strong effect on the expression of ASD-related genes (King et al., 2013). The 
authors provide support for this model showing that pharmacological or genetic disruption in 




have previously validated roles in the development or proper function of excitatory synapses, 
including Cntnap2 (ref), Neurexin 3 (Aoto et al., 2013), Grid2 (Lomeli et al., 1993), IL1RAPL1 
(Pavlowsky et al., 2010), PARK2 (Helton et al., 2008), Cntn5 (Toyoshima et al., 2009), Ptprt 
(Lim et al., 2009), Frmpd4 (Lee et al., 2008), Neurexin1 (de Wit et al., 2009), Gpc6 (Allen et al., 
2012), Grm7 (Boudin et al., 2007), Nlgn1 (Irie et al., 1997), Grid1 (Roche et al., 1999), Kcnma1 
(Hu et al., 2001), Grik2 (Lanore et al., 2012), Plcb1 (Spires et al., 2005), Nbea (Niesmann et al., 
2011), Grm5 (Ko et al., 2012), Kalrn (Penzes et al., 2003), Robo2 (Campbell et al., 2007), 
Cacna1c (Obermair et al., 2004), Lrrc7 (Apperson et al., 1996), Reln (Qiu and Weber, 2007), and 
Nxph1 (Petrenko et al., 1996).  
 There is also growing support for a specific contribution of disrupted synaptic 
homeostatic mechanisms in the development of circuit abnormalities seen in ASD. In this model, 
loss of synaptic flexibility via mutations in proteins which serve vital roles in the expression of 
homeostatic plasticity lead to profound and progressive circuit level abnormalities.  If these 
dysfunctional networks reside in brain regions responsible for communication, social interaction 
or repetitive behaviors, the behavioral phenotypes that emerge will likely be those most 
commonly associated with ASP patients (Ramocki and Zoghbi, 2008; Toro et al., 2010). Recent 
experimental evidence has shown an overlap between proteins known to be important for 
synaptic homeostasis and those known to be mutated in several forms of ASD. For example, loss 
of function in FMRP has been shown to disrupt synaptic homeostasis induced by concurrent 
TTX and APV treatent (Soden and Chen, 2010). Synaptic levels of SHANKs, PSD scaffolding 
proteins implicated in several forms of ASD (Jiang and Ehlers, 2013), have been shown to be 
under homeostatic control via UPS-mediated degradation (Ehlers, 2003). Additionally, multiple 




repressor linked to Rett syndrome (Amir et al., 1999), is necessary for homeostatic reductions in 
the strength of excitatory synapses after prolonged network level activity increases (Qiu et al., 
2012; Zhong t al., 2012). Our finding that mTORC1 critically regulates the synthesis of a 
retrograde signal at work in trans-synaptic homeostatic signaling further suggests that failure in 
adaptive plasticity measures may be a central feature of many forms of ASD. The type of 
dysregulated homeostatic measures we report here could be a contributing factor to the gradual 
emergence of E/I circuit level imbalances common to ASD. Mutations in proteins which 
normally serve to dampen mTOR function such as TSC1/2, NF1 or PTEN, would presumably 
limit the ability of mTORC1 to homeostatically regulate synaptic function, and may instead lead 
to unchecked strengthening of presynaptic connectivity via retrograde feedback mechanisms. As 
such, treatments that alter E/I imbalance are emerging as a promising point of therapeutic 
intervention in ASD, as discussed below.  
 
Current attempts to treat mTOR-opathies and future prospects 
 Limited but encouraging progress has been made in recent years to correct the synaptic 
and behavioral deficits in mTOR-related neurodevelopmental disorders.  Of particular interest 
have been attempts to modify mTORC1 signaling specifically, or translational regulation in 
general, to ameliorate abnormal phenotypes in ASD mouse models (Delorme et al., 2013). 
Multiple mouse models of ASD with disruptions in mTORC1 signaling have been shown to 
benefit from rapamycin treatment. TSC2-/- mice, for example, show improvements in L-LTP 
and spatial learning after receiving 5 days of rapamycin injections (Ehninger et al., 2008). 
Rapamycin treatment also improved deficits in social interactions and anxiety-like behaviors in a 




temsirolimus has been shown to reduce the threshold for audiogenic seizures and correct deficits 
in object recognition memory in Fmr1 knockout mice (Busquets-Garcia et al., 2013). These data 
from mouse models of ASD, combined with emerging reports of reduced seizure frequency in 
human patients with TSC or PMSE (polyhydramnios, megalencephaly, and symptomatic 
epilepsy syndrome) after treatment with rapamycin or the rapalog everolimus (Kreuger et al., 
2013; Parker et al., 2013), are remarkable in that they suggest that reduction in dysregulated 
mTORC1 signaling is perhaps sufficient to correct behavioral phenotypes in animals for which 
the major steps of neuronal circuit development have already occurred. This is not a finding 
shared by all attempted interventions in animals models of neurodevelopmental disorders. 
Mutations in SynGAP1, for example, disrupt the maturation of excitatory synapses and lead to 
ASD-like phenotypes. If this mutation is corrected before a critical period of circuit formation, 
the associated behavioral phenotype is eliminated (Clement et al, 2012).  If interventions are 
made after this developmental window, however, no correction in ASD-like behaviors are 
observed, suggesting that disrupted circuit formation itself is the central cause of phenotypic 
dysfunction observed in this form of ASD, which is perhaps not that case for conditions linked to 
mTOR dysfunction.  
 Recalling the earlier stated hypothesis of E/I imbalance as a central feature of ASD, 
exciting recent work has provided initial indications that increasing systemic inhibitory tone 
could be a useful alterntive strategy for correcting the maladaptive phenotypes associated with 
certain forms of ASD. As a truly inspiring example of “bench-to-bedside” science at work, a 
group from Seaside therapeutics has recently used the GABA-B receptor agonist Arbaclofen to 
correct the abnormal protein synthesis, increased dendritic spine density, seizure frequency and 




exciting possibility for potential therapeutic interventions in mTOR-opathies such as PTEN 
Hamartoma syndrome and Tuberous Sclerosis. There is evidence for hyperactive mTOR 
signaling in both fmr1-knockout animals (Sharma et al., 2010) and in fragile x patients (Hoeffer 
et al, 2012), and recent work suggests that impaired inhibitory synaptic function is an early to 
emerge feature of hyperactive mTORC1 activity in TSC1 knockout neurons (Bateup et al., 
2013). Additional work is necessary to determine if a similar approach targeted at elevating 
inhibition would be equally efficacious in forms of ASD with specific links to dysregulated 
mTORC1 activity. The work collected here identifies BDNF-mediated augmentation of 
presynaptic signaling as an immediate consequence of hyperactive mTORC1 signaling. This 
presynaptic enhancement requires the presence of the UPS at synaptic terminals, the distribution 
of which can be altered by diminished spike activity. As such, increasing inhibitory tone using an 
approach similar to that taken by Henderson and colleagues could serve to reduce proteasome 
accumulation at synaptic boutons, thereby potentially mitigating the effects of hyperactive 
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Materials and Methods 
 
 
 BDNF shRNA Transfection: U6 promotor-driven scrambled and BDNF shRNA-
expressing plasmids were obtained from OriGene Technologies (Rockville, MD); BDNF shRNA 
1: 5′-TGTTCCACCAGGTGAGAAGAGTGATGACC-3, BDNF shRNA 2: 5′-
GTGATGCTCAGCAGTCAAGTGCCTTTGGA-3′, scrambled: 5′-
GCACTACCAGAGCTAACTCAGATAGTACT-3′. Each plasmid additionally contains a tRFP 
expression cassette driven by a distinct (pCMV) promoter. Neurons were transfected with 0.5 μg 
of total DNA with the CalPhos Transfection kit (ClonTech; Mountain View, CA) according to 
the manufacturer's protocol. All experiments were performed 24 hr after transfection. 
 Cell culture: Dissociated hippocampal neuron cultures were prepared according to 
previously published methods (Banker and Goslin, 1990). Briefly, hippocampi from Sprague–
Dawley rat pups (P1–P3) were dissected in cold dissociation media (DM; 82 mM Na2SO4, 30 
mM K2SO4, 5.8 mM MgCl2–6H2O, 252 μM CaCl2–2H2O, 1 mM HEPES, 200 mM glucose, 
0.001% w/v phenol red), and transferred to a 15 ml conical tube. Dissociation media (DM) was 
gently removed (save roughly 500 μl covering the tissue itself) and replaced with 5 ml of pre-
warmed (37 °C) cysteine-activated papain solution (3.2 mg l-cysteine (Sigma-Aldrich, Saint 
Louis, MO, USA) with 500 μl papain (Sigma-Aldrich, Saint Louis, MO, USA) in 10 ml DM, pH 
∼7.2). The tissue was then incubated in activated papain solution for 15 min at 37 °C to allow for 




inactivation was achieved via two washes in ice-cold DM containing 12.5% v/v fetal bovine 
serum, followed by two washes in DM alone. Dissociated cells were then washed 2× in chilled 
normal growth medium [NGM; Neurobasal A (Gibco, Grand Island, NY, USA) supplemented 
with 2% v/v B27 (Invitrogen, Carlsbad, CA, USA) and 1% v/v Glutamax (Invitrogen, Carlsbad, 
CA, USA)], then titurated ∼10–15 times in 5 ml NGM to obtain a single cell suspension. This 
single cell suspension was incubated on ice for ∼3–5 min. 4.5 ml of the cell suspension was then 
transferred to a new 15 ml tube and centrifuged at 67×g (0.5×1000 rcf) at 4 °C. For plating, 50–
70 K cells (in a volume of 150 μl) were dispensed onto poly-d-lysine-coated glass-bottom petri 
dishes (Mattek, Ashland, MA, USA) and maintained at 5% CO2/37 °C. Roughly 4 h after 
plating, cells were supplied with 2 ml of NGM-GC (NGM supplemented with 15% v/v glial 
conditioned media and 10% v/v cortical conditioned media). 24Hr after plating, cells were fed by 
replacing 50% of the total volume with fresh NGM-GC and every 4 days thereafter by replacing 
25% of the total volume with fresh media. Cells were maintained for 14 days with NGM-GC 
supplementation, then fed every 4 days thereafter with NGM alone. All neurons used for 
experiments were allowed to mature to an age of ≥21 DIV, unless otherwise noted. 
 Chemical LTP protocol: Pharmacological induction of LTP in cultured hippocampal 
neurons was achieved using one of two stimulus solutions, designated cLTP1 or cLTP2. cLTP1 
stimulus consisted of the following: 0.2mM Glycine, 0.02mM Bicuculline, and 0.003mM 
Strychnine in a Mg2+-free extracellular solution. The cLTP2 stimulus also used Mg2+-free 
extracellular solution as a base but contained 50M Forskolin and 0.1M Rolipram. Both means 
of cLTP induction followed a similar protocol: Dissociated cultures (DIV 21 or older) were 
removed from the incubator and place on bench top for 10 min to acclimate to room temperature. 




solution. Neurons were incubated in cLTP solution for 10 min at room temp. After 10 min, cLTP 
solution was removed and cells were washed 2x with neuronal media. Dishes were then allowed 
to recover at 37
o
C for 2 Hr before use in subsequent electrophysiology or imaging experiments. 
 Electrophysiology: Whole-cell patch-clamp recordings were made with an Axopatch 
200B amplifier from cultured hippocampal neurons bathed in HEPES-buffered saline (HBS) 
containing (in mM) the following: 119 NaCl, 5 KCl, 2 CaCl2, 2 MgCl2, 30 Glucose, 10 HEPES, 
pH 7.4. Whole-cell pipette had resistances ranging from 3 to 6 MΩ. Internal solution contained 
(in mM) the following: 100 cesium gluconate, 0.2 EGTA, 5 MgCl2, 2 adenosine triphosphate, 0.3 
guanosine triphosphate, 40 HEPES, pH 7.2. mEPSCs were recorded at −70 mV from neurons 
with a pyramidal-like morphology in the presence of 1 μM TTX and 10 μM bicuculline and 
analyzed off-line using Synaptosoft minianalysis software. sEPSCs in active networks were 
recorded at −70 mV in modified HBS (as above, except with 0.5 mM CaCl2 and 3.5 mM MgCl2) 
without TTX or bicuculline. mIPSCs were recorded at -70mV in the presence of 1M TTX, 
10M CNQX and 50 μM DL-APV. Internal solution contained (in mM) the following: 135 
CsCl, 1 EGTA, 10 HEPES, 5 MgCl2, 4 Mg-ATP, and 1 Li-GTP, pH 7.2. During loose-patch 
recordings, neurons were bathed in HBS lacking pharmacological inhibitors to permit recording 
of background spike activity. Pipette solution contained extracellular solution. 
 For current clamp recordings, changes in intrinsic excitability were assessed in neurons 
subject to pharmacological isolation via 10M CNQX, 50 μM DL-APV, and 10 μM bicuculline. 
Internal solution contained (in mM) the following: 120 K-MeSO4, 20 KCl, 0.2 EGTA, 10 
HEPES, 2 MgCl2, 4 Mg-ATP, 0.3 Na-GTP, and 7 phosphocreatine, pH 7.2.  A series of 500 ms 
current injections were used to depolarize the soma from resting membrane potential in step-wise 




resting membrane potential above -55 mV were not included in further analysis. Membrane 
hyperpolarization in response to a -25 pA current step was used to measure input resistance. 
Action potential properties and spike frequency data were analyzed using Clampfit 10.0 
(Molecular Devices).  Statistical differences between experimental conditions were determined 
by ANOVA followed by Fisher's LSD post hoc tests 
 Total excitatory synaptic input onto recorded neurons was assessed by computing charge 
transfer >30 randomly selected 1 s intervals for each recording. NMDAR EPSCS were recorded 
in HBS with 0 MgCl2 and were evoked with a bipolar stimulating electrode positioned close to 
the recorded neuron. Once a stable response was obtained to stimuli delivered at 0.33 Hz, 
MK801 (20 μM) was applied to the bath for 5 min without stimulation. Following wash in, 200 
stimulations were delivered in the presence of MK801. The peak of the NMDAR current was 
measured for each and normalized to the first response. Group comparisons are presented as the 
normalized mean peak NMDAR current as a function of number of stimulations in the presence 
of MK801. Statistical differences between experimental conditions were determined by ANOVA 
and post hoc Fisher's least significant difference (LSD) test, unless otherwise indicated. 
 Ca2
+
 phosphate transfection: To achieve sparse expression, neurons were transfected 
with 0.5 μg of total DNA using the Ca2
+
 phosphate CalPhos Transfection kit (ClonTech) 
according to the manufacturer's protocol. Unless otherwise indicated, all experiments were 
performed 24 h post-transfection. 
 DNA Constructs: Plasmids encoding TSC1, TSC2, RhebWT, and RhebQ64L were used 
as previously described (Inoki et al., 2002, 2003). vglut-pHluorin was provided by Robert 
Edwards (UCSF). Human HA-PLD1, human HA-PLD2, rat HA-PLD2, and pEGFP-




PABD was provided by Dr. Frank Schmitz (Universität des Saarlandes Medizinische Fakultät). 
Rapamycin-resistant (S2035T) and Rapamycin/Phosphatic acid resistant (32035T/R2109A) 
mTOR point mutants were provided by Dr. Jie Chen (University of Illinois at Urbana-
Champaign). FLAG-Rpt3, HA-Rpt6, GFP-Rpt6, HA-Rpt6 S120A, HA-Rpt6 S120D, PAGFP-
Rpt6 WT, PAGFP-Rpt6 S120A, and PAGFP-Rpt6 S120D were all prpvided by Dr. Gentry 
Patrick (USCD). 
 Hippocampal slice electrophysiology: Transverse hippocampal slices (400 m) were 
prepared with a Stoelting tissue chopper from P18-24 Sprague Dawley rats, and allowed to 
recover at room temperature in a humidified interface chamber saturated with 95% O2 5% CO2 
for at least 2 hours prior to experiments. Slices were then transferred to a separate submersion 
chamber containing the appropriate treatment dissolved in 80ml artificial cerebrospinal fluid 
(aCSF) containing, in mM: 120NaCl, 2.5 KCl, 2.5 CaCl2, 1.3 MgCl2, 26.2 NaHCO3, 1 NaH2PO4, 
11 glucose, pH 7.4 saturated with 95% O2 5% CO2. For recording, slices were transferred to a 
submerged recording chamber and continuously perfused at a rate of ~ 3 ml/min with aCSF 
saturated with 95% O2 5% CO2. Recordings were made at 28-29ºC, with bath temperature 
maintained using an in-line temperature controller (Warner Instruments). Extracellular field 
potentials were recorded with glass micropipettes filled with 3 M NaCl (filled either with 3 M 
NaCl) placed in the middle of stratum radiatum of area CA1. Pairs of cathodal stimuli (0.1 ms 
pulse width) were delivered to the commissural/Schaffer collateral afferents by bipolar stainless 
steel electrodes (FHC, Brunswick, ME) at intervals of 50, 100, 200, 300, and 1000 ms, with 
stimulus intensity set to evoke fEPSPs 50% of their maximal amplitude. 
 Immunocytochemisty and microscopy: Except for experiments involving vglut-




microscope using a Plan-Apochromat 63×/1.4 oil objective with 1× or 2× digital zoom. Alexa 
488 was excited with the 488 nm line of an argon ion laser and emitted light was typically 
collected between 500 and 530 nm with a tunable emission filter. Alexa 555/568 were excited 
with a 559 nm diode laser and emitted light was typically collected between 570 and 670 nm. 
Before image collection, the acquisition parameters for each channel were optimized to ensure a 
dynamic signal range and to ensure no signal bleed-through between detection channels. For 
every experiment, identical parameters were used for each treatment option. We verified that no 
detectable staining was observed in control samples incubated in the absence of primary 
antibody (but otherwise processed identically). 
 For BDNF and phospho-S6 (PS6) staining, cells were treated in conditioned media as 
indicated, then fixed at room temperature for 20 min with 4% paraformaldehyde (PFA)/4% 
sucrose in PBS with 1 mM MgCl2 and 0.1 mM CaCl2 (PBS-MC). After washing in PBS-MC (5 
min), cells were permeabilized (0.1% Triton X in PBS-MC, 5 min), blocked with 2% bovine 
serum albumin in PBS-MC for 30 min, and labeled with a rabbit polyclonal antibody against 
BDNF (Santa Cruz Biotechnology, 1:100), or a rabbit polyclonal S235/236 phosphospecific 
antibody (Cell Signaling Technology; 1:50); for each, colabeling and a mouse monoclonal 
antibody against MAP2 (Sigma-Aldrich, 1:5000) for either 60 min at room temperature or 
overnight at 4°C. Alexa 555-conjugated goat anti-rabbit (1:500) and Alexa 635-conjugated goat 
anti-mouse (1:500) secondary antibodies (each 60 min at room temperature) were used to 
visualize BDNF/PS6 and MAP2 staining, respectively. To ensure blind sampling of BDNF/PS6 
expression, neurons with a pyramidal-like morphology were selected for imaging by 
epifluorescent visualization of MAP2 staining. Analysis of expression in somatic or dendritic 




Dendrites were linearized and extracted from the full-frame image using the straighten plug-in 
for ImageJ. For both somatic and dendritic signal, expression was estimated by the average 
nonzero pixel intensity for each compartment. To analyze dendritic BDNF expression, dendrites 
were linearized and extracted from the full-frame image using the straighten plug-in for ImageJ. 
To combine data across multiple experimental runs of the same experiment, expression in each 
image was normalized against the average nonzero pixel intensity for the respective control 
group. In experiments where BDNF or PS6 were assessed in transfected cells, neurons were also 
colabeled with a chicken polyclonal antibody against GFP (Millipore, 1:1000) and an Alexa 488-
conjugated goat anti-chicken secondary antibody. Statistical differences were assessed by 
ANOVA, followed by Fisher's LSD post hoc tests. 
 To assess presynaptic UPS levels in neurons subject to pharmacological activity 
manipulations, neurons were transfected with mCh-Syn as well as FLAG-Rpt3, FLAG-Rpt1, 
HA-Rpt6 WT, HA-Rpt6 S120A, HA-Rpt6 S120D. 48Hrs post transfection, neurons were fixed 
and permeabilized as described previously, then blocked in 2% BSA prior to staining with a 
mouse monoclonal primary antibody against HA (1:500 in 2% BASA, 1Hr at RT, Cell Signaling, 
Danvers MA) or a rabbit polyclonal primary antibody against FLAG (1:500 in 2% BSA, 1Hr at 
RT, Sigma). Following incubation in primary antibody, neurons were washed 3x with RT PBS-
MC and incubated with a goat anti mouse or goat anti rabbit Alexa 488 secondary antibody 
(1:500 in 2% BSA, 1Hr at RT, Molecular Probes, Eugene, OR). Neurons were imaged on an 
inverted confocal microscope (Olypus FV1000) using a Plan-Apochromat 63x/1.4 oil objective 
with 2x digital zoom, as described earlier. Regions of interest were selected based on 
epifluorescent visualization of mCH-Syn expression to ensure blind sampling of HA or FLAG 




intensity z-compressed image stacks. Axons were linearized and extracted from the full-frame 
image using the „straighten‟ plug-in for ImageJ. For analysis, the integrated intensity of HA or 
FLAG fluorescence that co-localized with regions of high mCH-Syn expression was quantified 
using custom written analysis routines. To control for differences in reporter expression across 
cells, levels of HA or FLAG intensity in somatic regions were used to normalize presynaptic 
HA/FLAG levels within each neuron. A similar approach was used to quantify changes in 
presynaptic GFP fluorescence intensity under conditions of GFP-Rpt6 WT, GFP-Rpt6 S120A, or 
GFP-Rpt6 S120D expression. 
 For analysis of surface GluA1 expression, neurons were live-labeled with a rabbit 
polyclonal antibody recognizing a surface epitope of GluA1 (10 μg/ml, EMD Biosciences) for 15 
min at 37°C, followed by fixation (2% PFA in PBS-MC for 15 min at room temperature), and 
immunocytochemical labeling with a mouse monoclonal anti-PSD95 antibody (1:1000, Millipore 
Bioscience Research Reagents) as described above. Alexa 488-conjugated goat anti-mouse 
(1:500) and Alexa 555-conjugated goat anti-rabbit (1:500) secondary antibodies (each 60 min at 
room temperature) were used to visualize PSD95 and GluA1 staining, respectively. Neurons 
were selected based on PSD95 epiflourescence to ensure blind sampling of surface GluA1. For 
analysis, “synaptic” GluR1 was defined as a particle that occupied >10% of the area defined by a 
PSD95 particle, and the average integrated intensity (total number of nonzero pixels times 
intensity) of synaptic GluR1 particles was calculated using custom written analysis routines for 
ImageJ. Analysis was performed on both full-frame images as well on dendrites straightened and 
extracted from the full-frame image, where “n” equals the number of images or number of 
dendrites, respectively. Both analysis methods yielded similar results. Statistical differences were 




 Optical analysis of presynaptic function used live-labeling with an Oyster 550-conjugated 
rabbit polyclonal antibody against the lumenal domain of synaptotagmin 1 (syt-lum; 1:100, 
Synaptic Systems). Before labeling, neurons were treated with 2 μM TTX for 15 min to isolate 
spontaneous neurotransmitter release. Neurons were then labeled with anti-syt-lum for 5 min at 
room temperature, washed, fixed with 4% PFA/4% sucrose in PBS-MC, permeabilized, and 
blocked as above, then labeled with a guinea pig polyclonal anti-vglut1 antibody (1: 2500, 
Millipore Bioscience Research Reagents). The intrinsic fluorescent signal of the anti-syt-lum at 
synaptic sites was amplified by an Alexa 555-conjugated goat anti-rabbit (1:500) secondary 
antibody. An Alexa 488-conjugated goat anti-guinea pig (1:250) secondary antibody (each for 60 
min at room temperature) was used to visualize vglut1 staining. Neurons were selected based on 
vglut1 epiflourescence to ensure blind sampling of syt-lum expression. For analysis, a “synaptic” 
syt-lum particle was defined as a particle that occupied >10% of the area defined by a vglut1 
particle, and the proportion of vglut1 particles containing synaptic syt-lum particles was 
calculated using custom written analysis routines for ImageJ. Statistical differences were 
assessed by ANOVA, followed by Fisher's LSD post hoc tests. 
 Local perfusion: All local perfusion experiments were performed on an inverted 
Olympus FV1000 laser-scanning confocal microscope using Plan-Apochromat 40×/0.95 air (for 
live imaging) and Plan-Apochromat 40×/1.0 oil (for retrospective imaging) objectives. Stable 
microperfusion was achieved by use of a dual micropipette delivery system, as described 
previously (Sutton et al., 2006). The delivery micropipette was pulled as a typical whole-cell 
recording pipette with an aperture of ∼0.5 μm. The area of dendrite targeted for local perfusion 
was controlled by a suction pipette, which was used to draw the treatment solution across one or 




(Alexa 488, 1 μg/ml) was included in the perfusate to visualize the affected area. In all local 
perfusion experiments, the bath was maintained at 37°C and continuously perfused at 1.5 ml/min 
with HBS. 
 For analysis, the size of the treated area was determined in each linearized dendrite based 
on Alexa 488 fluorescence integrated across all images taken during local perfusion. Adjacent 
nonoverlapping dendritic segments, 25 μm in length, proximal (i.e., toward the cell soma) and 
distal to the treated area were assigned negative and positive values, respectively. To examine 
localized changes in syt-lum uptake, 2 μM TTX was bath applied for 10 min to isolate 
spontaneous neurotransmitter release immediately following local perfusion. Neurons were then 
live-labeled with syt-lum for 5 min at room temperature, and processed for 
immunocytochemistry as described above. To assess relative changes in syt-lum and vglut1 
staining in perfused dendrites, the average nonzero pixel intensity was calculated for each 
dendritic segment. The average value in untreated segments was assigned a value of 1, which 
was then used to normalize vlgut and syt-lum intensity in all segments (including the treated 
area). Statistical differences in these measurements between syt and vglut at each segment were 
assessed by Student's t test. 
 Magnetofection-based siRNA delivery: BDNF siRNA or non-targeting control siRNA 
were purchased from Dharmacon (siGENOME SMARTpool, M-080046, Thermo Fisher 
Scientific., Lafayette, CO.). To favor rapid translational knockdown, a combination of four 
BDNF-targeting siRNAs were pooled: (1): Sense = 5'-UCGAAGAGCUGCUGGAUGAUU-3', 
Antisense = 5'-UCAUCCAGCAGCUCUUCGAUU-3'; (2): Sense = 
5'UAUGUACACUGACCAUUAAUU-3', Antisense: 5'-UUAAUGGUCAGUGUACAUAUU-3'; 




AAUACUGUCACACACGCUCUU-3'; (4): Sense: 5'-GAACUACCCAAUCGUAUGUUU-3', 
Antisense: 5'- ACAUACGAUUGGGUAGUUCUU-3'; Control siRNA: Sense: 5'-
UAAGGCUAUGAAGAGAUACUU-3'; Antisense: 5'-GUAUCUCUUCAUAGCCUUAUU-3'. 
Each annealed double-stranded RNA oligonucleotide contained 3'-UU overhangs, a single 
isomer 6-FAM on the 5'- end of the sense strand, and a 5'-phosphate on the antisense strand. For 
rapid siRNA transfection, siRNA (67.5 μg in 100 μl media) was combined with 3.5 μl neuromag 
transfection reagent (Oz Biosciences, France). After a 20 minute incubation period, cultured 
neurons were bathed in the Neuromag/siRNA mix, and then placed on the manufacturer supplied 
magnet for 15 min at 37°C. After magnetofection, cells were immediately treated with PA or 
vehicle, and used in experiments as described.  
 Preparation of PA vesicles: The lipid second messenger phosphatidic acid (PA) was 
acquired from Avanti Polar Lipids (Alabaster, Alabama), and was prepared according to 
previously described methods (Yoon et al., 2011). PA lipids in chloroform were dried under a 
stream of nitrogen gas in a 20ml glass scintillation vial. Dried lipids were reconstituted in a 
buffer of 150 mM NaCl and 10 mM Tris-Cl (pH8.0), to a concentration of 6mM.  The solution 
was briefly vortexed, then subjected to bath sonication for a period of 5min, resulting in a 
homogenous solution of unilaminar vesicles (15-50nm in diameter). PA vesicles were added 
directly to cell media to produce a concentration of 100M. Lipid vesicles were made fresh at 
the start of each experiment. 
 vglut1-pHluorin imaging: Cultured hippocampal neurons were transfected at DIV 14–
16 with vglut-pHluorin as well as mCherry-synaptophysin to aid in visual identification of 
terminal boutons. Experiments were conducted 2–3 d post-transfection in HBS containing 10 μM 




custom fabricated electric field stimulator, which was inserted into each dish just before start of 
an experiment. Each stimulus consisted of a 2 ms 10 V potential difference between platinum-
iridium wires 6 mm apart. To observe changes in evoked release, we recorded the change in 
vglut-pHluorin fluorescence intensity elicited by delivering stimulus repetitions at 10 Hz for 10 
s, which has been shown to provide a measure of exocytosis undiluted by signal degradation due 
to endocytosis or reacidification (Kim and Ryan, 2009). Each stimulus train was delivered three 
times for each set of synapses, with a 5 min interval separating each train. Images were taken 
using a Hammamatsu EM-CCD camera mounted on an inverted microscope (Olympus IX8) 
using a 40× 1.3 NA oil-immersion objective (Olympus). The filter set consisted of a 472/30 
excitation filter, a 495 edge dichroic mirror, and a 520/30 emission filter. Illumination was 
achieved via a Sutter Lambda LS/OR30 300 W xenon bulb control by a Sutter Lambda 10 
shutter (Sutter Instrument). All images were captured at a depth of 16 bits to a Dell Optiplex 
computer using MetaMorph software (Molecular Devices). Full frame (512 × 512, 16 μm pixels) 
imaging sequences were acquired at a rate of 5 Hz using 50 ms exposure for vglut-pHluorin. 
Image sequences were analyzed using the “time series” plug-in for ImageJ 
(http://rsb.info.nih.gov/ij/plugins/time-series.html). Active synapses were identified for each 
experiment by subtracting the signal before the initiation of each stimulus train from the peak 
increase in vglut-pHluorin signal elicited by the train. Rectangular ROIs (1.55 × 1.55 μm) were 
placed over each of the resulting puncta in the “difference image.” The time-lapse plug-in was 
then used to measure average fluorescence for each ROI over time. To correct for 
photobleaching during image series acquisition, an identically sized ROI was positioned in a 
nonsynaptic region adjacent to an identified release site. Measurements obtained from this 




subtracted from the data traces associated with active release sites. Automated image analysis 
and photobleaching correction was performed in MATLB (see Appendix 2). Fluorescence 
signals were quantified as ΔF/F0, where F0 is defined as the average of five sequential images 
recorded before the onset of stimulation for each ROI. 
 Western blotting: Samples were collected in lysis buffer containing 100 mM NaCl, 10 
mM NaPO4, 10 mM Na4P2O7, 10 mM lysine, 5 mM EDTA, 5 mM EGTA, 50 mM NaF, 1 mM 
NaVO3, 1% Triton-X, 0.1% SDS, and 1 tablet Complete Mini protease inhibitor mixture 
(Roche)/7 ml, pH 7.4. Equal amounts of protein for each sample were loaded and separated on 
12% polyacrylamide gels, then transferred to PVDF membranes. Blots were blocked with Tris-
buffered saline containing 0.1% Triton-X (TBST) and 5% nonfat milk for 60 min at room 
temperature, and incubated with a rabbit polyclonal primary antibody against BDNF (Santa Cruz 
Biotechnology, 1: 200) for either 60 min at room temperature or overnight at 4°C. After washing 
with TBST, blots were incubated with HRP-conjugated anti-rabbit or anti-mouse secondary 
antibody (1:5000; Jackson Immunoresearch), followed by enhanced chemiluminescent detection 
(GE Healthcare). All blots were probed with a mouse monoclonal antibody against α-tubulin 
(1:5000, Sigma-Aldrich) to confirm equal loading. Band intensity was quantified with 
densitometry with NIH ImageJ and expressed relative to the matched control sample. Statistical 
differences between treatment conditions and control were assessed first by an overall 
nonparametric ANOVA (Kruskal–Wallis test) followed by a post hoc Wilcoxon signed rank test 













A Fragile Balance at Synapses: New Evidence Supporting a Role for FMRP in 
Homeostatic Plasticity 
 
 Homeostatic synaptic scaling operates in tandem with forms of neuronal plasticity such 
as long-term potentiation and long-term depression to maintain neural circuit activity within a 
stable range. Experimentally, homeostatic adaptations at synapses are usually induced by 
prolonged spike blockade [with tetrodotoxin (TTX)], yielding a form of synaptic scaling thought 
to involve cell-wide, transcription-dependent changes that affect every synapse on a given 
neuron (Turrigiano, 2008). However, more recent evidence has also identified locally mediated 
adaptive mechanisms that allow spatially discrete synaptic compensation within a neuron's 
highly compartmentalized dendritic arbor (Sutton et al., 2006; Rabinowitch and Segev, 2008). 
Early work in this area demonstrated that concurrent action potential and NMDA receptor 
(NMDAR) blockade (TTX + the NMDAR antagonist APV) promotes dendritic translation of 
GluA1 AMPAR subunits, leading to localized enhancement of synaptic strength (Sutton et al., 
2006). Other work demonstrated that TTX and APV treatment drives intracellular synthesis of 
retinoic acid (RA), which reduces the association of the RNA-binding protein RARα with select 




 Another RNA-binding protein that regulates dendritic translation is the fragile X mental 
retardation protein (FMRP) (Zalfa et al., 2003; Muddashetty et al., 2007). As evidenced by the 
devastating symptoms in fragile X syndrome (FXS), mutations in the Fmr1 gene result in severe 
disruptions in cognitive and social abilities, suggesting a pivotal role for FMRP in basic learning 
and memory processes (Bassell and Warren, 2008). In a recent article published in The Journal 
of Neuroscience, Soden and Chen (2010) demonstrate that FMRP is directly involved in 
homeostatic plasticity, and provide evidence to support it acting within dendrites to regulate the 
translation of specific mRNAs in response to increases in RA signaling. 
 To investigate a potential role for FMRP in local synaptic scaling, Soden and Chen first 
examined the effects of prolonged action potential and NMDAR blockade (36 h TTX + APV) in 
organotypic hippocampal slices prepared from wild-type (WT) or Fmr1 knock-out (KO) mice. 
Whereas CA1 pyramidal neurons exhibited enhanced mEPSC amplitude following TTX+APV 
treatment, no such scaling response was evident in CA1 neurons from Fmr1 KO mice (their Fig. 
1). Because this group had previously shown a role for RA in homeostatic scaling induced by 
TTX+APV treatment (Aoto et al., 2008), the authors next examined whether FMRP was required 
upstream or downstream of activity-dependent RA synthesis. Using a fluorescent reporter in 
which three tandem retinoic acid response elements (RAREs) control GFP transcription, the 
authors found that cultured WT and Fmr1 KO hippocampal neurons displayed equivalent levels 
of RARE-GFP reporter expression after TTX+APV treatment (their Fig. 2). However, the 
protein synthesis-dependent increase in mEPSC amplitude induced by direct RA treatment (4 h) 
was lost in Fmr1 KO neurons. In addition, Soden and Chen found that RA application induced a 
translation-dependent increase in the levels of GluA1, GluA2, and eEF2 in synaptoneurosomes 




specific proteins were immunoprecipitated following metabolic labeling with radiolabeled amino 
acids, the increase in GluA1 synthesis driven by RA treatment was also lost in Fmr1 KO 
neurons. Together, these results suggest that FMRP plays a role downstream of RA in dendritic 
protein synthesis, where it is required for the translation of specific mRNAs in response to RA 
signaling. 
 Although Soden and Chen (2010) demonstrated a critical role for FMRP in homeostatic 
plasticity dependent on RA synthesis, interestingly, they found that neither FMRP nor RA was 
required for homeostatic enhancement of synaptic strength induced by TTX alone [Soden and 
Chen (2010), their Fig. 4]. In WT and Fmr1 KO neurons, 60 h of TTX treatment induced a 
similar increase in mEPSC amplitude, and in each case the enhanced mEPSCs were resistant to 
inhibition with the polyamine philanthotoxin, which targets GluA2-lacking AMPARs. In 
contrast, scaled mEPSCs following TTX+ APV treatment are specifically reversed by polyamine 
toxins [Sutton et al. (2006); Aoto et al. (2008); Soden and Chen (2010), their Fig. 2]. These 
observations underscore the notion that multiple forms of homeostatic plasticity exist in 
hippocampal neurons, and suggest that FMRP plays a specific role in synaptic adaptations that 
require local translation near synaptic sites. 
 Rescue experiments using viral expression of FMRP in organotypic hippocampal slices 
from Fmr1 KO mice indicated that proper RA-induced scaling in CA1 neurons can be restored 
by returning FMRP to appropriate levels (their Fig. 7). That acute restoration of FMRP 
expression can restore RA-induced scaling argues against the possibility that defects in synapse 
development or maturation in Fmr1 KO neurons accounts for the absence of homeostatic control, 
and supports a specific requirement for FMRP in RA-induced scaling. To elucidate FMRP's 




mutants in additional rescue experiments. One mutant, FMRPΔRGG, lacked the RGG box 
necessary for binding to G-quartet structures on select target mRNAs. The other mutant, 
FMRP(I304N), carried a point mutation in a crucial KH domain necessary for binding to 
mRNAs with a “kissing complex” motif. Neither of these mutants had an effect on AMPAR 
levels or basal synaptic transmission when expressed in WT neurons (their supplemental Fig. 5). 
Likewise, expression of FMRPΔRGG-GFP in slices from Fmr1 KO mice had no effect on 
baseline mEPSC amplitude (their Fig. 7) or GluA1 levels as assessed via Western blotting (their 
Fig. 8). In contrast, expression of FMRP(I304N)-GFP decreased basal mESPC amplitude and 
reduced GluA1 protein levels in Fmr1 KO cells (their Fig. 7, Fig. 8). Given previous work 
showing an interaction between FMRP and GluA1 mRNA in synaptoneurosomes (Muddashetty 
et al., 2007), these results raise the possibility that FMRP may normally associate with and 
suppress the translation of GluA1 mRNA via its RGG box and not its KH domain, though Soden 
and Chen did not directly examine the mRNA binding properties of either mutant. Importantly, 
neither mutant rescued scaling induced by RA or TTX+APV treatment, indicating that recovery 
of FMRP's ability to suppress GluA1 synthesis may not be sufficient to restore its role in RA-
induced dendritic translation. 
 The differential effect of the FMRP mutants on baseline mEPSC amplitude and GluA1 
levels suggests that their inability to rescue synaptic scaling results from distinct impairments. 
The inability of FMRPΔRGG to rescue synaptic scaling in Fmr1 KO cells may stem from the 
possibility that the RGG box is necessary for FMRP's interaction with GluA1 mRNA. If this is 
the case, why then is expression of the FMRP(I304N) mutant, which contains an intact RGG box 
and clearly exerts a suppressive effect on GluA1 expression, not successful in restoring RA-




associate with translating polyribosomes, as well as with its autosomal paralog FXR2P (Feng et 
al., 1997). It may be that mRNP particles containing FMRP must be associated with actively 
translating ribosomes for RA-induced translational regulation to occur, so disrupting this 
interaction renders FMRP(I304N) unable to rescue the scaling effect in Fmr1 KO cells. On the 
other hand, given recent data suggesting that FMRP and FXR2P play unique roles during the 
expression of mGluR-LTD (Zhang et al., 2009), it is possible that FXR2P may also serve an 
important function during RA-induced synaptic scaling, and that this function requires its 
interaction with FMRP. Future experiments should clarify the precise aspect of FMRP function 
that is necessary for homeostatic plasticity. 
 In the experiments detailed above, Soden and Chen have provided compelling evidence 
that FMRP plays an important role in RA-induced synaptic scaling. However, one remaining 
unanswered issue concerns the mechanism by which FMRP regulates the effects of RA on 
dendritic protein synthesis. In coimmunoprecipitation studies, Soden and Chen found no 
evidence for a direct physical interaction between FMRP and RARα (their Fig. 6), yet FMRP 
was clearly required for increased translation signaled through RARα. The authors suggest that 
FMRP and RARα need to be bound to the same mRNAs for RA-induced translational changes to 
occur. Indeed, two of the RARα targets highlighted in this study, GluA1 and GluA2 mRNA, are 
also known targets of FMRP (Muddashetty et al., 2007), suggesting that combinatorial action of 
these two RNA-binding proteins might be responsible for mediating the specific alterations in 
translational efficiency necessary for local homeostatic plasticity. While this idea is attractive, it 
is also possible that FMRP is necessary for the appropriate targeting of GluA1 mRNA to specific 
RA-response sites near synapses. Another possibility is that FMRP, through an allosteric 




necessary for translational disinhibition of specific mRNAs. In the Chen laboratory's initial series 
of studies of RA-induced synaptic scaling, they found that treatment with the RARα-specific 
agonist AM580 was sufficient to stimulate local synthesis of GluA1 and cause an enhancement 
of mEPSC amplitude (Aoto et al., 2008). Although the authors clearly demonstrate that scaling 
induced by direct RA application is lost in FMR1 KO neurons, it would be informative to know 
whether this same effect is observed following RARα activation with AM580. 
 Although a number of important questions remain, Soden and Chen's work clearly 
establishes a role for FMRP in homeostatic control of excitatory synapse function and serves to 
further our understanding of the synaptic etiology of FXS. To this point, the abnormal mGluR-
LTD observed in FMR1 KO mice has received considerable attention as a potential link to the 
cognitive dysfunction associated with this disorder. These new results raise the intriguing 
possibility that dysfunctional homeostatic regulation, perhaps in concert with defects in mGluR-
dependent signaling in neurons, plays an important role in the devastating symptoms of FXS. 
The extent to which altered homeostatic plasticity contributes to the pathogenesis of FXS and 
other such disorders is an important area of future study. 
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 Deep insights into the functional consequences of perturbing particular components of 
the presynaptic molecular machinery have been difficult to acquire. Over the past decade, 
exciting advances using newly developed optical tools to read out presynaptic function have 
allowed large scale investigation of multiple aspects of presynaptic function in the context of 
intact cellular circuitry. The resulting data from these types of experiments can be extremely 
large and is well suited to automated analysis.  Here, the matlab programming environment was 
utilized for the purposed of large-scale, fast, and accurate analysis of data acquired from live-
imaging investigations of presynaptic function using pH-sensitive variants of GFP. 
 
A2.2 Introduction 
 The synapse, defined as the unique site of cellular contact and communication between 
neuronal cells, is the fundamental element of the nervous system (Shepherd and Erulkar, 1997). 




processing network of the mature brain is thought to number in the trillions (Pakkenberg et al., 
2003). The synapse is comprised of a pre and a post synaptic compartment, each containing a 
unique set of molecular machinery suited to its particular role in synaptic communication (Chua 
et al, 2010). The presynaptic compartment is generally suited to converting the electrical signal 
of an action potential into a chemical signal via the release of chemical neurotransmitters such as 
glutamate, while the postsynaptic compartment has evolved to reconvert the chemical message 
back into an electrical signal via activation of ligand-gated ion channels embedded in the 
postsynaptic membrane.  This is a highly simplified view of chemical neurotransmission, 
focusing on a single aspect of excitatory signalling in the central nervous system, but will serve 
well for the purposes of this text, as glutamatergic signalling at excitatory synapses in the 
mammalian central nervous system is the topic of study in the experiments described herein.  
While the molecular mechanisms of postsynaptic signalling and plasticity have received much 
attention over the past several decades, delving into the physiology of the presynaptic terminal is 
much more difficult owing to the small size of the sites of vesicular release. Presynaptic 
machinery is extraordinarily complex, though biochemical and genetic approaches have yielded 
great insight into much of the molecular components at work (Jahn and Fasshauer 2012). Deep 
insights into the functional consequences of perturbing particular components of the presynaptic 
molecular machinery have been harder to acquire, however. Historically, efforts to understand 
the functional aspects of  the presynaptic release machinery have been guided largely through the 
use of electrophysiological experiments, which can relay a great deal of information regarding 
the function of a large number of synapses (Katz, 1971). Over the past decade, however, exciting 
advances using newly developed optical tools to readout presynaptic function have allowed large 




circuitry (Dreosti and Lagnado, 2011). These experimental advances allow unprecedented 
analysis of vesicle release properties on a synapse by synapse basis, but the resulting data set 
from live-imaging experiments is so large as to be unwieldy using conventional manual analysis 
strategies.  Thus, the goal of this project was to utilize the matlab programming environment to 
automate and systematize analysis of live imaging data for experiments investigating various 
functional aspects of presynaptic release. It is essential to gain a better understanding of the 
mechanisms involved in presynaptic vesicle release, as many neurological and psychiatric 
disorders have a presynaptic locus (Waites and Garner, 2011).  
 
A2.3 Results 
 The overall workflow of data analysis for vglut1-pHluorin live imaging experiments is 
shown in Figure 1. After determining sites of active presynaptic release, labeling and saving 
these regions of interest (ROIs), and obtaining fluorescence intensity measurements at each time 
point for each synapse in a given run, the data stored in an excel file for subsequent automated 
processing in Matlab.  It appears possible to port some aspects of these initial steps into a setup 
acting via matlab (see discussion), but for ease of immediate use with current data sets these 
initial processing steps were performed outside the matlab environment.  After organizing the 
raw data in excel files in a centralized location, the task accomplished using matlab proceeds as 
such: 1) Import data from excel files into matlab and concatenate data across separate trails into a 
single variable for processing, 2) correct distortions that result from photobleaching that is 
unavoidable over the course of the imaging session, 3) normalize the resulting bleach-corrected 




fluorescence intensity achieved after stimulus and 4) graph up the resulting timecourse plots and 
any other relevant features able to be extracted from the data.  
 The first three of these tasks (collect, correct, normalize) have been accomplished using a 
combination of multiple custom-written functions aligned together in a single script entitled 
“phluorin_group_collect” (see Script 1 in supplemental material).  This script begins by using the 
xlsread function to import data from a specified folder denoted by a directory change command. 
The data in these files are assigned to variable names according to experimental group and order 
in which the data was collected (e.g. „Control1‟,‟bdnf3‟,etc.).  After data import, experimental 
trails are subject to photobleach correction.  Due to a combination of factors (the compound 
phenol-red in cell culture media, high levels of autofluorescence in the monolayer of astrocytes 
and glia on which the neurons are plated, etc.) there is an unavoidable level of photobleaching 
inherent in these live imaging experiments. An example of this phenomenon may be seen in 
Figure 2, wherein the same point on the image yields a significant reduction (~30%) in 
fluorescence measured in arbitrary units (a.u.) when comparing frames taken at the start and end 
of a 60s imaging session. The function „bleach_correct_func‟ was constructed to automate the 
task of photobleach correction (see Function 1 in supplemental material). This function receives 
as input a matrix of raw data pulled directly from the „timeseries‟ ImageJ plugin used in the 
initial analysis steps.  As the first 4 columns of the resulting matrix do not carry information 
regarding the synaptic ROIs image in that experiment, the bleach corrector function first creates 
a separate variable containing columns solely related to synaptic ROIs (termed „data_act‟).  All 
rows from this dataset are then averaged, and the resulting mean synaptic timecourse 
(„mean_data‟) is then plotted to provide the user an account of the raw data trace (Figure 3, top 




background photobleaching (taken as the fluorescence timecourse from a non-synaptic ROI 
placed in a background region of the imaging field) to construct a photobleach decay curve 
(Figure 3, middle panel, „bleach timecourse and curve fit‟).  The general strategy was to fit a 
polynomial function to the fluorescence decay timecourse provided by the non-synaptic ROI and 
then subtract these values from each point in the synaptic ROIs in the dataset.  The success of the 
strategy can be seen by comparing the top and bottom panels in Figure 3.  Note that in the top 
panel, the stimulus-induced increase in fluorescence is imposed on an overall downward slope in 
fluorescence levels. The bottom panel, in contrast, shows a stable baseline, characteristic 
stimulus-induced increase in fluorescence and stable return roughly to baseline levels by the end 
of the trial.  Occasionally the background ROI selected to provide information regarding the 
general photobleaching trend for a given trial will be contaminated by increases in fluorescence 
emanating from nearby synaptic regions. The resulting decay curve will contain a stimulus 
artifact which obstructs proper curve fitting (see top panel of Figure 4). To overcome this 
artifact, a linear interpolation was fit between the timecourse points immediately preceding and 
following the stimulus bout (occurring from 5 – 20 seconds in the trail). These interpolated 
points were then introduced in place of the artifactual points in the bleach decay curve. Note the 
difference in curve fit between the uncorrected (top panel) and artifact-corrected (bottom panel) 
bleach decay curves in Figure 4.  
 After correcting for photobleaching, experimental trails are subject to two forms of 
normalization: normalization to baseline levels of fluorescence, or normalization to peak levels 
of fluorescence.  Each of these normalization strategies serves a particular purpose.  Baseline 
normalization is useful for comparing differences in the peak intensity and rate of change in 




fluorescence change are generally thought to reflect changes in vesicular release probability, a 
fundamental aspect of presynaptic function subject to several multifaceted forms of plasticity. 
The function „base_norm_func is utilized as part of the phluorin_group_collect script, and 
subtracts the value of baseline fluorescence (established as the mean of the 10 frames directly 
proceeding onset of stimulus train) from each point in the time series. The results of a baseline 
normalized experimental trail can be seen in Figure 5, with DF/F0 in the y axis representing the 
change in fluorescence  levels at each time point compared to fluorescence levels at time 0. Once 
the data has been baseline normalized, relevant features are then extracted for additional analysis 
including average peak values for each experimental group, as well as average rate of exocytosis, 
defined as the slope of the line starting from stimulus onset to peak change in fluorescence levels 
(see Figure 6 for illustration of this analysis for two experimental groups). These features are 
extracted and plotted alongside the combined timecourse for each experimental group by using 
the function entitled „phluporin_graph_func‟. An example of the result of applying this function 
to a set of four experimental groups can be seen in Figure 7.  
 Parallel to baseline normalization, the resulting dataset from photobleach correction is 
also subject to peak normalization, wherein each trial is normalized such that the baseline levels 
of fluorescence is defined as 0 while peak levels of fluorescence is defined as 1 (see Function 3 
„peak_norm_func‟ in supplemental material). This is not particularly useful for comparing 
overall changes in exocytosis levels, but can potentially be used to provide information about 
changes in endocytosis, which is the process of vesicular reassembly and repositioning after a 
membrane fusion event.  Because the fluorescence signal of pHlouorin depends fundamentally 
on the slightly acidic environment of the intravesicular lumen, changes in fluorescence back to 




changes in the endocytotic machinery.  Tau values for endocytosis are generally accepted to be 
the point at which fluorescence levels retune to ~37% of peak levels. Proper comparison between 
groups, however, required normalizing each experimental condition to its own max fluorescence 
levels, which is achieved by the peak_norm_func. Figure 8 shows the same data set used for 
baseline normalization in Figure 5, now subject to peak normalization. After peak normalization, 
a double exponential decay curve is fit to the region following stimulus offset and continuing to 
the end of the imaging session.  Tauendo values are calculated for the mean peak normalized 
trace for each experimental condition and plotted. An example of this analysis strategy for 
determining tau values for endocytosis for on „control‟ trail can be seen in Figure 9. The 
comprehensive endocytosis plot created by the function entitled phluorin_endograph_func, 
containing mean peak normalized timecourses, extracted endocytosis subsections for the 
timecourse with labeled tau values, as well as tau values represented as text can be seen in Figure 
10.   
 
A2.4 Discussion 
 In a given experimental run for these types of live imaging experiments, the number of 
synapses imaged in a given trial may range from 25 to 150.  Thus by imaging at an acquisition 
frequency of 5Hz for a period of 60s, a single imaging session can yield a data set between 7,500 
and 45,000 unique data points. When all experiments of a group are concatenated into a single 
file, the size of the data set becomes even more intimidating. For example, the experimental 
“Control” group shown in Figure 7 contained timecourse data for 750 synapses, resulting in a 
dataset containing 225,000 points. The size and iterative nature of certain aspects of the analysis 




some degree of automation using Matlab, as has been demonstrated. Comparison between the 
automated analysis performed using the functions and script described in this text were 
remarkably similar to results from manual analysis performed on the same data set (manual 
analysis not shown), confirming the efficacy of the automation for use in future experiments. 
Differences between analysis performed using the automated process described here and manual 
analysis performed previously are potentially due to particular aspect of the photobleach 
correction process. The stimulus artifact correction shown in Figure 5 was not performed in the 
manual analysis, which limited the goodness-of-fit able to be applied to the bleach decay curve.  
Additionally, unlike the manual analysis performed previously, the bleach decay curve used in 
the automated analyses described here was fit with a 6th degree polynomial, which was 
empirically determined to yield optimal results. The most salient effect of these features is that 
the baseline period in the 5s prior to stimulus train onset is notably more flat and stable than it 
appears after manual analysis.   
 As it currently stands, some degree of manual processing appears unavoidable for these 
experiments.  For instance, though the act of determining active number of synapses proceeds 
very quickly using the „diffimage‟ plugin tool for ImageJ, actual selection of synaptic ROIs 
requires user input to define each region.  Some attempts have been made to automate this 
process using tools in the ImageJ suite, though none have been satisfactory.  Future use of matlab 
for imaging analysis in these experiments might be well suited to defining regions of high signal 
intensity compared to surrounding regions, which could in principle be used to define active 
synaptic puncta.  In addition, automatic statistical comparison between experimental groups is 
not currently a feature of the automation process described here. Future efforts will be made to 




here is extremely effective in automating data analysis for the set of experiments they were 
designed for (imaging at 5Hz, 60s experiment duration, 10s stimulus, stim train onset at 5s, etc), 
the code is not robust with respect to altering any of the experimental parameters.  In order to 
facilitate ease of use in other types of experiments (as well as by other members of the imaging 
community), future versions will ideally include user-defined input variables that will allow a 
greater range of experimental conditions to be processed and analysed.    
 
A2.5 Conclusion 
 In sum, optical readouts of presynaptic function such as the use of pH-sensitive variants 
of GFP used to vesicular proteins have promoted significant progress in our understanding of 
basic presynaptic function over the past decade.  Automation of the large datasets acquired from 
such experiments not only saves the experimenter valuable time, but provides more biologically 
accurate depictions of the data, particularly through the use of the enhanced photobleach 
correction features described above. Additional work is needed to make the automation 
described herein as user friendly as possible, but this initial work was completely successful in 
accomplishing the predetermined goal of largely automated analysis of synaptic data acquired 
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Figure A2.6: Illustration of process used to determine rate of exocytosis  
 
  




































































































Figure A2.10: Example of plot produced by the function ‘phluorin_endograph_func’. 
